Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Plaintiff:	Plexxikon Inc.
Defendant:	Novartis Pharmaceuticals Corporation
3Rd Party Defendant:	GlaxoSmithKline PLC and GlaxoSmithKline LLC
Case Number:	4:2017cv04405
Filed:	August 3, 2017
Court:	US District Court for the Northern District of California
Presiding Judge:	Haywood S Gilliam
Referring Judge:	Howard R Lloyd
2 Judge:	Alex G Tse
Nature of Suit:	Patent
Cause of Action:	35 U.S.C. § 271 Patent Infringement
Jury Demanded By:	Plaintiff

Date Filed	Document Text
February 8, 2022	Filing 609 NOTICE by Novartis Pharmaceuticals Corporation of Withdrawal of Attorney (Steindler, Thomas) (Filed on 2/8/2022)
January 12, 2022	Filing 608 CLERK'S NOTICE RE DOCKET NOS. #582 , #585 , AND #586 . Notice is hereby given that the Court takes the pending motions filings under submission. The hearings previously scheduled for January 20, 2022 at 2:00 p.m. are vacated. The Court will issue a written order. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndr, COURT STAFF) (Filed on 1/12/2022)
January 4, 2022	Filing 607 ORDER by Hon. Haywood S. Gilliam, Jr. The Court has reviewed Dkt. No. #606 Plexxikon's letter, and the parties are advised that each side may have more than one counsel argue at the January 20, 2022 hearing if they believe doing so will aid in the discussion of the issues. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1, COURT STAFF) (Filed on 1/4/2022)
January 4, 2022	Filing 606 Letter from Daralyn Durie, counsel for Plexxikon Inc. concerning the January 20, 2022 hearing on the parties post-trial motions. (Durie, Daralyn) (Filed on 1/4/2022)
December 6, 2021	Filing 605 CLERK'S NOTICE RE DOCKET NOS. #582 , #585 , AND #586 . Notice is hereby given that the hearings on the motions, previously set for December 16, 2021, are continued to January 20, 2022, at 2:00 p.m. These proceedings will be held by AT&T Conference Line. The parties are advised that in the event of an audio problem, counsel should be prepared to attend the hearing via Zoom conference at the Courts direction.The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (This is a text-only entry generated by the court. There is no document associated with this entry.)(ndr, COURT STAFF) (Filed on 12/6/2021)
November 16, 2021	Filing 604 REPLY (re #585 MOTION Enhanced Damages ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Hannah Jiam, #2 Exhibit A to Declaration of Hannah Jiam, #3 Exhibit B to Declaration of Hannah Jiam, #4 Exhibit C to Declaration of Hannah Jiam, #5 Exhibit D to Declaration of Hannah Jiam)(Novikov, Eugene) (Filed on 11/16/2021)
November 16, 2021	Filing 603 REPLY (re #586 MOTION for Ongoing Royalties and Interest ) filed byPlexxikon Inc.. (Davis, Kira) (Filed on 11/16/2021)
November 16, 2021	Filing 602 REPLY (re #582 MOTION for Judgment as a Matter of Law MOTION for New Trial And/Or Remittur ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 11/16/2021)
November 4, 2021	Filing 601 Declaration of Nathanael R. Luman in Support of #596 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #596 ) (Luman, Nathanael) (Filed on 11/4/2021)
November 2, 2021	Filing 600 OPPOSITION/RESPONSE (re #586 MOTION for Ongoing Royalties and Interest ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 11/2/2021)
November 2, 2021	Filing 599 OPPOSITION/RESPONSE (re #585 MOTION Enhanced Damages ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 11/2/2021)
November 2, 2021	Filing 598 OPPOSITION/RESPONSE (re #582 MOTION for Judgment as a Matter of Law MOTION for New Trial And/Or Remittur ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Novikov, Eugene) (Filed on 11/2/2021)
November 2, 2021	Filing 597 CERTIFICATE OF SERVICE by Plexxikon Inc. re #596 Administrative Motion to File Under Seal (Novikov, Eugene) (Filed on 11/2/2021)
November 2, 2021	Filing 596 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Proposed Order, #3 Redacted Version of Exhibit 3, #4 Unredacted Version Exhibit 3)(Novikov, Eugene) (Filed on 11/2/2021)
October 19, 2021	Filing 595 STIPULATION re #587 Bill of Costs,, filed by Novartis Pharmaceuticals Corporation. (Schoenhard, Paul) (Filed on 10/19/2021)
October 13, 2021	Filing 594 ORDER by Judge Haywood S. Gilliam, Jr. Granting #593 Motion for Pro Hac Vice for E. Joshua Rosenkranz. Terminated Docket No. #591 , Re-Filed as Docket No. #593 .(ndrS, COURT STAFF) (Filed on 10/13/2021)
October 13, 2021	Filing 593 MOTION for leave to appear in Pro Hac Vice for E. Joshua Rosenkranz ( Filing fee $ 317, receipt number 0971-16484246.) Filing fee previously paid on 10/11/2021 filed by Plexxikon Inc.. (Rosenkranz, E. Joshua) (Filed on 10/13/2021)
October 13, 2021	Filing 592 CLERK'S NOTICE TO COUNSEL RE DOCKET NO. #591 . Counsel is directed to re-file his/her pro hac vice application along with a true and correct copy of a certificate of good standing or other similar official document issued by the appropriate authority governing attorney admissions for the relevant bar. Said certificate or other document must be dated no more than one year prior to the date of application for admission. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 10/13/2021)
October 11, 2021	Filing 591 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 317, receipt number 0971-16484246.) filed by Plexxikon Inc.. (Rosenkranz, E. Joshua) (Filed on 10/11/2021)
October 11, 2021	Filing 590 ASSOCIATION of Counsel on Plexxikon Inc. by Plexxikon Inc.. (Moulton, Elizabeth) (Filed on 10/11/2021)
October 11, 2021	Filing 589 NOTICE of Appearance by Elizabeth R Moulton (Moulton, Elizabeth) (Filed on 10/11/2021)
October 8, 2021	Filing 588 Declaration of Nathanael R. Luman in Support of #583 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #583 ) (Luman, Nathanael) (Filed on 10/8/2021)
October 5, 2021	Filing 587 BILL OF COSTS by Plexxikon Inc.. Objections due by 10/19/2021. (Attachments: #1 Declaration of Eugene Novikov, #2 Exhibit A to the Declaration of Eugene Novikov, #3 Exhibit B to the Declaration of Eugene Novikov, #4 Declaration of Andy Fredericks, #5 Exhibit A to the Declaration of Andy Fredericks, #6 Declaration of Brian Lee, #7 Declaration of Melanie Antoon, #8 Exhibit A to the Declaration of Melanie Antoon, #9 Exhibit B to the Declaration of Melanie Antoon, #10 Exhibit C to the Declaration of Melanie Antoon)(Novikov, Eugene) (Filed on 10/5/2021)
October 5, 2021	Filing 586 MOTION for Ongoing Royalties and Interest filed by Plexxikon Inc.. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/19/2021. Replies due by 10/26/2021. (Attachments: #1 Declaration of Gregory K. Leonard, #2 Exhibit A, #3 Exhibit B, #4 Proposed Order)(Davis, Kira) (Filed on 10/5/2021)
October 5, 2021	Filing 585 MOTION Enhanced Damages filed by Plexxikon Inc.. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/19/2021. Replies due by 10/26/2021. (Attachments: #1 Declaration of Hannah Jiam, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27, #29 Exhibit 28, #30 Proposed Order)(Novikov, Eugene) (Filed on 10/5/2021)
October 5, 2021	Filing 584 CERTIFICATE OF SERVICE by Plexxikon Inc. re #583 Administrative Motion to File Under Seal (Jiam, Hannah) (Filed on 10/5/2021)
October 5, 2021	Filing 583 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Hannah Jiam, #2 Proposed Order, #3 Redacted version of Plaintiff's Motion for Enhanced Damages, #4 Unredacted version of Plaintiff's Motion for Enhanced Damages, #5 Redacted version of Exhibit 10, #6 Unredacted version of Exhibit 10, #7 Redacted version of Exhibit 12, #8 Unredacted version of Exhibit 12, #9 Redacted version of Exhibit 13, #10 Unredacted version of Exhibit 13, #11 Redacted version of Exhibit 23, #12 Unredacted version of Exhibit 23, #13 Redacted version of Exhibit 27, #14 Unredacted version of Exhibit 27)(Jiam, Hannah) (Filed on 10/5/2021)
October 5, 2021	Filing 582 MOTION for Judgment as a Matter of Law , MOTION for New Trial And/Or Remittur filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 11/2/2021. Replies due by 11/16/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 10/5/2021)
September 17, 2021	Filing 581 ORDER by Judge Haywood S. Gilliam, Jr. Granting #579 Joint Administrative Motion to Exceed Page Limits. (ndrS, COURT STAFF) (Filed on 9/17/2021)
September 17, 2021	Filing 580 JUDGMENT. Signed by Judge Haywood S. Gilliam, Jr. on 9/17/2021. *Civil Case Terminated.* (ndrS, COURT STAFF) (Filed on 9/17/2021)
September 16, 2021	Filing 579 Joint ADMINISTRATIVE MOTION to Exceed Page Limits filed by Novartis Pharmaceuticals Corporation. Responses due by 9/20/2021. (Attachments: #1 Stipulation, #2 Proposed Order)(Steindler, Thomas) (Filed on 9/16/2021)
September 15, 2021	Filing 578 NOTICE by Plexxikon Inc. of Proposed Judgment (Attachments: #1 Proposed Judgment)(Novikov, Eugene) (Filed on 9/15/2021)
August 10, 2021	Filing 577 JOINT STIPULATION AND ORDER AS MODIFIED BY THE COURT REGARDING ENTRY OF JUDGMENT AND POST-TRIAL BRIEFING SCHEDULE by Judge Haywood S Gilliam, Jr granting #576 Stipulation. Judgment to be entered on 9/7/2021. Motions due by 10/5/2021. Oppositions due 11/2/2021. Replies due 11/16/2021. Motion Hearing set for 12/16/2021 at 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. (kcS, COURT STAFF) (Filed on 8/10/2021)
August 9, 2021	Filing 576 Joint Stipulation Regarding Entry of Judgment and Post-Trial Briefing Schedule filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Steindler, Thomas) (Filed on 8/9/2021) Modified on 8/10/2021 (bnsS, COURT STAFF).
July 26, 2021	Filing 569 TRANSCRIPT ORDER for proceedings held on July 9-21, 2021 before Judge Haywood S Gilliam, Jr for Court Reporter Raynee Mercado. (oh, COURT STAFF) (Filed on 7/26/2021)
July 23, 2021	Exhibit Location (C-4): Trial Exhibit (1 Envelope). (bnsS, COURT STAFF) (Filed on 7/23/2021)
July 22, 2021	Filing 566 Jury Notes. (ndrS, COURT STAFF) (Filed on 7/22/2021)
July 22, 2021	Filing 565 JURY VERDICT. (ndrS, COURT STAFF) (Filed on 7/22/2021)
July 22, 2021	Filing 564 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial completed on 7/22/2021.(ndrS, COURT STAFF) (Date Filed: 7/22/2021)
July 21, 2021	Filing 563 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/21/2021. Further Jury Trial July 22, 2021 at 09:00 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/21/2021)
July 21, 2021	Filing 562 OPPOSITION/RESPONSE (re #559 MOTION for Judgment as a Matter of Law Under Rule 50(a) ) filed byPlexxikon Inc.. (Novikov, Eugene) (Filed on 7/21/2021)
July 21, 2021	Filing 560 Final Jury Instructions. (hsglc1S, COURT STAFF) (Filed on 7/21/2021)
July 21, 2021	Filing 559 MOTION for Judgment as a Matter of Law Under Rule 50(a) filed by Novartis Pharmaceuticals Corporation. Responses due by 8/4/2021. Replies due by 8/11/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 7/21/2021)
July 20, 2021	Filing 561 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/20/2021. Further Jury Trial July 21, 2021 at 08:00 AM (for counsel) and 8:30 AM (for jury) in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/20/2021)
July 20, 2021	Filing 556 OPPOSITION/RESPONSE (re #554 MOTION for Judgment as a Matter of Law ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/20/2021)
July 20, 2021	Filing 555 RESPONSE re #553 Statement Request regarding Closing Arguments by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/20/2021)
July 19, 2021	Filing 554 MOTION for Judgment as a Matter of Law filed by Plexxikon Inc.. Responses due by 8/2/2021. Replies due by 8/9/2021. (Durie, Daralyn) (Filed on 7/19/2021)
July 19, 2021	Filing 553 Plaintiff Plexxikon Inc.'s Memorandum Regarding Request to Exclude Closing Arguments that are Contrary to Law by Plexxikon Inc.. (Durie, Daralyn) (Filed on 7/19/2021) Modified on 7/20/2021 (bnsS, COURT STAFF).
July 19, 2021	Filing 552 July 19, 2021 Joint Statement by Novartis Pharmaceuticals Corporation and Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 7/19/2021) Modified on 7/20/2021 (bnsS, COURT STAFF).
July 19, 2021	Filing 551 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/19/2021. Further Jury Trial July 20, 2021 at 08:00 AM (for counsel) and 8:30 AM (for jury) in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/19/2021) Modified on 7/21/2021 to add date (ndrS, COURT STAFF).
July 16, 2021	Filing 550 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/16/2021, Further Jury Trial Monday, 7/19/2021 at 8:00AM. Jury at 8:30AM.Total Time in Court: 4:40. Court Reporter: Raynee Mercado. (Attachments: #1 Exhibit Trial sheet)(fs, COURT STAFF) (Date Filed: 7/16/2021)
July 15, 2021	Filing 549 OPPOSITION/RESPONSE (re #545 MOTION for Judgment as a Matter of Law on Willfulness ) filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Durie, Daralyn) (Filed on 7/15/2021)
July 15, 2021	Filing 548 July 15, 2021 Joint Statement by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Steindler, Thomas) (Filed on 7/15/2021) Modified on 7/16/2021 (bnsS, COURT STAFF).
July 15, 2021	Filing 547 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/15/2021. Jury trial continued to July 16, 2021 at 8:00 a.m.Total Time in Court: 5 hours 29 minutes. Court Reporter: Raynee Mercado. Attachment: Minute order and Trial/Exhibit Log. (mllS, COURT STAFF) (Date Filed: 7/15/2021)
July 14, 2021	Filing 546 Reply in Support of Proffer re Testimony of Dr. Tara Rheault re #543 Response ( Non Motion ), 544 Order, by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).
July 14, 2021	Filing 545 MOTION for Judgment as a Matter of Law on Willfulness filed by Novartis Pharmaceuticals Corporation. Responses due by 7/28/2021. Replies due by 8/4/2021. (Steindler, Thomas) (Filed on 7/14/2021)
July 14, 2021	Filing 544 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Defendant to file any response to Dkt. No. #543 Plaintiff's Response to Novartis's Proffer of Testimony of Dr. Tara Rheault by 10:00 p.m. PDT tonight. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/14/2021)
July 14, 2021	Filing 543 Plaintiff Plexxikon Inc.'s Response to Novartis's Proffer of Testimony of Dr. Tara Rheault re #541 by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit 1, #3 Exhibit 2 (PUBLIC SLIPSHEET), #4 Exhibit 3 (PUBLIC SLIPSHEET))(Durie, Daralyn) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).
July 14, 2021	Filing 542 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie re Motion to Seal, #2 Proposed Order, #3 Redacted Version of Brief, #4 Unredacted Version of Brief, #5 Sealed Version of Ex. 2, #6 Sealed Version of Ex. 3, #7 Certificate/Proof of Service)(Durie, Daralyn) (Filed on 7/14/2021)
July 14, 2021	Filing 541 Novartis Proffer of Testimony of Dr. Tara Rheault by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).
July 14, 2021	Filing 540 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/14/2021. Further Jury Trial set for 7/15/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr.Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet) (kcS, COURT STAFF) (Date Filed: 7/14/2021)
July 13, 2021	Filing 539 Administrative Motion to File Under Seal re July 13, 2021 Joint Statement filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Daralyn Durie, #2 Joint Statement - Sealed, #3 Joint Statement - Redacted, #4 Exhibit 2, #5 Proposed Order)(Steindler, Thomas) (Filed on 7/13/2021)
July 13, 2021	Filing 538 July 13, 2021 Joint Statement by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Durie Tangri, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Steindler, Thomas) (Filed on 7/13/2021) Modified on 7/14/2021 (bnsS, COURT STAFF).
July 13, 2021	Filing 537 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial (Day 2) held on 7/13/2021. Further Jury Trial set for 7/14/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet) (kcS, COURT STAFF) (Date Filed: 7/13/2021)
July 13, 2021	Filing 536 ORDER REGARDING DEPOSITION DESIGNATIONS re #524 Statement. Signed by Judge Haywood S. Gilliam on 7/13/2021. (fs, COURT STAFF) (Filed on 7/13/2021)
July 12, 2021	Filing 535 ERRATA re #534 Statement by Plexxikon Inc.. (Attachments: #1 TDX1140, #2 TDX1405-06)(Durie, Daralyn) (Filed on 7/12/2021)
July 12, 2021	Filing 534 July 12, 2021 Joint Statement by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 7/12/2021) Modified on 7/13/2021 (bnsS, COURT STAFF).
July 12, 2021	Filing 533 RESPONSE re 532 Order, by Plexxikon Inc.. (O'Byrne, Whitney) (Filed on 7/12/2021)
July 12, 2021	Filing 532 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Plaintiff to identify the next three witnesses that it anticipates calling in its case-in-chief after Dr. Michael Metzker. Plaintiff shall file the list by 6:00 p.m. today, July 12, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/12/2021)
July 12, 2021	Filing 531 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial - Day 1 began on 7/12/2021.Total Time in Court: 4 hours 21 minutes. Court Reporter: Raynee Mercado. Plaintiff Attorney: Deralyn Durie. Defendant Attorney: Thomas Steindler. Attachment: Trial Minute and Exhibit Witness List. (jjoS, COURT STAFF) (Date Filed: 7/12/2021)
July 12, 2021	Filing 530 Order by Judge Haywood S Gilliam, Jr granting #528 Joint Stipulation and Proposed Order Regarding Metadata.(mllS, COURT STAFF) (Filed on 7/12/2021)
July 11, 2021	Filing 528 Joint Stipulation and Proposed Order Regarding Metadata filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (O'Byrne, Whitney) (Filed on 7/11/2021) Modified on 7/12/2021 (bnsS, COURT STAFF).
July 9, 2021	Filing 529 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Selection held on 7/9/2021. Jury Trial set for 7/12/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Total Time in Court: 4:44. Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet)(kcS, COURT STAFF) (Date Filed: 7/9/2021)
July 9, 2021	Filing 527 ORDER by Hon. Haywood S. Gilliam, Jr. OVERRULING Dkt. No. #524 Defendant's objections to the deposition designations for Plaintiff's case-in-chief and DENYING Defendant's request to include the counter-designation. Short written order detailing the Court's reasoning to issue. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/9/2021)
July 9, 2021	#Electronic filing error. REMINDER TO COUNSEL: Incorrect Event Used. In the future, the correct event is Statement. Correct event is found under Civil Events > Other Fil ings > Other Documents. [err101] Corrected by Clerk's Office. No further action is necessary. Re: #519 Response ( Non Motion ), filed by Novartis Pharmaceuticals Corporation (bnsS, COURT STAFF) (Filed on 7/9/2021)
July 8, 2021	Filing 526 Corrected Exhibit C to Joint Statement re Deposition Designations for Plaintiff's Case-in-chief re #524 Statement filed by Plexxikon Inc.. (Attachments: #1 Exhibit C)(Related document(s) #524 ) (Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).
July 8, 2021	Filing 525 *RE-FILED AT DOCKET NO. #526 * Exhibit C to Joint Statement re Deposition Designations for Plaintiff's Case-in-chief re #524 Statement filed by Plexxikon Inc.. (Attachments: #1 Exhibit C)(Related document(s) #524 ) (Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF). Modified on 7/9/2021 (bnsS, COURT STAFF).
July 8, 2021	Filing 524 Joint Statement Regarding Deposition Designations for Plaintiff's Case-in-Chief by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B)(Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).
July 8, 2021	Filing 523 Notice of Withdrawal of Motion to Seal, Dkt 495 (Steindler, Thomas) (Filed on 7/8/2021)
July 8, 2021	Filing 522 ORDER by Haywood S. Gilliam, Jr. granting #518 Joint Stipulation Regarding N.D. Cal. Model Patent Jury Instruction No. A.1. (ig, COURT STAFF) (Filed on 7/8/2021)
July 8, 2021	Filing 521 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Case Management Conference held on 7/8/2021. Total Time in Court: 11 minutes. Not Reported. Plaintiff's Attorney: Daralyn Durie. Defendant's Attorney: Thomas Steindler. Trial issues discussed. Parties intend to provide deposition designations and any objections for Plaintiff's case-in-chief to Court today. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ig, COURT STAFF) (Date Filed: 7/8/2021).
July 8, 2021	CLERKS NOTICE SETTING TELEPHONIC HEARING. See Docket No. 520 Telephone Conference set for 7/8/2021 11:00 AM in Oakland, - Telephonic Only before Judge Haywood S. Gilliam Jr. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. Telephone Conference set for 7/8/2021 11:00 AM in Oakland, - Telephonic Only before Judge Haywood S Gilliam Jr.. (This is a text-only entry generated by the court. There is no document associated with this entry.) (amgS, COURT STAFF) (Filed on 7/8/2021)
July 7, 2021	Filing 520 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a telephonic case management conference on July 8, 2021, at 11:00 a.m. The parties' recent filings reflect that there appear to be a mushrooming number of new disputes and needless problems arising on the eve of trial, including fights over the basic authentication of financial documents and the addition of Defendant's lead counsel to Plaintiff's witness list. This trend is unacceptable. Neither party shall file anything further on the docket until after the case management conference tomorrow. All counsel shall use the following dial-in information to access the call:Dial-In: 888-808-6929;Passcode: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III.Signed by Hon. Haywood S. Gilliam, Jr. on 7/7/2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/7/2021)
July 7, 2021	Filing 519 JOINT STATEMENT REGARDING CHANGES TO PRETRIAL STATEMENT AND EXHIBITS re 516 Order,,,, by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Steindler, Thomas) (Filed on 7/7/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).
July 7, 2021	Filing 518 Joint Stipulation Regarding N.D. Cal. Model Patent Jury Instruction No. A.1 re 507 Order filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/7/2021) Modified on 7/8/2021 (bnsS, COURT STAFF).
July 7, 2021	Filing 517 ORDER AS MODIFIED by Judge Haywood S Gilliam, Jr Granting #510 STIPULATION REGARDING REQUEST TO BRING IN EQUIPMENT FOR TRIAL.(amgS, COURT STAFF) (Filed on 7/7/2021)
July 7, 2021	Filing 516 ORDER by Hon. Haywood S. Gilliam, Jr. Since the pretrial conference and in the last few days leading up to trial, the parties have filed several revised and unsolicited documents, including another version of their proposed joint pretrial statement. Dkt. No. #502 . As detailed in the Court's Civil Pretrial and Trial Standing Order, the pretrial statement was due 14 days before the pretrial conference. The parties have not explained the need for the revised pretrial statement, nor have they explained what changes, if any, have been made. The parties are therefore DIRECTED to provide a detailed explanation of what has changed in this latest version of the pretrial statement and accompanying exhibits by 5:00 p.m. today, July 7, 2021. The time for amendments to the pretrial filings has passed, and the parties may not file any further revisions before jury selection without obtaining leave of Court and explaining the basis for the request. Any such request for leave should be jointly submitted whenever possible. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/7/2021)
July 6, 2021	Filing 515 Novartis Pharmaceuticals Corp.'s Form Witness List by Novartis Pharmaceuticals Corporation (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 514 Novartis Pharmaceuticals Corp.'s Form Exhibit List by Novartis Pharmaceuticals Corporation.. (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 513 Plexxikon Inc.'s Form Witness List by Plexxikon Inc.. (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 512 Plexxikon Inc.'s Form Exhibit List by Plexxikon Inc... (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 511 ORDER by Hon. Haywood S. Gilliam, Jr. DENYING Dkt. No. #494 motion to preclude Plaintiff from calling Dr. Zuosheng Liu as a witness at trial. (hsglc1S, COURT STAFF) (Filed on 7/6/2021)
July 6, 2021	Filing 510 Joint Stipulation Regarding Request to Bring in Equipment for Trial filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 509 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation - Revised. (Steindler, Thomas) (Filed on 7/6/2021)
July 6, 2021	Filing 508 JOINT CASE MANAGEMENT STATEMENT Regarding Special Verdict Form filed by Novartis Pharmaceuticals Corporation and Plexxikon Inc.. (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).
July 6, 2021	Filing 507 ORDER by Hon. Haywood S. Gilliam, Jr. The Court has considered the FJC patent video that the parties propose be shown to the jury after Stipulated Preliminary Instruction No. 2. The Court believes that juror comprehension will be aided by giving an oral instruction that the jurors can follow along with in writing in addition to the video, as this Court and others in this district have done in patent trials. The Court therefore intends to give N.D. Cal. Model Patent Jury Instruction No. A.1 before showing the video, rather than showing the video in lieu of the instruction as the parties propose. The parties may submit any objection to this approach by 5:00 p.m. on Wednesday, July 7, 2021. Regardless of any objections, however, the parties are further DIRECTED to meet and confer on the assumption that the Court will proceed as set out above, and determine whether they can agree on a form of Model Instruction No. A.1. The Court intends to hew directly to the language of the model instruction, and the parties' proposal should do so too (without prejudice to assertion on appeal of any objections, which will be preserved for the record). For example, it would be helpful for the parties to agree on whether the bracketed language in the model instruction should be included or omitted. The parties shall submit the stipulated instruction by 5:00 p.m. on Wednesday, July 7, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/6/2021)
July 6, 2021	Filing 506 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation . (Steindler, Thomas) (Filed on 7/6/2021)
July 6, 2021	Filing 505 Proposed Form of Verdict by Plexxikon Inc. . (Novikov, Eugene) (Filed on 7/6/2021)
July 3, 2021	Filing 504 REPLY (re #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further,,,,,, ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/3/2021)
July 2, 2021	Filing 503 ADMINISTRATIVE MOTION to Bring in Equipment For Trial filed by Plexxikon Inc.. Responses due by 7/6/2021. (Attachments: #1 Proposed Order)(Novikov, Eugene) (Filed on 7/2/2021)
July 2, 2021	Filing 502 Proposed Joint Pretrial Statement and Order by Plexxikon Inc and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).
July 2, 2021	Filing 501 Joint Trial Stipulation Regarding Undisputed Facts with Proposed Order filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).
July 2, 2021	Filing 500 Third Amended Joint Proposed Jury Instructions by Plexxikon Inc. (Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).
July 2, 2021	Filing 499 Administrative Motion to File Under Seal re: Plexxikon Opposition to Novartis Motion to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial filed by Plexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Proposed Order, #3 Redacted Version of Opposition, #4 Unredacted Version of Opposition, #5 Certificate/Proof of Service)(Novikov, Eugene) (Filed on 7/2/2021)
July 2, 2021	Filing 498 ADMINISTRATIVE MOTION Regarding Request to Bring in Equipment for Trial filed by Novartis Pharmaceuticals Corporation. Responses due by 7/6/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 7/2/2021)
July 2, 2021	Filing 497 OPPOSITION/RESPONSE (re #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further,,,,,, ) filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Novikov, Eugene) (Filed on 7/2/2021)
July 2, 2021	Filing 496 ORDER REGARDING VERDICT FORM AND EXPERT REPORTS. Signed by Judge Haywood S. Gilliam, Jr. on 7/2/2021. (ndrS, COURT STAFF) (Filed on 7/2/2021)
June 30, 2021	#Electronic filing error. REMINDER TO COUNSEL: Incorrect Event Used. In the future, the correct event is Administrative Motion. Correct event is found under Civil Events &g t; Motion and Related Filings & Motions- General.[err101] Re: #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further filed by Novartis Pharmaceuticals Corporation (bnsS, COURT STAFF) (Filed on 6/30/2021)
June 29, 2021	Filing 495 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Declaration of David Mlaver, #3 Proposed Order, #4 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/29/2021)
June 29, 2021	Filing 494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further filed by Novartis Pharmaceuticals Corporation. Motion Responses due by 7/2/2021. (Attachments: #1 Exhibit A, #2 Proposed Order)(Steindler, Thomas) (Filed on 6/29/2021) Modified on 6/30/2021 (bnsS, COURT STAFF).
June 28, 2021	Filing 493 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Plexxikon Inc.. (Jones, Andrew) (Filed on 6/28/2021)
June 28, 2021	Filing 492 NOTICE of Appearance by Whitney Rose O'Byrne (O'Byrne, Whitney) (Filed on 6/28/2021)
June 25, 2021	Filing 491 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Further Case Management Conference held on 6/25/2021. Total Time in Court: 10 minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Court gives the attorneys the following updated trial information, in light of the COVID-19 rules, effective July 1st: 1) the jury trial will be held in courtroom 2, 4th floor; 2) everyone in the courtroom will be required to wear a mask at all times except for: witnesses who certify that they are fully vaccinated while testifying and attorneys who certify that they are fully vaccinated during opening, closing, witness examinations, and any sidebar; 3) all 41 prospective jurors will be in the courtroom at one time for jury selection; 4) each side will be given 15 minutes for follow-up questions during voir dire; 5) jury deliberations will occur in the jury deliberation room adjacent to courtroom 2; 6) team size of 7 per side, not including experts, can be accommodated; and 7) trial will be in person in a courtroom open to the public, so no phone access will be available. The Court sets Friday, July 2nd as the deadline for the following to be submitted: trial stipulation, PTO and sample patent, updated jury instructions and definitions. Counsel for defendant is directed to file his motion to exclude plaintiffs witness by close of business on Tuesday, June 29th and counsel for plaintiff has until close of business on Friday, July 2nd to respond. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 6/25/2021)
June 23, 2021	Filing 490 ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS #307 MOTION TO STRIKE AND DEFENDANTS #272 MOTION IN LIMINE NO. 5. Signed by Judge Haywood S. Gilliam, Jr. on 6/23/2021. Further Case Management Conference set for 6/25/2021 01:00 PM. This proceeding will be held by AT&T Conference Line. The parties are advised that in the event of an audio problem, counsel should be prepared to attend the hearing via Zoom conference at the Courts direction. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (ndrS, COURT STAFF) (Filed on 6/23/2021)
June 22, 2021	Filing 489 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/22/2021)
June 12, 2021	Filing 488 Transcript of Proceedings held on June 8, 2021, before Judge Haywood S. Gilliam. Court Reporter Diane E. Skillman, telephone number 925-899-2912, Diane_Skillman@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #484 Transcript Order ) Release of Transcript Restriction set for 9/10/2021. (Related documents(s) #484 ) (Skillman, Diane) (Filed on 6/12/2021)
June 11, 2021	Filing 487 TRANSCRIPT ORDER for proceedings held on 6/8/2021 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Diane Skillman. (Novikov, Eugene) (Filed on 6/11/2021)
June 10, 2021	Filing 486 Minute Entry for proceedings held before Magistrate Judge Susan van Keulen: Settlement Conference held on 6/10/2021 via Zoom.Settlement discussions continue.Time in Court: 6 hours. Court Reporter: Not reported. Pre-Settlement Conference Calls held 6/1/21.50 hours and 6/9/21 2 hours.Total Time in Court: 8.5 hours. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Date Filed: 6/10/2021)
June 9, 2021	Filing 485 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Plexxikon Inc.. (Novikov, Eugene) (Filed on 6/9/2021)
June 9, 2021	Filing 484 TRANSCRIPT ORDER for proceedings held on 6/8/2021 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Diane Skillman. (Steindler, Thomas) (Filed on 6/9/2021)
June 8, 2021	Filing 483 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Pretrial Conference held on 6/8/2021. Total Time in Court: 1 hour and 3 minutes. Court Reporter: Diane Skillman. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas P. Steindler. The Court DENIES the request for bifurcation. The Court advises the parties that: 1) the telephonic conference line will be used during the trial for public access; 2) July 23rd will be a dark day; 3) 8 jurors will be selected; 4) each side will be allotted 20 hours of trial time; 5) the U.S. Patent and Trademark Office video and sample patent they intend to provide to the jury should be submitted to the Court; and 5) the parties shall meet and confer regarding the disputed jury instructions as discussed on the record. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 6/8/2021)
June 8, 2021	Filing 482 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #206 MOTION TO EXCLUDE EXPERT TESTIMONY OF TED SWEENEY. (ndrS, COURT STAFF) (Filed on 6/8/2021)
June 7, 2021	Filing 481 Submission of Alternative Language for Jury Instruction per June 3, 2021 Order, Dkt 476 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/7/2021) Modified on 6/8/2021 (bnsS, COURT STAFF).
June 4, 2021	Filing 480 CLERK'S NOTICE CHANGE OF TIME FOR 6/9/21 FURTHER PRE-SETTLEMENT CONFERENCE CALLS. Further Pre-Settlement Conference Call with Plaintiff set for 6/9/2021 01:00 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen.Further Pre-Settlement Conference Call with Defendant set for 6/9/2021 02:30 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/4/2021)
June 3, 2021	Filing 479 ORDER REGARDING JUNE 8th PRETRIAL CONFERENCE. Signed by Judge Haywood S. Gilliam, Jr. on 6/3/2021. Pretrial Conference set for 6/8/2021 02:00 PM in Oakland, - Videoconference Only before Judge Haywood S. Gilliam Jr. This proceeding will be held via a Zoom webinar.Webinar Access: All counsel, members of the public, and media may access the webinar information at #https://www.cand.uscourts.gov/hsg General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited.Zoom Guidance and Setup: #https://www.cand.uscourts.gov/zoom/. (ndrS, COURT STAFF) (Filed on 6/3/2021)
June 3, 2021	Filing 478 ORDER by Judge Haywood S. Gilliam, Jr. Granting Amended #477 Motion for Pro Hac Vice as to Nicole M. Jantzi. #474 Motion for Pro Hac Vice Terminated, Re-filed as Docket No. #477 .(ndrS, COURT STAFF) (Filed on 6/3/2021)
June 3, 2021	Filing 477 Amended MOTION for leave to appear in Pro Hac Vice - Nicole M. Jantzi ( Filing fee $ 317, receipt number 0971-16032530.) Filing fee previously paid on 6/2/2021 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Jantzi, Nicole) (Filed on 6/3/2021)
June 3, 2021	Filing 476 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART PLAINTIFFS #264 MOTION IN LIMINE NO. 4 AND DENYING PLAINTIFFS #266 MOTION IN LIMINE NO. 5.(ndrS, COURT STAFF) (Filed on 6/3/2021)
June 2, 2021	Filing 475 ORDER REGARDING PLAINTIFFS MOTION IN LIMINE NO. 1 AND DEFENDANTS MOTIONS IN LIMINE NOS. 2, 3, AND 4. Signed by Judge Haywood S. Gilliam, Jr. on 6/2/2021. (ndrS, COURT STAFF) (Filed on 6/2/2021)
June 2, 2021	Filing 474 MOTION for leave to appear in Pro Hac Vice - Nicole M. Jantzi ( Filing fee $ 317, receipt number 0971-16032530.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Jantzi, Nicole) (Filed on 6/2/2021)
June 1, 2021	Filing 473 Novartis' Trial Time Estimates re 456 Order by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/1/2021) Modified on 6/2/2021 (bnsS, COURT STAFF).
June 1, 2021	Filing 472 Plaintiff Plexxikon, Inc.'s Trial Time Estimates re 456 Order by Plexxikon Inc.. (Krishnapriyan, Raghav) (Filed on 6/1/2021) Modified on 6/2/2021 (bnsS, COURT STAFF).
June 1, 2021	Filing 471 CLERK'S NOTICEBrief joint and confidential settlement statements due 6/3/21.Further Pre-Settlement Conference Call with Plaintiff set for 6/9/2021 01:30 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Further Pre-Settlement Conference Call with Defendant set for 6/9/2021 03:00 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Counsel/parties emailed Judge van Keulen's AT&T Conference Call information.Settlement Conference remains set for 6/10/21 09:30 AM before Magistrate Judge Susan van Keulen. This proceeding will be held via Zoom.Counsel/parties emailed Judge van Keulen's Recurring Zoom Meeting Link.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. Zoom Guidance and Setup: https://www.cand.uscourts.gov/zoom/. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)
June 1, 2021	Filing 470 CLERK'S NOTICE CHANGE OF TIME FOR 6/1/21 PRE-SETTLEMENT CONFERENCE CALL VIA AT&T FROM 11:30AM TO 12:00PM.Pre-Settlement Conference Call set for 6/1/21 at 12:00 PM before Magistrate Judge Susan van Keulen.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)
June 1, 2021	Filing 469 CLERK'S NOTICE CHANGE OF TIME FOR 6/1/21 PRE-SETTLEMENT CONFERENCE CALL VIA AT&T FROM 11:00AM TO 11:30AM.Pre-Settlement Conference Call set for 6/1/21 at 11:30 AM before Magistrate Judge Susan van Keulen.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)
May 28, 2021	Filing 468 CLERK'S NOTICE: SETTING OF ZOOM SETTLEMENT CONFERENCE.Settlement Conference set for 6/10/21 09:30 AM before Magistrate Judge Susan van Keulen. This proceeding will be held via Zoom.Counsel/parties emailed Judge van Keulen's Recurring Zoom Meeting Link.Settlement conference statements are due by 6/3/21.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. Zoom Guidance and Setup: https://www.cand.uscourts.gov/zoom/. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 5/28/2021)
May 28, 2021	Filing 467 CLERK'S NOTICE RE PRE-SETTLEMENT CONFERENCE CALL VIA AT&T.Pre-Settlement Conference Call set for 6/1/21 at 11:00 AM before Magistrate Judge Susan van Keulen.Settlement conference statements are due 6/3/21.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 5/28/2021)
May 26, 2021	Filing 466 ORDER by Hon. Haywood S. Gilliam, Jr. REFERRING CASE to Magistrate Judge van Keulen for Settlement. Signed by Judge Haywood S. Gilliam, Jr. on 5/26/2021. (hsglc1S, COURT STAFF) (Filed on 5/26/2021)
May 26, 2021	Filing 465 NOTICE of Appearance by Hannah Jiam (Jiam, Hannah) (Filed on 5/26/2021)
May 25, 2021	Filing 464 Proposed Joint Pretrial Statement and Order filed by Plexxikon Inc., and Novartis Pharmaceuticals Corporation (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).
May 25, 2021	Filing 463 TRIAL BRIEF by Plexxikon Inc.. (Novikov, Eugene) (Filed on 5/25/2021)
May 25, 2021	Filing 462 Proposed Joint Statement of the Case by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).
May 25, 2021	Filing 461 Proposed Form of Verdict by Plexxikon Inc. . (Novikov, Eugene) (Filed on 5/25/2021)
May 25, 2021	Filing 460 Joint Proposed Voir Dire Questions by Plexxikon Inc, and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).
May 25, 2021	Filing 459 Second Amended Joint Proposed Jury Instructions by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).
May 25, 2021	Filing 458 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation . (Steindler, Thomas) (Filed on 5/25/2021)
May 25, 2021	Filing 457 ORDER by Hon. Haywood S. Gilliam, Jr. ADVANCING the jury selection to July 9, 2021, at 8:30 a.m. Opening statements and the presentation of evidence will still begin as scheduled on July 12, 2021, at 8:30 a.m. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/25/2021)
May 21, 2021	Filing 456 ORDER by Hon. Haywood S. Gilliam, Jr. The Court intends to impose time limits on each party at trial. Each party is therefore DIRECTED to submit (1) the projected duration of the direct examination of each of its witnesses listed in Dkt. No. [313-2] and Dkt. No. [313-3], the Joint Pretrial Statement and related exhibits; (2) the anticipated duration of the cross-examination of each of the other party's disclosed witnesses; and (3) the total number of hours projected (i.e., the sum of categories (1) and (2)). These estimates should be realistic, not padded. The parties shall file their submissions by June 1, 2021, and should be prepared to discuss these estimates during the pretrial conference. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/21/2021)
May 10, 2021	Filing 455 NOTICE of Appearance by Andrew Treloar Jones (Jones, Andrew) (Filed on 5/10/2021)
May 10, 2021	Filing 454 NOTICE of Appearance by Katherine E. McNutt (McNutt, Katherine) (Filed on 5/10/2021)
April 7, 2021	Filing 453 Notice of Compliance with Court Order Dated March 31, 2021 by Plexxikon Inc. re #452 Order on Administrative Motion per Civil Local Rule 7-11 (Attachments: #1 Exhibit 1 to Miller Declaration (Dkt. No. 169-2/ (Dkt. No. 168-4)), #2 Exhibit 2 to Steindler Declaration (Dkt. No. 202-3/ (Dkt. No. 201-6)))(Krishnapriyan, Raghav) (Filed on 4/7/2021) Modified on 4/8/2021 (bnsS, COURT STAFF).
March 31, 2021	Filing 452 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING Dkt. No. #394 Plaintiff's Administrative Motion for Leave to Move for Reconsideration of Motions to Seal. (hsglc1S, COURT STAFF) (Filed on 3/31/2021)
March 26, 2021	Filing 451 ORDER by Judge Haywood S. Gilliam, Jr. DENYING PLAINITFFS ( #262 , #260 ) MOTIONS IN LIMINE NO. 2 AND 3 AND GRANTING DEFENDANTS #268 MOTION IN LIMINE NO. 1. (ndrS, COURT STAFF) (Filed on 3/26/2021)
March 15, 2021	Filing 450 ORDER by Judge Haywood S. Gilliam, Jr. DENYING DEFENDANT'S #177 MOTION FOR SUMMARY JUDGMENT. (ndrS, COURT STAFF) (Filed on 3/15/2021)
February 23, 2021	Filing 449 ORDER by Judge Haywood S. Gilliam, Jr. Granting Plexxikon Inc.s #167 Motion for Summary Judgment of no Anticipation. (ndrS, COURT STAFF) (Filed on 2/23/2021)
January 15, 2021	Filing 448 ORDER by Judge Haywood S. Gilliam, Jr. Granting #447 Stipulation Regarding Trial Re Docket No. 446 . Pretrial Conference set for 6/8/2021 03:00 PM before Judge Haywood S. Gilliam Jr. and Jury Selection /Jury Trial (2-week) set for 7/12/2021 08:30 AM before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 1/15/2021)
January 14, 2021	Filing 447 STIPULATION WITH PROPOSED ORDER Regarding Trial re 446 Terminate Hearings, Status Conference, Set Deadlines filed by Novartis Pharmaceuticals Corporation, and Plexxikon Inc.. (Steindler, Thomas) (Filed on 1/14/2021) Modified on 1/15/2021 (bnsS, COURT STAFF).
January 12, 2021	Filing 446 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Status Conference held on 1/12/2021. Status Report due by 1/15/2021.Total Time in Court: 13 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Court directs the parties to confer with their teams and witnesses to determine if July 12th would work as a trial date. If July 12th works, the pretrial conference would be set on June 8th at 3:00 p.m. Counsel for plaintiff is directed to confer with her client to determine if a bench trial is a possibility. Parties are directed to update the Court regarding these two issues by Friday, January 15th. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 1/12/2021)
January 12, 2021	Filing 445 ORDER by Judge Haywood S. Gilliam, Jr. REGARDING ( #169 , #202 ) MOTIONS TO EXCLUDE DAMAGES EXPERTS OPINIONS. (ndrS, COURT STAFF) (Filed on 1/12/2021)
January 7, 2021	Filing 444 RESPONSE re #443 Order Regarding Motion to Exclude Expert Testimony of Dr. Gregory K. Leonard, Ph.D by Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Durie, Daralyn) (Filed on 1/7/2021)
January 7, 2021	Filing 443 ORDER REGARDING #202 MOTION TO EXCLUDE EXPERT TESTIMONY OF DR. GREGORY K. LEONARD, PH.D. Signed by Judge Haywood S. Gilliam, Jr. on 1/7/2021. (ndrS, COURT STAFF) (Filed on 1/7/2021)
January 6, 2021	Filing 442 ORDER Granting #441 Joint Motion for Hearing Re Status Conference Re Trial Date. Telephonic Status Conference set for 1/12/2021 02:00 PM in Oakland before Judge Haywood S. Gilliam Jr. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III.. Signed by Judge Haywood S. Gilliam, Jr. on 1/6/2021 (ndrS, COURT STAFF) (Filed on 1/6/2021)
January 5, 2021	Filing 441 Joint MOTION for Hearing re Status Conference re Trial Date filed by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Durie, Daralyn) (Filed on 1/5/2021) Modified on 1/6/2021 (bnsS, COURT STAFF).
December 8, 2020	Filing 440 NOTICE by Novartis Pharmaceuticals Corporation re #438 Order on Administrative Motion to File Under Seal, (Attachments: #1 Proposed Motion for Summary Judgment, #2 Exhibit C-04, #3 Exhibit C-10, #4 Exhibit C-11, #5 Exhibit C-12, #6 Exhibit C-13, #7 Exhibit C-14, #8 Exhibit C-15, #9 Exhibit C-16, #10 Exhibit C, #11 Exhibit D, #12 Exhibit F, #13 Exhibit G, #14 Exhibit I, #15 Exhibit J, #16 Exhibit K, #17 Exhibit L)(Steindler, Thomas) (Filed on 12/8/2020)
November 30, 2020	Filing 439 ORDER by Hon. Haywood S. Gilliam, Jr. DENYING Dkt. No. #383 Defendant's motion to file a reply brief regarding Plaintiff's Motion in Limine No. 1. Although the Court directed the parties to file proffers related to Motion in Limine No. 1, this was not an invitation to brief the issues anew. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 11/30/2020)
November 30, 2020	Filing 438 ORDER by Judge Haywood S. Gilliam, Jr. DENYING ( #344 , #390 )MOTIONS TO SEAL. (ndrS, COURT STAFF) (Filed on 11/30/2020)
September 16, 2020	Filing 437 ORDER by Judge Haywood S. Gilliam, Jr. Granting #436 Motion for Pro Hac Vice as to Columbia, Sarah. (ndrS, COURT STAFF) (Filed on 9/16/2020)
September 15, 2020	Filing 436 MOTION for leave to appear in Pro Hac Vice re Sarah Chapin Columbia ( Filing fee $ 310, receipt number 0971-14943938.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Certificate of Good Standing, #2 Proposed Order)(Columbia, Sarah) (Filed on 9/15/2020) Modified on 9/16/2020 (bnsS, COURT STAFF).
August 31, 2020	Filing 435 ORDER by Judge Haywood S. Gilliam, Jr. Granting #433 Motion for Pro Hac Vice Re: Kira Alexis Davis. (ndrS, COURT STAFF) (Filed on 8/31/2020)
August 24, 2020	Filing 434 Declaration of Kira A. Davis in Support of #433 MOTION for leave to appear in Pro Hac Vice Re: Kira Alexis Davis filed byPlexxikon Inc.. (Related document(s) #433 ) (Davis, Kira) (Filed on 8/24/2020)
August 17, 2020	Filing 433 MOTION for leave to appear in Pro Hac Vice Re: Kira Alexis Davis(Filing fee $ 310, receipt number 0971-14825848) filed by Plexxikon Inc. (Attachments: #1 Certificate/Proof of Service Certificate of Good Standing)(Davis, Kira) (Filed on 8/17/2020) Modified on 8/17/2020 (cjlS, COURT STAFF).
August 12, 2020	Filing 432 REVISED SCHEDULING ORDER: Pretrial Conference set for 3/2/2021 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. and Jury Selection / Jury Trial (10 day) set for 4/5/2021 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. Signed by Judge Haywood S. Gilliam, Jr. on 8/12/2020. (ndrS, COURT STAFF) (Filed on 8/12/2020)
August 10, 2020	Filing 431 Joint Notice Re: Proposed Trial Dates re 430 Order, 428 Status Conference by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 8/10/2020) Modified on 8/11/2020 (bnsS, COURT STAFF).
August 10, 2020	Filing 430 ORDER by Hon. Haywood S. Gilliam, Jr. GRANTING Dkt. No. #429 the parties' request to extend the deadline to file a joint statement advising the Court as to their preferred new trial date. The parties shall file their joint statement by August 10, 2020. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 8/10/2020)
August 7, 2020	Filing 429 Joint Notice Re: Proposed Trial Dates by Plexxikon Inc. (Durie, Daralyn) (Filed on 8/7/2020) Modified on 8/10/2020 (cjlS, COURT STAFF).
August 4, 2020	Filing 428 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Status Conference held on 8/4/2020. Total Time in Court: 10 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. Counsel are directed to meet and confer with the clients and witnesses by Friday, August 7, 2020, and e-file a joint statement advising the Court which of the proposed trial dates they agree to. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 8/4/2020)
August 4, 2020	Filing 427 NOTICE of Withdrawal of Laura E. Miller by Eugene Novikov. (Novikov, Eugene) (Filed on 8/4/2020) Modified on 8/5/2020 (cjlS, COURT STAFF).
July 30, 2020	Filing 426 ORDER GRANTING #425 Joint MOTION for Hearing Re Status Conference Re Trial Date. Telephonic Status Conference set for 8/4/2020 02:00 PM before Judge Haywood S. Gilliam Jr. Signed by Judge Haywood S. Gilliam, Jr. on 7/30/2020. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (ndrS, COURT STAFF) (Filed on 7/30/2020)
July 29, 2020	Filing 425 Joint MOTION for Hearing re Status Conference re Trial Date filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Durie, Daralyn) (Filed on 7/29/2020) Modified on 7/30/2020 (jmlS, COURT STAFF).
June 8, 2020	Filing 424 NOTICE of Withdrawal of Counsel by Plexxikon Inc. (Durie, Daralyn) (Filed on 6/8/2020) Modified on 6/8/2020 (cjlS, COURT STAFF).
May 29, 2020	Filing 423 NOTICE for Withdrawal of Counsel by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 5/29/2020) Modified on 6/1/2020 (cjlS, COURT STAFF).
May 26, 2020	Filing 422 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART #204 MOTION TO EXCLUDE THE EXPERT TESTIMONY OF SUSANA ORTIZ-URDA. (ndrS, COURT STAFF) (Filed on 5/26/2020)
May 8, 2020	Filing 421 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #165 MOTION TO EXCLUDE CERTAIN OPINIONS AND TESTIMONY OF DEFENDANT'S TECHNICAL EXPERTS. (ndrS, COURT STAFF) (Filed on 5/8/2020)
April 20, 2020	Filing 420 ORDER by Hon. Haywood S. Gilliam, Jr. CONTINUING the case schedule as follows: September 8, 2020, at 3:00 p.m. for pretrial conference, and October 5, 2020, at 8:30 a.m. for 10-day jury trial. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 4/20/2020)
April 20, 2020	Reset Hearing, See Docket No. 420 : Pretrial Conference set for 9/8/2020 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. and Jury Selection \Jury Trial (10- day) set for 10/5/2020 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 4/20/2020)
April 17, 2020	Filing 419 Statement of Joint Availability re Trial by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 4/17/2020) Modified on 4/20/2020 (cjlS, COURT STAFF).
April 14, 2020	Filing 418 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 4/14/2020. Total Time in Court: 8 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler and David Mlaver. Parties are directed meet with their clients and witnesses and e-file a short statement indicating whether a September 8th pretrial conference and an October 5th jury trial will work. The Court is alternatively available for trial beginning on November 2nd or December 7th if necessary, though would prefer to set trial as early as possible. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 4/14/2020)
April 10, 2020	Set Hearing, See Docket No. 415 : Telephonic Further Case Management Conference set for 4/14/2020 02:00 PM. (ndrS, COURT STAFF) (Filed on 4/10/2020)
April 10, 2020	Filing 417 Document Sealed. ORDER GRANTING #179 MOTION TO STRIKE PORTIONS OF EXPERTREPORT. *UNREDACTED VERSION* Signed by Judge Haywood S. Gilliam, Jr. on 4/10/2020. (ndrS, COURT STAFF) (Filed on 4/10/2020) (Additional attachment(s) added on 4/15/2020: #1 Certificate/Proof of Service) (ndrS, COURT STAFF).
April 10, 2020	Filing 416 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING #179 MOTION TOSTRIKE PORTIONS OF EXPERT REPORT. REDACTED VERSION (ndrS, COURT STAFF) (Filed on 4/10/2020)
April 10, 2020	Filing 415 ORDER by Hon. Haywood S. Gilliam, Jr. GRANTING Dkt. No. #414 the parties' joint request for a status conference. The Court SETS a telephonic case management conference on April 14, 2020, at 2:00 p.m. All counsel shall use the following dial-in information to access the case management conference: Dial-In: 888-808-6929; and Passcode: 6064255. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 4/10/2020)
April 10, 2020	#Electronic filing error. REMINDER: Incorrect event used. [err101] Proper event to use is a motion. Additionally, future request should be accompanied by a proposed order. Correc ted by Clerk's Office. No further action is necessary. Re: #414 Joint Request for Status Conference Regarding Trial Date filed by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (cjlS, COURT STAFF) (Filed on 4/10/2020)
April 9, 2020	Filing 414 Joint Request for Status Conference Regarding Trial Date by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (Steindler, Thomas) (Filed on 4/9/2020) Modified on 4/10/2020 (cjlS, COURT STAFF).
March 26, 2020	Filing 413 Transcript of Proceedings held on 03/25/2020, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #412 Transcript Order ) Redaction Request due 4/16/2020. Redacted Transcript Deadline set for 4/27/2020. Release of Transcript Restriction set for 6/24/2020. (Related documents(s) #412 ) (Batalo, Pam) (Filed on 3/26/2020)
March 26, 2020	Filing 412 TRANSCRIPT ORDER for proceedings held on 3/25/2020 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Miller, Laura) (Filed on 3/26/2020)
March 26, 2020	Filing 411 TRANSCRIPT ORDER for proceedings held on 3/25/2020 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 3/26/2020)
March 25, 2020	Filing 410 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Telephonic Case Management Conference held on 3/25/2020. Total Time in Court: 12 minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Judge advises the parties that he's not inclined to vacate the trial date at this time. Parties are advised that no oral argument will be needed on the pending motions unless advised otherwise. Parties are advised that lead counsel will be the only counsel permitted to argue any issue presented to the Court beginning now through trial (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 3/25/2020) Modified on 3/26/2020 to correct typo(ndrS, COURT STAFF).
March 25, 2020	Filing 409 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #200 MOTION TO EXCLUDE TESTIMONY OF DR. MICHAEL L. METZKER. (ndrS, COURT STAFF) (Filed on 3/25/2020)
March 24, 2020	Filing 408 ORDER by Judge Haywood S. Gilliam, Jr. Granting #407 Motion for Extension of Time to File Public Versions of Documents.(ndrS, COURT STAFF) (Filed on 3/24/2020)
March 23, 2020	Filing 407 MOTION for Extension of Time to File Public Versions of Documents filed by Plexxikon Inc.. (Attachments: #1 Declaration of Matthew W. Samuels In Support of Plaintiff Plexxikon Inc.'s Unopposed Motion and [Proposed] Order to Extend Time to Submit Public Versions of Documents)(Samuels, Matthew) (Filed on 3/23/2020)
March 23, 2020	Filing 406 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a case management conference on March 25, 2020, at 1:00 p.m., to be held in lieu of the pretrial conference and hearing on the motions in limine that day. In light of the evolving circumstances with the COVID-19 outbreak, the Court does not need argument on the motions in limine at this time, and would instead like to prioritize discussing whether the case may proceed under the current case schedule. The Court's inclination is to proceed for now under the assumption that trial will proceed on June 15, 2020, as planned. However, the parties should be prepared to discuss how this case may proceed realistically under the circumstances. The Court is exploring whether video conference will be available, but for now, all counsel shall use the following dial-in information to access the case management conference: Dial-In: 888-808-6929; and Passcode: 6064255. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 3/23/2020)
March 23, 2020	Filing 405 EXHIBITS 9 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 367-2/(366-7) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: Novartis's MIL No. 3, #2 Exhibit Dkt. No. 367-3/(366-9) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 3, #3 Exhibit Dkt. No. 367-4/(366-11) Exhibit 3 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL NO. 3, #4 Exhibit Dkt. No. 367-5/(366-13) Exhibit 4 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 3, #5 Dkt. No. 369/(368-4) Plaintiff's Offer of Proof Re: Novartis's MIL No. 4, #6 Exhibit Dkt. No. 369-2/(368-6) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 4, #7 Exhibit Dkt. No. 369-3/(368-8) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 4)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 404 EXHIBITS 8 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Dkt. No. 333/(332-4) Opposition to Novartis's Motion to Strike Second Supplemental Report of Leonard, #2 Exhibit Dkt. No. 333-6/(332-10) Exhibit 5 to Miller Declaration ISO Opposition to Novartis's MTS, #3 Exhibit Dkt. No. 333-7/(332-12) Exhibit 6 to Miller Declaration ISO Opposition to Novartis's MTS, #4 Dkt. No. 364/(363-4) Plaintiff's Offer of Proof Re: Novartis's MIL No. 2, #5 Exhibit Dkt. No. 364-2/(363-6) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #6 Exhibit Dkt. No. 364-3/(363-8) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #7 Exhibit Dkt. No. 364-7/(363-12) Exhibit 6 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #8 Exhibit Dkt. No. 364-10/(363-14) Exhibit 9 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 403 EXHIBITS 7 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 298-7/(297-16) Exhibit 6 to Miller Declaration ISO Opposition to Novartis's MIL No. 4, #2 Exhibit Dkt. No. 298-8/(297-18) Exhibit 7 to Miller Declaration ISO Opposition to Novartis's MIL No. 4, #3 Exhibit Dkt. No. 327-4/(299-4) Exhibit 3 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #4 Exhibit Dkt. No. 327-5/(299-6) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #5 Dkt. No. 325/(314-5) Plaintiff's Opposition to Motion to Exclude Leonard Testimony, #6 Exhibit Dkt. No. 325-2/(314-7) Exhibit 1 to Miller Declaration ISO Opposition to Motion to Exclude Leonard Testimony, #7 Exhibit Dkt. No. 327-4/(314-15) Exhibit 3 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #8 Exhibit Dkt. No. 327-5/(314-17) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 5)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 402 EXHIBITS 6 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 292-6/(291-5) Exhibit 5 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #2 Exhibit Dkt. No. 292-8/(291-7) Exhibit 7 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #3 Exhibit Dkt. No. 292-9/(291-9) Exhibit 8 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #4 Dkt. No. 294/(293-3) Opposition to Novartis's MIL No. 2, #5 Exhibit Dkt. No. 294-3/(293-5) Exhibit 2 to Miller Declaration ISO Opposition to Novartis's MIL No. 2, #6 Exhibit Dkt. No. 294-5/(293-7) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 2, #7 Exhibit Dkt. No. 296-2/(295-3) Exhibit 1 to Miller Declaration ISO Opposition to Novartis's MIL No. 3, #8 Exhibit Dkt. No. 296-3/(295-5) Exhibit 2 to Miller Declaration ISO Opposition to Novartis's MIL No. 3)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 401 EXHIBITS 5 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 262-2/(261-6) Exhibit 1 to Miller Declaration ISO MIL No. 3, #2 Exhibit Dkt. No. 262-3/(261-8) Exhibit 2 to Miller Declaration ISO MIL No. 3, #3 Exhibit Dkt. No. 262-4/(261-10) Exhibit 3 to Miller Declaration ISO MIL No. 3, #4 Exhibit Dkt. No. 262-5/(261-12) Exhibit 4 to Miller Declaration ISO MIL No. 3, #5 Exhibit Dkt. No. 262-6/(261-14) Exhibit 5 to Miller Declaration ISO MIL No. 3, #6 Dkt. No. 264/(263-4) Plaintiff's MIL No. 4, #7 Declaration Dkt. No. 264-1/(263-6) Miller Declaration ISO MIL No. 4, #8 Exhibit Dkt. No. 264-6/(263-8) Exhibit 5 to Miller Declaration ISO MIL No. 4, #9 Exhibit Dkt. No. 264-7/(263-10) Exhibit 6 to Miller Declaration ISO MIL No. 4)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 400 EXHIBITS 4 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 234-3/(232-6) Exhibit 2 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #2 Exhibit Dkt. No. 234-5/(232-8) Exhibit 4 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #3 Exhibit Dkt. No. 234-6/(232-10) Exhibit 5 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #4 Dkt. No. 236/(235-4) Plaintiff's Motion to Strike Daubert Motions Filed June 6, 2019, #5 Exhibit Dkt. No. 236-2/(235-6) Exhibit 1 to Miller Declaration ISO MTS Daubert Motions, #6 Exhibit Dkt. No. 236-3/(235-8) Exhibit 2 to Miller Declaration ISO MTS Daubert Motions, #7 Dkt. No. 259/(258-4) Plaintiff's MIL No. 1, #8 Exhibit Dkt. No. 259-2/(258-6) Exhibit 1 to Miller Declaration ISO MIL No. 1, #9 Exhibit Dkt. No. 295-3/(258-8) Exhibit 2 to Miller Declaration ISO MIL No. 1)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 399 EXHIBITS 3 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 213-1/(211-6) Exhibit A to Metzker Declaration ISO Opposition to Motion for Partial Summary Judgment, #2 Exhibit Dkt. No. 213-2/(211-8) Exhibit B to Metzker Declaration ISO Opposition to Motion for Partial Summary Judgment, #3 Exhibit Dkt. No. 212-13/(211-10) Exhibit 12 to Miller Declaration ISO Opposition to Motion for Partial Summary Judgment, #4 Exhibit Dkt. No. 212-20/(211-12) Exhibit 19 to Miller Declaration ISO Opposition to Motion for Partial Summary Judgment, #5 Exhibit Dkt. No. 214-1/(211-14) Exhibit A to Winkler Declaration ISO Opposition to Motion for Partial Summary Judgment, #6 Exhibit Dkt. No. 325-3/(224-8) Exhibit 2 to Miller Declaration ISO Opposition to Defendant's Motion to Exclude Leonard Testimony, #7 Dkt. No. 227/(226-4) Plaintiff's Opposition to Motion to Preclude Certain Testimony of Ortiz-Urda Under Daubert, #8 Exhibit Dkt. No. 227-2/(226-6) Exhibit 1 to Miller Declaration ISO Opposition to Motion to Preclude Certain Testimony of Ortiz-Urda, #9 Exhibit Dkt. No. 227-3/(226-8) Exhibit 2 to Miller Declaration ISO Opposition to Motion to Preclude Testimony of Ortiz-Urda)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 398 EXHIBITS 2 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Dkt. No. 197/(196-4) Plaintiff's Reply ISO Motion to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #2 Exhibit Dkt. No. 208-15/(207-14) Exhibit 14 to Miller Declaration, #3 Dkt. No. 210/(209-4) Plaintiff's Opposition to Novartis's Motion for Judgment on the Pleadings, #4 Exhibit Dkt. No. 210-10/(209-14) Exhibit 9 to Miller Declaration, #5 Exhibit Dkt. No. 210-11/(209-16) Exhibit 10 to Miller Declaration, #6 Exhibit Dkt. No. 210-12/(209-18) Exhibit 11 to Miller Declaration, #7 Exhibit Dkt. No. 210-13/(209-20) Exhibit 12 to Miller Declaration, #8 Exhibit Dkt. No. 210-14/(209-22) Exhibit 13 to Miller Declaration)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 397 EXHIBITS 1 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 167-2/(166-6) Exhibit 1 to Samuels Declaration, #2 Exhibit Dkt. No. 167-10/(166-8) Exhibit 9 to Samuels Declaration, #3 Exhibit Dkt. No. 167-20/(166-10) Exhibit 19 to Samuels Declaration, #4 Dkt. No. 169/(168-10) Plaintiff's Motion to Exclude the Opinions and Testimony of Malackowski, #5 Exhibit Dkt. No. 169-3/(168-8) Exhibit 2 to Miller Declaration, #6 Exhibit Dkt. No. 169-4/(168-8) Exhibit 3 to Miller Declaration)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 396 NOTICE OF COMPLIANCE WITH COURT ORDER DATED MARCH 13, 2020 (DKT. NO. #386 ) by Plexxikon Inc. (Attachments: #1 Dkt. No. 165/(164-4) Plaintiff's Motion to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #2 Exhibit Dkt. No. 165-2(164-6) Exhibit 1 to Miller Declaration, #3 Exhibit Dkt. No. 165-3(164-8) Exhibit 2 to Miller Declaration, #4 Exhibit Dkt. No. 165-5(164-10) Exhibit 4 to Miller Declaration, #5 Exhibit Dkt. No. 165-6(164-12) Exhibit 5 to Miller Declaration, #6 Exhibit Dkt. No. 165-8(164-14) Exhibit 7 to Miller Declaration)(Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).
March 23, 2020	Filing 395 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a telephonic hearing for Monday, March 23, 2020, at 12:30 p.m., regarding logistics for the pretrial conference currently scheduled for March 25, 2020. All counsel shall use the following dial-in information to access the call today: Dial-In: 888-808-6929; and Passcode: 6064255. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 3/23/2020)
March 23, 2020	Reset Hearings, See Docket No. 406 : Telephonic Case Management Conference set for 3/25/2020 01:00 PM in Oakland, Courtroom 2, 4th Floor. (ndrS, COURT STAFF) (Filed on 3/23/2020)
March 20, 2020	Filing 394 PLAINTIFF PLEXXIKON INC.S MOTION FOR ADMINISTRATIVE RELIEF PURSUANT TO CIVIL L.R. 7-11 AND 79-5 AND MOTION FOR LEAVE TO MOVE FOR RECONSIDERATION PURSUANT TO CIVIL L.R. 7-9 filed by Plexxikon Inc. Responses due by 3/24/2020. (Attachments: #1 Declaration of Marguerite Hutchinson in Support of Plaintiff Plexxikon Inc.'s Motion for Administrative Relief, #2 Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.'s Motion for Administrative Relief, #3 Proposed Order Granting Plaintiff Plexxikon Inc.'s Motion for Administrative Relief)(Miller, Laura) (Filed on 3/20/2020) Modified on 3/23/2020 (cjlS, COURT STAFF).
March 20, 2020	Filing 393 NOVARTISS NOTICE OF COMPLIANCE WITH COURT ORDER DATED MARCH 20, 2020 (Dkt. No. #386 ) by Novartis Pharmaceuticals Corporation. (Attachments: #1 Dkt. No. 177 / (176-4) - Public Version of Partial SJ Motion, #2 Dkt. No. 177-14 / (176-10) - Public Version of Ex 12 to Baran Dec ISO Partial SJ Motion, #3 Dkt. No. 177-20 / (176-15) - Public Version of Ex 1 to Steindler Dec ISO Partial SJ Motion, #4 Dkt. No. 177-22 / (176-16) - Public Version of Ex 3 to Steindler Dec ISO Partial SJ Motion, #5 Dkt. No. 179 / (178-4) - Public Version of Motion to Strike - Metzker, #6 Dkt. No. 179-3 / (178-5) - Public Version of Ex 1 to Motion to Strike - Metzker, #7 Dkt. No. 179-7 / (178-7) - Public Version of Ex 5 to Motion to Strike - Metzker, #8 Dkt. No. 179-9 / (178-8) - Public Version of Ex 7 to Motion to Strike - Metzker, #9 Dkt. No. 186 / (185-4) - Public Version of Opp to Plex SJ Motion, #10 Dkt. No. 186-3 / (185-5) - Public Version of Ex 2 to Opp to Plex SJ Motion, #11 Dkt. No. 186-4 / (185-7) - Public Version of Ex 3 to Opp to Plex SJ Motion, #12 Dkt. No. 186-6 / (185-8) - Public Version of Ex 5 to Opp to Plex SJ Motion, #13 Dkt. No. 186-8 / (185-9) - Public Version of Ex 7 to Opp to Plex SJ Motion, #14 Dkt. No. 186-11 / (185-12) - Public Version of Ex 10 to Opp to Plex SJ Motion, #15 Dkt. No. 186-12 / (185-13) - Public Version of Ex 11 to Opp to Plex SJ Motion, #16 Dkt. No. 188 / (187-4) - Public Version of Opp to Plex Motion to Exclude - Malackowski, #17 Dkt. No. 188-2 / (187-5) - Public Version of Ex A to Opp to Plex Motion to Exclude - Malackowski, #18 Dkt. No. 188-3 / (187-6) - Public Version of Ex B to Opp to Plex Motion to Exclude - Malackowski, #19 Dkt. No. 188-4 / (187-7) - Public Version of Ex C to Opp to Plex Motion to Exclude - Malackowski, #20 Dkt. No. 200 / (199-4) - Public Version of Motion to Exclude - Metzker, #21 Dkt. No. 200-1 / (199-6) - Public Version of Baran Dec ISO Motion to Exclude - Metzker, #22 Dkt. No. 200-5 / (199-7) - Public Version of Ex 3 to Motion to Exclude - Metzker, #23 Dkt. No. 200-6 / (199-8) - Public Version of Ex 4 to Motion to Exclude - Metzker, #24 Dkt. No. 200-7 / (199-9) - Public Version of Ex 5 to Motion to Exclude - Metzker, #25 Dkt. No. 200-8 / (199-10) - Public Version of Ex 6 to Motion to Exclude - Metzker, #26 Dkt. No. 200-9 / (199-11) - Public Version of Ex 7 to Motion to Exclude - Metzker, #27 Dkt. No. 200-10 / (199-12) - Public Version of Ex 8 to Motion to Exclude - Metzker, #28 Dkt. No. 202 / (201-4) - Public Version of Motion to Exclude - Leonard, #29 Dkt. No. 202-2 / (201-5) - Public Version of Ex 1 to Motion to Exclude - Leonard, #30 Dkt. No. 202-3 / (201-6) - Public Version of Ex 2 to Motion to Exclude - Leonard, #31 Dkt. No. 204 / (203-4) - Public Version of Motion to Exclude - Ortiz, #32 Dkt. No. 204-2 / (203-5) - Public Version of Ex 1 to Motion to Exclude - Ortiz, #33 Dkt. No. 204-3 / (203-6) - Public Version of Ex 2 to Motion to Exclude - Ortiz, #34 Dkt. No. 206 / (205-4) - Public Version of Motion to Exclude - Sweeney, #35 Dkt. No. 206-2 / (205-5) - Public Version of Ex 1 to Motion to Exclude - Sweeney, #36 Dkt. No. 233 / (231-4) - Public Version of Reply ISO Partial SJ Motion, #37 Dkt. No. 233-2 / (231-6) - Public Version of Ex A ISO Reply ISO Partial SJ Motion, #38 Dkt. No. 233-3 / (231-7) - Public Version of Ex B ISO Reply ISO Partial SJ Motion, #39 Dkt. No. 233-4 / (231-8) - Public Version of Ex C ISO Reply ISO Partial SJ Motion, #40 Dkt. No. 233-5 / (231-9) - Public Version of Ex D ISO Reply ISO Partial SJ Motion, #41 Dkt. No. 233-6 / (231-10) - Public Version of Ex E ISO Reply ISO Partial SJ Motion, #42 Dkt. No. 272 / (267-4) - Public Version of MIL No. 5, #43 Dkt. No. 273-6 / (267-7) - Public Version of Ex F to Steindler Dec ISO MILs, #44 Dkt. No. 273-7 / (267-9) - Public Version of Ex G to Steindler Dec ISO MILs, #45 Dkt. No. 273-11 / (267-10) - Public Version of Ex K to Steindler Dec ISO MILs, #46 Dkt. No. 283 / (282-4) - Public Version of Opp to Plex MIL No. 1, #47 Dkt. No. 286-2 / (285-4) - Public Version of Ex A to Opp to Plex MIL No. 3, #48 Dkt. No. 286-7 / (285-6) - Public Version of Ex F to Opp to Plex MIL No. 3, #49 Dkt. No. 286-9 / (285-8) - Public Version of Ex H to Opp to Plex MIL No. 3, #50 Dkt. No. 286-10 / (285-10) - Public Version of Ex I to Opp to Plex MIL No. 3, #51 Dkt. No. 288-3 / (287-3) - Public Version of Ex B to Opp to Plex MIL No. 4, #52 Dkt. No. 288-4 / (287-4) - Public Version of Ex C to Opp to Plex MIL No. 4, #53 Dkt. No. 290-2 / (289-5) - Public Version of Ex A to Opp to Plex Mil No. 5, #54 Dkt. No. 307 / (306-4) - Public Version of Motion to Strike 2d Supp Leonard Report, #55 Dkt. No. 307-2 / (306-5) - Public Version of Ex 1 to Motion to Strike 2d Supp Leonard Report, #56 Dkt. No. 307-4 / (306-8) - Public Version of Ex 3 to Motion to Strike 2d Supp Leonard Report, #57 Dkt. No. 319 / (314-19) - Public Version of Ex 4 to Motion to Strike 2d Supp Leonard Report)(Steindler, Thomas) (Filed on 3/20/2020) Modified on 3/23/2020 (cjlS, COURT STAFF).
March 20, 2020	Filing 392 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART #236 MOTION TO STRIKE DEFENDANTS DAUBERT MOTIONS. (ndrS, COURT STAFF) (Filed on 3/20/2020)
March 18, 2020	Filing 390 Administrative Motion to File Under Seal re Objections to Special Master's Recommendation for Order re Plaintiff's Motion in Limine No. 4 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Exhibit C-4, #4 Exhibit C-10, #5 Exhibit C-11, #6 Exhibit C-12, #7 Exhibit C-13, #8 Exhibit C-14, #9 Exhibit C-15, #10 Exhibit C-16, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 3/18/2020)
March 18, 2020	Filing 389 OBJECTIONS to #388 Special Masters Order - Recommendation for Order on Plaintiff's Motion in Limine No. 4 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit C-1, #6 Exhibit C-2, #7 Exhibit C-3, #8 Exhibit C-4, #9 Exhibit C-5, #10 Exhibit C-6, #11 Exhibit C-7, #12 Exhibit C-8, #13 Exhibit C-9, #14 Exhibit C-10, #15 Exhibit C-11, #16 Exhibit C-12, #17 Exhibit C-13, #18 Exhibit C-14, #19 Exhibit C-15, #20 Exhibit C-16, #21 Exhibit C-17 - Part 1 of 2, #22 Exhibit C-17 - Part 2 of 2, #23 Exhibit D, #24 Exhibit E, #25 Exhibit E-1, #26 Exhibit F)(Steindler, Thomas) (Filed on 3/18/2020) Modified on 3/19/2020 (cjlS, COURT STAFF).
March 18, 2020	Filing 388 Special Masters Order - Recommendation for Order Regarding Plaintiff's Motion in Limine No. 4. (Steindler, Thomas) (Filed on 3/18/2020)
March 16, 2020	Filing 387 ORDER REGARDING MOTIONS TO SEAL. Signed by Judge Haywood S. Gilliam, Jr. on 3/16/2020. (ndrS, COURT STAFF) (Filed on 3/16/2020)
March 13, 2020	Filing 386 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART ( #363 ; #366 ; #368 ; #374 ; #149 ; #164 ; #235 ; #242 ; #258 ; #261 ; #263 ; #265 ; #267 ; #282 ; #285 ; #287 ; #289 ; #291 ; #293 ; #295 ; #297 ; #299 ; #306 ; #314 and #332 ) MOTIONS TO SEAL. (ndrS, COURT STAFF) (Filed on 3/13/2020)
March 12, 2020	Filing 385 ORDER by Judge Haywood S. Gilliam, Jr. Granting #157 Motion for Pro Hac Vice as to Schoenhard, Paul. (ndrS, COURT STAFF) (Filed on 3/12/2020)
February 27, 2020	Filing 384 OPPOSITION/RESPONSE (re #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Opposition, #2 Exhibit 1, #3 Exhibit 2)(Miller, Laura) (Filed on 2/27/2020)
February 13, 2020	Set Hearing as to #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1: Motion Hearing set for 3/25/2020 01:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 2/13/2020)
February 13, 2020	Filing 383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Reply)(Steindler, Thomas) (Filed on 2/13/2020)
February 13, 2020	#Electronic filing error. Proposed order was not included with the Motion in compliance with Local Rule 7-2(c). In the future, please include a proposed order as an attachment to t he motion. No further action is necessary. Re: #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 filed by Novartis Pharmaceuticals Corporation (jjbS, COURT STAFF) (Filed on 2/13/2020)
February 6, 2020	Filing 382 RESPONSE re #375 Offer of Proof by Plexxikon Inc.. (Miller, Laura) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).
February 6, 2020	Filing 381 RESPONSE re #369 Offer of Proof by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).
February 6, 2020	Filing 380 RESPONSE re #367 Offer of Proof by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).
February 6, 2020	Filing 379 RESPONSE re #364 Offer of Proof by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1)(Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).
February 3, 2020	Filing 378 ORDER REASSIGNING CASE. IT IS ORDERED that this case is reassigned to the Honorable Magistrate Judge Alex G. Tse in the San Francisco division as the referral judge. Any discovery related hearings and motions remain as scheduled. Existing discovery briefing schedules for motions remain unchanged. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ecgS, COURT STAFF) (Filed on 2/3/2020)
February 3, 2020	Case Reassigned to Magistrate Judge Alex G Tse. Chief Magistrate Judge Joseph C. Spero no longer assigned to the case. (ecgS, COURT STAFF) (Filed on 2/3/2020)
January 29, 2020	Filing 377 Declaration of Nathanael R. Luman in Support of #374 Administrative Motion to File Under Seal re Offer of Proof re Plexxikon's MIL #1 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #374 ) (Luman, Nathanael) (Filed on 1/29/2020)
January 28, 2020	Filing 376 ORDER by Judge Haywood S. Gilliam, Jr. Granting #373 Motion to Remove Incorrectly Filed Document. (ndrS, COURT STAFF) (Filed on 1/28/2020)
January 27, 2020	Filing 375 Offer of Proof re Plexxikon's MIL #1 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/27/2020) Modified on 1/28/2020 (jjbS, COURT STAFF).
January 27, 2020	Filing 374 Administrative Motion to File Under Seal re Offer of Proof re Plexxikon's MIL #1 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Offer of Proof, #4 Unredacted Version of Offer of Proof, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 1/27/2020)
January 27, 2020	Filing 373 MOTION to Remove Incorrectly Filed Document filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 1/27/2020)
January 27, 2020	Filing 372 Declaration of Nathanael R. Luman in Support of #368 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #368 ) (Luman, Nathanael) (Filed on 1/27/2020)
January 27, 2020	Filing 371 Declaration of Nathanael R. Luman in Support of #366 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #366 ) (Luman, Nathanael) (Filed on 1/27/2020)
January 27, 2020	Filing 370 Declaration of Nathanael R. Luman in Support of #363 Administrative Motion to File Under Seal Plaintiff Plexxikon's Offer of Proof re: Novartis's Motion in Limine No. 2 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #363 ) (Luman, Nathanael) (Filed on 1/27/2020)
January 23, 2020	Filing 369 Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 by Plexxikon Inc. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #2 Exhibit 1, #3 Exhibit 2)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).
January 23, 2020	Filing 368 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Administrative Motion to Seal, #2 Proposed Order, #3 Redacted version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #4 Unredacted version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #5 Redacted version of Exhibit 1, #6 Unredacted version of Exhibit 1, #7 Redacted version of Exhibit 2, #8 Unredacted version of Exhibit 2, #9 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)
January 23, 2020	Filing 367 Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 by Plexxikon Inc. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).
January 23, 2020	Filing 366 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Marguerite Hutchinson in support of Plexxikon's Administrative Motion to Seal, #2 Declaration of Laura Miller in support of Plexxikon's Administrative Motion to Seal, #3 Proposed Order, #4 Redacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #5 Unredacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #6 Redacted Version of Ex. 1 to the declaration, #7 Unredacted Version of Ex. 1, #8 Redacted Version of Ex. 2, #9 Unredacted Version of Ex. 2, #10 Redacted Version of Ex. 3, #11 Unredacted Version of Ex. 3, #12 Redacted Version of Ex. 4, #13 Unredacted Version of Ex. 4, #14 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)
January 23, 2020	Filing 365 * REMOVED PER ORDER AT DOCKET NO. #376 * Offer of Proof re Plexxikon's Motion In Limine #1 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF). Modified on 1/27/2020 (fff, COURT STAFF). (jjbS, COURT STAFF). Modified on 1/29/2020 (jjbS, COURT STAFF).
January 23, 2020	Filing 364 Offer of Proof by Plexxikon Inc. re: Novartis's Motion in Limine No. 2 (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).
January 23, 2020	Filing 363 Administrative Motion to File Under Seal Plaintiff Plexxikon's Offer of Proof re: Novartis's Motion in Limine No. 2 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura Miller in support of Plexxikon's Motion to file under seal, #2 Proposed Order, #3 Redacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #4 Unredacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #9 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #10 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #11 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #12 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #13 Redacted Version of Exhibit 9 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #14 Unredacted Version of Exhibit 9 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #15 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)
January 23, 2020	Filing 362 NOTICE re #361 Order on Motion for Leave to File Second Summary Judgment Motion by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/23/2020) Modified on 1/23/2020 (jjbS, COURT STAFF).
January 16, 2020	Filing 361 ORDER by Judge Haywood S. Gilliam, Jr. DENYING DEFENDANTS #345 MOTION FOR LEAVE TO FILE SECOND SUMMARY JUDGMENT MOTION.(ndrS, COURT STAFF) (Filed on 1/16/2020)
January 14, 2020	Filing 360 ORDER by Hon. Haywood S. Gilliam, Jr. VACATING the hearing previously scheduled for January 16, 2020, at 2:00 p.m. The Court takes Dkt. No. #345 , Defendant's motion for leave to file a second summary judgment motion, under submission. The Court will issue a written order. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 1/14/2020)
January 3, 2020	Filing 359 ORDER by Judge Haywood S. Gilliam, Jr. Granting #358 Stipulation re Leave to File Amended Joint Proposed Jury Instructions. (ndrS, COURT STAFF) (Filed on 1/3/2020)
December 31, 2019	Filing 358 STIPULATION WITH PROPOSED ORDER re Leave to File Amended Joint Proposed Jury Instructions filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 12/31/2019) Modified on 1/2/2020 (jjbS, COURT STAFF).
December 20, 2019	Filing 357 Proposed Jury Instructions by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Steindler, Thomas) (Filed on 12/20/2019) Modified on 12/20/2019 (jjbS, COURT STAFF).
December 17, 2019	Filing 356 ORDER by Judge Haywood S. Gilliam, Jr. Granting #354 Motion for Extension of Time to File Response/Reply. (ndrS, COURT STAFF) (Filed on 12/17/2019)
December 17, 2019	Filing 355 Statement of Non-Opposition re #354 MOTION for Extension of Time to File Response/Reply to Defendant's Motion for Leave to File Second Summary Judgment Motion filed byNovartis Pharmaceuticals Corporation. (Related document(s) #354 ) (Steindler, Thomas) (Filed on 12/17/2019)
December 16, 2019	Filing 354 MOTION for Extension of Time to File Response/Reply re #345 Motion for Leave to File Second Summary Judgment Motion filed by Plexxikon Inc. (Attachments: #1 Declaration of Eugene Novikov in support of Motion, #2 Exhibit A, #3 Exhibit B)(Novikov, Eugene) (Filed on 12/16/2019) Modified on 12/17/2019 (jjbS, COURT STAFF).
December 13, 2019	Filing 353 REPLY (re #345 MOTION for Leave to File Second Summary Judgment Motion ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 12/13/2019)
December 11, 2019	Filing 352 Transcript of Proceedings held on December 3, 2019, before Judge Haywood S. Gilliam. Court Reporter Diane E. Skillman, telephone number 925-899-2812, Diane_Skillman@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #348 Transcript Order ) Release of Transcript Restriction set for 3/10/2020. (Related documents(s) #348 ) (Skillman, Diane) (Filed on 12/11/2019)
December 10, 2019	Filing 351 OPPOSITION/RESPONSE (re #345 MOTION for Leave to File Second Summary Judgment Motion ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to the declaration of Laura E. Miller)(Miller, Laura) (Filed on 12/10/2019)
December 5, 2019	Filing 350 ORDER APPOINTING SPECIAL MASTER. Signed by Judge Haywood S. Gilliam, Jr. on 12/5/2019. (ndrS, COURT STAFF) (Filed on 12/5/2019)
December 4, 2019	Filing 349 TRANSCRIPT ORDER for proceedings held on 12/03/2019 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Diane Skillman. (Miller, Laura) (Filed on 12/4/2019)
December 4, 2019	Filing 348 TRANSCRIPT ORDER for proceedings held on 12/3/2019 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Diane Skillman. (Steindler, Thomas) (Filed on 12/4/2019)
December 3, 2019	Filing 347 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 12/3/2019. Total Time in Court: 38 Minutes. Court Reporter: Diane Skillman. Plaintiff Attorney: Eugene Novikov; Daralyn Duri and David McGowan. Defendant Attorney: Thomas Steindler. Parties are directed to meet and confer regarding substantive jury instructions and e-file by December 20th a revised set of complete jury instructions including any agreed upon instructions. The Court sets January 23rd as the deadline for Plaintiff to submit offer of proof regarding what they plan to introduce as it pertains to Defendants motions in limine nos. 2, 3 and 4, and Defendant to submit offer of proof regarding what they plan to introduce as it pertains to Plaintiffs motion in limine no. 1. Each side has until February 6th to respond to the other sides offer of proof. The Court shall appoint former Magistrate Judge Laporte as a special master to provide a report and recommendation regarding Plaintiffs motion in limine no. 4. The Court resets the case schedule as follows: January 16, 2020 at 2:00 p.m. for hearing on motion for leave to file second summary judgment motion (docket no. #345 ); March 25, 2020 at 1:00 p.m. for hearing on jury instructions and remaining motions in limine; May 19, 2020 at 3:00 p.m. for pretrial conference and June 15, 2020 at 8:30 a.m. for 10-day-jury trial. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 12/3/2019)
December 3, 2019	Reset Hearing as to #345 MOTION for Leave to File Second Summary Judgment Motion, See Docket No. 347 : Motion Hearing set for 1/16/2020 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 12/3/2019)
November 27, 2019	Filing 346 ORDER SETTING CASE MANAGEMENT CONFERENCE. Further Case Management Conference set for 12/3/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor. Signed by Judge Haywood S. Gilliam, Jr. on 11/27/2019. (ndrS, COURT STAFF) (Filed on 11/27/2019)
November 25, 2019	Set Hearing as to #345 MOTION for Leave to File Second Summary Judgment Motion : Motion Hearing set for 1/9/2020 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 11/25/2019)
November 25, 2019	Filing 345 MOTION for Leave to File Second Summary Judgment Motion filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order, #2 Motion for Summary Judgement, #3 Motion for Summary Judgment - Proposed Order, #4 Declaration of Thomas P. Steindler, #5 Exhibit Steindler Dec Ex A, #6 Exhibit Steindler Dec Ex B, #7 Exhibit Steindler Dec Ex C, #8 Exhibit Steindler Dec Ex D, #9 Exhibit Steindler Dec Ex E, #10 Exhibit Steindler Dec Ex F, #11 Exhibit Steindler Dec Ex G, #12 Exhibit Steindler Dec Ex H, #13 Exhibit Steindler Dec Ex I, #14 Exhibit Steindler Dec Ex J, #15 Exhibit Steindler Dec Ex K, #16 Exhibit Steindler Dec Ex L, #17 Declaration of Phil S. Baran, #18 Exhibit Baran Dec Ex A, #19 Exhibit Baran Dec Ex B, #20 Exhibit Baran Dec Ex C, #21 Declaration of Andy Jennings, #22 Exhibit Jennings Dec Ex A, #23 Exhibit Jennings Dec Ex B)(Steindler, Thomas) (Filed on 11/25/2019)
November 25, 2019	Filing 344 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion for Summary Judgment, #4 Unredacted Version of Motion for Summary Judgment, #5 Unredacted Version of Exhibit C, #6 Unredacted Version of Exhibit D, #7 Unredacted Version of Exhibit F, #8 Unredacted Version of Exhibit G, #9 Unredacted Version of Exhibit I, #10 Unredacted Version of Exhibit J, #11 Unredacted Version of Exhibit K, #12 Unredacted Version of Exhibit L, #13 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 11/25/2019) Modified on 11/26/2019 (jjbS, COURT STAFF).
November 20, 2019	Filing 343 TRANSCRIPT ORDER for proceedings held on 11/1/2019 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 11/20/2019)
November 15, 2019	Filing 342 CLERK'S NOTICE. Notice is hereby given that the #307 motion to strike Second Supplemental Report of Expert Gregory K. Leonard, previously set for December 3rd, will be held on that date before Judge Haywood S. Gilliam, Jr., at 3:00 p.m. in Courtroom 2, 4th Floor, 1301 Clay Street, Oakland, CA. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 11/15/2019)
November 8, 2019	Filing 341 Transcript of Proceedings held on 11/01/19, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #338 Transcript Order ) Redaction Request due 11/29/2019. Redacted Transcript Deadline set for 12/9/2019. Release of Transcript Restriction set for 2/6/2020. (Related documents(s) #338 ) (Batalo, Pam) (Filed on 11/8/2019)
November 6, 2019	Filing 340 STATEMENT OF RECENT DECISION pursuant to Civil Local Rule 7-3.d filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #309 ) (Steindler, Thomas) (Filed on 11/6/2019)
November 5, 2019	Filing 339 REPLY (re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 5)(Steindler, Thomas) (Filed on 11/5/2019)
November 5, 2019	Filing 338 TRANSCRIPT ORDER for proceedings held on 11/1/19 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Krishnapriyan, Raghav) (Filed on 11/5/2019)
November 4, 2019	Filing 336 STATEMENT OF RECENT DECISION pursuant to Civil Local Rule 7-3.d filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #268 ) (Steindler, Thomas) (Filed on 11/4/2019)
November 1, 2019	Filing 337 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Motions Hearings held on 11/1/2019. Total Time in Court: 2 hours and 31 minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Matt Samuels; David McGowan; Raghav Krishnapriyan; Daralyn Durie and Eugene Novokov. Defendant Attorney: Thomas Steindler; Paul Schoenhard; K. Nicole Clouse. Defendants motion for judgment on pleadings (docket no. #175 ) is argued and submitted by the parties and DENIED on the record by the Court. Plaintiffs motions for miscellaneous relief (docket nos. #165 and #169 ), motion for summary judgment (docket no. #167 ) and Defendants motion for summary judgment (docket no. #177 ), motion to strike (docket no. 179) and motions for miscellaneous relief (docket nos. #200 , #202 and #204 ) are argued and submitted by the parties and taken under submission by the Court. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 11/1/2019)
October 31, 2019	Filing 335 NOTICE of Supplemental Authority by Plexxikon Inc. (Samuels, Matthew) (Filed on 10/31/2019) Modified on 11/1/2019 (jjbS, COURT STAFF).
October 30, 2019	Filing 334 Declaration of Nathanael R. Luman in Support of #332 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #332 ) (Luman, Nathanael) (Filed on 10/30/2019)
October 29, 2019	Filing 333 OPPOSITION/RESPONSE (re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to the Declaration of Laura E. Miller, #3 Exhibit 2 to the Declaration of Laura E. Miller, #4 Exhibit 3 to the Declaration of Laura E. Miller, #5 Exhibit 4 to the Declaration of Laura E. Miller, #6 Exhibit 5 to the Declaration of Laura E. Miller, #7 Exhibit 6 to the Declaration of Laura E. Miller, #8 Exhibit 7 to the Declaration of Laura E. Miller, #9 Exhibit 8 to the Declaration of Laura E. Miller, #10 Exhibit 9 to the Declaration of Laura E. Miller, #11 Exhibit 10 to the Declaration of Laura E. Miller, #12 Exhibit 11 to the Declaration of Laura E. Miller)(Miller, Laura) (Filed on 10/29/2019)
October 29, 2019	Filing 332 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Marguerite Hutchinson in support of Plexxikon's Administrative Motion to File Under Seal, #2 Declaration of Laura E. Miller in support of Plexxikon's Administrative Motion to File Under Seal, #3 REDACTED version of Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #4 UNREDACTED version of Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #5 REDACTED version of Ex. 3 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #6 UNREDACTED version of Ex. 3 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #7 REDACTED version of Ex. 4 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #8 UNREDACTED version of Ex. 4 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #9 REDACTED version of Ex. 5 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #10 UNREDACTED version of Ex. 5 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #11 REDACTED version of Ex. 6 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #12 UNREDACTED version of Ex. 6 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #13 Proposed Order, #14 Proof of Service)(Miller, Laura) (Filed on 10/29/2019)
October 29, 2019	Filing 331 ORDER REASSIGNING CASE. Signed by the Clerk on 10/29/2019. (ecgS-adi, COURT STAFF) (Filed on 10/29/2019)
October 29, 2019	Case Reassigned to Magistrate Judge Joseph C. Spero. Magistrate Judge Elizabeth D. Laporte no longer assigned to the case. (ecgS-adi, COURT STAFF) (Filed on 10/29/2019)
October 28, 2019	Filing 330 Declaration of Nathanael R. Luman in Support of #314 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #314 ) (Luman, Nathanael) (Filed on 10/28/2019)
October 25, 2019	Filing 329 ORDER by Judge Haywood S. Gilliam, Jr. Granting #324 Motion to Remove Incorrectly Filed Document. (ndrS, COURT STAFF) (Filed on 10/25/2019)
October 24, 2019	Filing 328 NOTICE of Corrected Documents re #326 Opposition/Response to Motion, #327 Opposition/Response to Motion, #325 Opposition/Response to Motion by Plexxikon Inc. (Krishnapriyan, Raghav) (Filed on 10/24/2019) Modified on 10/25/2019 (cjlS, COURT STAFF).
October 24, 2019	Filing 327 OPPOSITION/RESPONSE (re #272 MOTION in Limine Number 5 re Damages ) CORRECTION OF DOCKET #300 filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Krishnapriyan, Raghav) (Filed on 10/24/2019)
October 24, 2019	Filing 326 OPPOSITION/RESPONSE (re #271 MOTION in Limine Number 4 re Alleged Copying ) CORRECTION OF DOCKET #298 filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Errata 3)(Krishnapriyan, Raghav) (Filed on 10/24/2019)
October 24, 2019	Filing 325 OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) CORRECTION OF DOCKET #225 filed byPlexxikon Inc.. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3)(Krishnapriyan, Raghav) (Filed on 10/24/2019)
October 24, 2019	Filing 324 MOTION to Remove Incorrectly Filed Document filed by Plexxikon Inc.. (Attachments: #1 Proposed Order)(Krishnapriyan, Raghav) (Filed on 10/24/2019)
October 24, 2019	Filing 323 OPPOSITION/RESPONSE (re #322 MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Steindler, Thomas) (Filed on 10/24/2019)
October 24, 2019	#Electronic filing error. Motion did not include a proposed order. Please re-file the motion in its entirety with the proposed order as an attachment. Re: #322 MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 filed by Plexxikon Inc. (jjbS, COURT STAFF) (Filed on 10/24/2019)
October 23, 2019	Filing 322 RE-FILED AT DOCKET NO. #324 MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 filed by Plexxikon Inc.. (Krishnapriyan, Raghav) (Filed on 10/23/2019) Modified on 10/24/2019 (jjbS, COURT STAFF).
October 23, 2019	Filing 321 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Plaintiff to re-file any corrections it has to motions or other filings on the docket in their entirety. Plaintiff is further DIRECTED to file a separate summary document explaining which documents or selections within those documents have been corrected, and the reason for each correction. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 10/23/2019)
October 23, 2019	Filing 320 NOTICE by Plexxikon Inc. of Withdrawal of Counsel for Victoria L. Weatherford (Samuels, Matthew) (Filed on 10/23/2019)
October 22, 2019	Filing 319 EXHIBITS re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard CORRECTION OF DOCKET # [307-5] filed byPlexxikon Inc.. (Related document(s) #307 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 22, 2019	Filing 318 EXHIBITS re #301 Declaration in Support, #300 Opposition/Response to Motion,, CORRECTION OF DOCKET # [300-2] and [300-3] filed byPlexxikon Inc.. (Attachments: #1 Exhibit 2)(Related document(s) #301 , #300 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 22, 2019	Filing 317 EXHIBITS re #300 Opposition/Response to Motion,, #299 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018 CORRECTION OF DOCKET # [299-4] and [299-6] filed byPlexxikon Inc.. (Attachments: #1 Exhibit 4)(Related document(s) #300 , #299 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 22, 2019	Filing 316 EXHIBITS re #298 Opposition/Response to Motion,, #297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying CORRECTION OF DOCKET # [297-10] filed byPlexxikon Inc.. (Related document(s) #298 , #297 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 22, 2019	Filing 315 OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) CORRECTION OF DOCKET #225 and [225-2] filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 22, 2019	Filing 314 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Raghav Krishnapriyan, #2 Declaration of Marguerite Hutchinson, #3 Proposed Order, #4 Redaacted Version of 225-00, #5 Unredaacted Version of 225-00, #6 Redaacted Version of 225-2, #7 Unredaacted Version of 225-2, #8 Redacted Version of 297-10, #9 Unredacted Version of 297-10, #10 Redacted Version of 300-02, #11 Unredacted Version of 300-02, #12 Redacted Version of 300-03, #13 Unredacted Version of 300-03, #14 Redacted Version of 299-04, #15 Unredacted Version of 299-04, #16 Redacted Version of 299-06, #17 Unredacted Version of 299-06, #18 Redacted Version of 307-05, #19 Unredacted Version of 307-05)(Krishnapriyan, Raghav) (Filed on 10/22/2019)
October 18, 2019	Filing 313 Joint Proposed Pretrial Statement and Order by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).
October 18, 2019	Filing 312 Declaration of Marguerite Hutchinson in Support of #306 Administrative Motion to File Under Seal re Motion to Strike Second Supplemental Report of Expert Gregory K. Leonard filed byPlexxikon Inc.. (Related document(s) #306 ) (Krishnapriyan, Raghav) (Filed on 10/18/2019)
October 18, 2019	Filing 311 Proposed Joint Statement of the Case by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).
October 18, 2019	Filing 310 Joint Proposed Voir Dire Questions by Plexxikon Inc. and Novartis Pharmaceuticals Corporation (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF). Modified on 10/21/2019 (jjbS, COURT STAFF).
October 18, 2019	Filing 309 Joint Proposed Jury Instructions by Plexxikon Inc. and Novartis Pharmaceuticals Corporation (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).
October 18, 2019	Filing 308 Joint Proposed Verdict Form by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).
October 15, 2019	Filing 307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 12/3/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/29/2019. Replies due by 11/5/2019. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, # 5REMOVED PER #329 ORDER Exhibit 4)(Steindler, Thomas) (Filed on 10/15/2019) Modified on 10/18/2019 (jjbS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).
October 15, 2019	Filing 306 Administrative Motion to File Under Seal re Motion to Strike Second Supplemental Report of Expert Gregory K. Leonard filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Strike, #4 Unredacted Version of Motion to Strike, #5 Unredacted Version of Exhibit 1, #6 Redacted Version of Exhibit 2, #7 Unredacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 3, #9 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 10/15/2019)
October 1, 2019	Filing 305 NOTICE of Appearance by Eugene Novikov (Novikov, Eugene) (Filed on 10/1/2019)
September 19, 2019	Filing 304 ORDER Granting Non-Party Glaxosmithklien's Administrative Motion to File Under Seal Exhibits to Joint Report to the Court Regarding Discovery Disputes by Magistrate Judge Elizabeth D. Laporte: granting #128 Administrative Motion. (shyS, COURT STAFF) (Filed on 9/19/2019)
September 9, 2019	Filing 303 Order by Magistrate Judge Elizabeth D. Laporte granting #250 Plaintiff's Motion to Strike Novartis's Supplemental Initial Disclosures.(tmiS, COURT STAFF) (Filed on 9/9/2019)
September 9, 2019	Filing 302 Declaration of Nathanael R. Luman in Support of #297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #297 ) (Luman, Nathanael) (Filed on 9/9/2019)
September 9, 2019	Filing 301 Declaration of Nathanael R. Luman in Support of #289 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #289 ) (Luman, Nathanael) (Filed on 9/9/2019)
September 6, 2019	Filing 300 *DISREGARD, SEE DOCKET ENTRY #327 * OPPOSITION/RESPONSE (re #272 MOTION in Limine Number 5 re Damages ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, # 2 REMOVED PER #329 ORDER Exhibit 1 to Declaration of Laura E. Miller, # 3 REMOVED PER #329 ORDER Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019) Modified on 10/17/2019 (ddkS, COURT STAFF). Modified on 10/25/2019 (cjlS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).
September 6, 2019	Filing 299 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018, #4 Unredacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #5 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #6 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #7 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 298 *DISREGARD, SEE DOCKET ENTRY #326 * OPPOSITION/RESPONSE (re #271 MOTION in Limine Number 4 re Alleged Copying ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019) Modified on 10/25/2019 (cjlS, COURT STAFF).
September 6, 2019	Filing 297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying filed by Plexxikon Inc.. (Attachments: #1 Declaration Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #9 Redacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #10 Unredacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #11 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #12 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #13 Redacted Version of Exhibit 5 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #14 Unredacted Version of Exhibit 5 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #15 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #16 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #17 Redacted Version of Exhibit 7 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #18 Unredacted Version of Exhibit 7 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #19 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 296 OPPOSITION/RESPONSE (re #270 MOTION in Limine Number 3 re Scope of Patent Rights ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 295 Administrative Motion to File Under Seal re Plexxikon Inc Opposition to Novartis Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #4 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #5 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #6 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #7 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 294 OPPOSITION/RESPONSE (re #269 MOTION in Limine Number 2 re Unasserted Patents ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 293 Administrative Motion to File Under Seal re Plexxikon Opposition to Novartis Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #5 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #6 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #7 Redacted Version Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #8 Unredacted Version Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #9 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 292 OPPOSITION/RESPONSE (re #268 MOTION in Limine Number 1 re PTAB Proceedings ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 291 Administrative Motion to File Under Seal Plaintiff Plexxikon Inc.'s Opposition to Novartis's Motion in Limine No. 1 re: PTAB Proceedings filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Opposition to Novartis MIL No 1, #4 Unredacted Version of Opposition to Novartis MIL No 1, #5 Redacted Version of Exhibit 5 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #6 Unredacted Version of Exhibit 5 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #7 Redacted Version of Exhibit 7 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #8 Unredacted Version of Exhibit 7 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #9 Redacted Version of Exhibit 8 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #10 Unredacted Version of Exhibit 8 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #11 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)
September 6, 2019	Filing 290 OPPOSITION/RESPONSE (re #266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 289 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #4 Unredacted Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #5 Unredacted Version of Exhibit A to Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #6 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 288 OPPOSITION/RESPONSE (re #264 MOTION in Limine No. 4 re: Excluding Withheld Evidence ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A to Steindler Declaration, #3 Exhibit B to Steindler Declaration, #4 Exhibit C to Steindler Declaration, #5 Exhibit D to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 287 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Unredacted Version of Exhibit B to Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence, #4 Unredacted Version of Exhibit C to Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 286 OPPOSITION/RESPONSE (re #262 MOTION in Limine No. 3 re: Cumulative Expert Testimony ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit A to Steindler Declaration, #3 Exhibit B to Steindler Declaration, #4 Exhibit C to Steindler Declaration, #5 Exhibit D to Steindler Declaration, #6 Exhibit E to Steindler Declaration, #7 Exhibit F to Steindler Declaration, #8 Exhibit G to Steindler Declaration, #9 Exhibit H to Steindler Declaration, #10 Exhibit I to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 285 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit A Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #4 Unredacted Version of Exhibit A Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #5 Redacted Version of Exhibit F Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #6 Unredacted Version of Exhibit F Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #7 Redacted Version of Exhibit H Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #8 Unredacted Version of Exhibit H Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #9 Redacted Version of Exhibit I Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #10 Unredacted Version of Exhibit I Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 284 OPPOSITION/RESPONSE (re #260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 283 OPPOSITION/RESPONSE (re #259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 9/6/2019)
September 6, 2019	Filing 282 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges, #4 Unredacted Version of Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)
September 5, 2019	Filing 281 Transcript of Proceedings held on August 27, 2019, before Judge Elizabeth D. Laporte. Court Reporter/Transcriber Joan Marie Columbini, CSR, RPR, telephone number (510) 367-3043, joan.columbini.csr@gmail.com. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #278 Transcript Order ) Redaction Request due 9/26/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/4/2019. (Related documents(s) #278 ) (Columbini, Joan) (Filed on 9/5/2019)
September 5, 2019	Filing 280 Transcript of Proceedings held on 08/29/19, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #277 Transcript Order ) Redaction Request due 9/26/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/4/2019. (Related documents(s) #277 ) (Batalo, Pam) (Filed on 9/5/2019)
September 4, 2019	Filing 279 TRANSCRIPT ORDER for proceedings held on 8/29/19 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 9/4/2019)
September 4, 2019	Filing 278 TRANSCRIPT ORDER for proceedings held on 8/27/2019 before Magistrate Judge Elizabeth D. Laporte by Novartis Pharmaceuticals Corporation, for Court Reporter FTR - San Francisco. (Steindler, Thomas) (Filed on 9/4/2019)
September 3, 2019	Filing 277 TRANSCRIPT ORDER for proceedings held on 8/29/2019 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Miller, Laura) (Filed on 9/3/2019)
August 29, 2019	Filing 276 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 8/29/2019. Total Time in Court: 13 Minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The judge reset the following dates: November 1, 2019, at 2:00 p.m. for hearing on motions (docket nos. #165 , #167 , #169 , #175 , #177 , #179 , #200 , #202 and #204 ); December 3, 2019, at 3:00 p.m. for pretrial conference/hearing on motions in limine (docket nos. #259 , #260 , #262 , #264 , #266 , #268 , #269 , #270 , #271 and #272 ) and January 21, 2020, at 8:30 a.m. for jury trial. Parties are directed to meet and confer regarding any discovery dispute, consistent with the discovery magistrate judges procedures. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 8/29/2019)
August 29, 2019	Filing 274 Declaration of Nathanael R. Luman in Support of #265 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 5 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #265 ) (Luman, Nathanael) (Filed on 8/29/2019)
August 29, 2019	#Electronic filing error. In the future, please be sure to set the correct opposition deadlines when filing your Motion in Limine pursuant to number 8 on page 4 of the Judge's Pre-trial Standing order. Corrected by Clerk's Office. No further action is necessary. Re: #264 MOTION in Limine No. 4 re: Excluding Withheld Evidence filed by Plexxikon Inc., #260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office filed by Plexxikon Inc., #266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony filed by Plexxikon Inc., #262 MOTION in Limine No. 3 re: Cumulative Expert Testimony filed by Plexxikon Inc., #259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges filed by Plexxikon Inc. (jjbS, COURT STAFF) (Filed on 8/29/2019)
August 28, 2019	#Electronic filing error. REMINDER TO COUNSEL: In the future, please attach all supporting document and to the Motion. No further action is necessary. Re: #273 Declarati on in Support, filed by Novartis Pharmaceuticals Corporation (jjbS, COURT STAFF) (Filed on 8/28/2019)
August 27, 2019	Filing 275 Minute Entry for proceedings held on 8/27/2019 before Magistrate Judge Elizabeth D. Laporte regarding the motion to strike. Hearing held The Court takes the motion under submission. FTR Time: 2:09 - 2:23. Plaintiff Attorney: Luara Miller. Defendant Attorney: Jennifer Routh. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Date Filed: 8/27/2019) Modified on 9/4/2019: Matter transcribed by Joan Columbini. (rjdS, COURT STAFF).
August 27, 2019	Filing 273 Declaration of Thomas P. Steindler in Support of #272 MOTION in Limine Number 5 re Damages, #271 MOTION in Limine Number 4 re Alleged Copying, #268 MOTION in Limine Number 1 re PTAB Proceedings, #269 MOTION in Limine Number 2 re Unasserted Patents, #270 MOTION in Limine Number 3 re Scope of Patent Rights filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K)(Related document(s) #272 , #271 , #268 , #269 , #270 ) (Steindler, Thomas) (Filed on 8/27/2019)
August 27, 2019	Filing 272 MOTION in Limine Number 5 re Damages filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 271 MOTION in Limine Number 4 re Alleged Copying filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 270 MOTION in Limine Number 3 re Scope of Patent Rights filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 269 MOTION in Limine Number 2 re Unasserted Patents filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 268 MOTION in Limine Number 1 re PTAB Proceedings filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 267 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of MIL #5, #4 Unredacted Version of MIL #5, #5 Unredacted Version of Exhibit E, #6 Redacted Version of Exhibit F, #7 Unredacted Version of Exhibit F, #8 Redacted Version of Exhibit G, #9 Unredacted Version of Exhibit G, #10 Unredacted Version of Exhibit K, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 8/27/2019)
August 27, 2019	Filing 266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony filed by Plexxikon Inc. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/28/2019 (jjbS, COURT STAFF). Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 265 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 5 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #7 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)
August 27, 2019	Filing 264 MOTION in Limine No. 4 re: Excluding Withheld Evidence filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 263 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 4 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #5 Redacted Version of Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #6 Unredacted Version of Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #7 Redacted Version of Exhibit 5 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #8 Unredacted Version of Exhibit 5 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #9 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #10 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #11 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)
August 27, 2019	Filing 262 MOTION in Limine No. 3 re: Cumulative Expert Testimony filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 261 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 3 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #5 Redacted Version of Exhibit 1 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #6 Unredacted Version of Exhibit 1 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #7 Redacted Version of Exhibit 2 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #8 Unredacted Version of Exhibit 2 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #9 Redacted Version of Exhibit 3 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #10 Unredacted Version of Exhibit 3 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #11 Redacted Version of Exhibit 4 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #12 Unredacted Version of Exhibit 4 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #13 Redacted Version of Exhibit 5 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #14 Unredacted Version of Exhibit 5 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #15 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)
August 27, 2019	Filing 260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura Miller, #2 Exhibit 1 to the Declaration of Laura Miller, #3 Exhibit 2 to the Declaration of Laura Miller, #4 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).
August 27, 2019	Filing 258 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 1 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plexxikon's MIL 1, #4 Unredacted version of Plexxikon's MIL 1, #5 Redacted Version of Exhibit 1 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #6 Unredacted Version of Exhibit 1 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #7 Redacted Version of Exhibit 2 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #8 Unredacted Version of Exhibit 2 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #9 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)
August 26, 2019	Set Hearing, See Docket No. #257 : Further Case Management Conference set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor. (ndrS, COURT STAFF) (Filed on 8/26/2019)
August 26, 2019	Filing 257 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING case management conference on August 29, 2019, at 2:00 p.m. (hsglc1S, COURT STAFF) (Filed on 8/26/2019)
August 19, 2019	Filing 256 ORDER by Judge Haywood S. Gilliam, Jr. Granting #255 Motion for Pro Hac Vice as to Jennifer B. Routh. (ndrS, COURT STAFF) (Filed on 8/19/2019)
August 16, 2019	Filing 255 MOTION for leave to appear in Pro Hac Vice for Jennifer B. Routh ( Filing fee $ 310, receipt number 0971-13620000.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Proposed Order)(Routh, Jennifer) (Filed on 8/16/2019)
August 13, 2019	Filing 254 REPLY (re #250 MOTION to Strike Novartis's Supplemental Initial Disclosures ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit A to the declaration of Laura E. Miller)(Miller, Laura) (Filed on 8/13/2019)
August 6, 2019	Filing 253 OPPOSITION/RESPONSE (re #250 MOTION to Strike Novartis's Supplemental Initial Disclosures ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Steindler, Thomas) (Filed on 8/6/2019)
July 31, 2019	Filing 252 ORDER by Judge Haywood S. Gilliam, Jr. Granting #249 Motion for Pro Hac Vice as to Michael S. Nadel. (ndrS, COURT STAFF) (Filed on 7/31/2019)
July 26, 2019	Filing 251 CLERK'S NOTICE: The parties are hereby notified that the hearing on Plaintiff's motion to strike #250 is rescheduled to 8/27/2019 at 2:00 PM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Filed on 7/26/2019)
July 23, 2019	Filing 250 MOTION to Strike Novartis's Supplemental Initial Disclosures filed by Plexxikon Inc.. Motion Hearing set for 8/27/2019 09:00 AM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. Responses due by 8/6/2019. Replies due by 8/13/2019. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon Inc.'s Motion to Strike, #2 Exhibit A to the Declaration of Laura E. Miller, #3 Exhibit B to the Declaration of Laura E. Miller, #4 Exhibit C to the Declaration of Laura E. Miller, #5 Exhibit D to the Declaration of Laura E. Miller, #6 Proposed Order)(Miller, Laura) (Filed on 7/23/2019)
July 23, 2019	Filing 249 MOTION for leave to appear in Pro Hac Vice - Michael S. Nadel ( Filing fee $ 310, receipt number 0971-13543679.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Nadel, Michael) (Filed on 7/23/2019)
July 11, 2019	Filing 248 REPLY (re #236 MOTION to Strike #206 MOTION to Exclude Expert Testimony of Ted Sweeney , #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda , #200 MOTION to Exclude Expert Testimony of Michael L. Metzker , [20 ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 7/11/2019)
July 3, 2019	Filing 247 OPPOSITION/RESPONSE (re #236 Motion to Strike #206 Motion to Exclude Expert Testimony of Ted Sweeney, #204 Motion to Exclude the Expert Testimony of Susana Ortiz-Urda, #200 Motion to Exclude Expert Testimony of Michael L. Metzker), filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 7/3/2019) Modified on 7/5/2019 (jlmS, COURT STAFF).
June 28, 2019	Filing 391 SEALED DOCUMENT EXHIBIT 5 (CD) to #243 REPLY (re 204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byNovartis Pharmaceuticals Corporation. (jjbS, COURT STAFF) (Filed on 6/28/2019)
June 27, 2019	Filing 246 REPLY (re #206 MOTION to Exclude Expert Testimony of Ted Sweeney ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/27/2019)
June 27, 2019	Filing 245 REPLY (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/27/2019)
June 27, 2019	Filing 244 REPLY (re #200 MOTION to Exclude Expert Testimony of Michael L. Metzker ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Steindler, Thomas) (Filed on 6/27/2019)
June 27, 2019	Filing 243 REPLY (re #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5 (NMF), #7 Exhibit 6)(Steindler, Thomas) (Filed on 6/27/2019)
June 27, 2019	Filing 242 Administrative Motion to File Under Seal - Exhibit to Steindler Dec in Support of Reply in Support of Daubert Motion - Dr. Ortiz filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Exhibit Notice of Manual Filing of Steindler Dec Ex 5, #4 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/27/2019)
June 27, 2019	Filing 241 ORDER by Judge Haywood S. Gilliam, Jr. Granting #239 Motion for Pro Hac Vice for Ian B. Brooks. (ndrS, COURT STAFF) (Filed on 6/27/2019)
June 27, 2019	Filing 240 ORDER by Judge Haywood S. Gilliam, Jr. Granting #238 Motion for Pro Hac Vice for Paul Schoenhard. (ndrS, COURT STAFF) (Filed on 6/27/2019)
June 27, 2019	Filing 239 Amended MOTION for leave to appear in Pro Hac Vice for Ian B. Brooks ( Filing fee $ 310, receipt number 0971-13043124.) Filing fee previously paid on 1/29/2019 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Brooks, Ian) (Filed on 6/27/2019) Modified on 6/28/2019 (cjlS, COURT STAFF).
June 27, 2019	Filing 238 Amended MOTION for leave to appear in Pro Hac Vice for Paul Schoenhard ( Filing fee $ 310, receipt number 0971-13293802.) Filing fee previously paid on 4/26/2019 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Schoenhard, Paul) (Filed on 6/27/2019) Modified on 6/28/2019 (cjlS, COURT STAFF).
June 24, 2019	Filing 237 Declaration of Nathanael R. Luman in Support of #224 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D. filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #224 ) (Luman, Nathanael) (Filed on 6/24/2019)
June 20, 2019	Filing 236 MOTION to Strike #206 MOTION to Exclude Expert Testimony of Ted Sweeney , #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda , #200 MOTION to Exclude Expert Testimony of Michael L. Metzker , #202 MOTION to Exclude Expert Testimony of Gregory Leonard filed by Plexxikon Inc.. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 7/5/2019. Replies due by 7/12/2019. (Attachments: #1 Declaration Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Proposed Order)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 235 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #9 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 234 OPPOSITION/RESPONSE (re #206 MOTION to Exclude Expert Testimony of Ted Sweeney ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 233 REPLY (re #177 MOTION for Patial Summary Judgment ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit Steindler Dec Ex A, #3 Exhibit Steindler Dec Ex B, #4 Exhibit Steindler Dec Ex C, #5 Exhibit Steindler Dec Ex D, #6 Exhibit Steindler Dec Ex E, #7 Exhibit Steindler Dec Ex F)(Steindler, Thomas) (Filed on 6/20/2019)
June 20, 2019	Filing 232 Administrative Motion to File Under Seal Re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Ted Sweeney filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff's Opposition to Defendant's Motion to Exclude Expert Testimony of Ted Sweeney, #4 Unredacted Version of Plaintiff's Opposition to Defendant's Motion to Exclude Expert Testimony of Ted Sweeney, #5 Redacted Version of Exhibit 2, #6 Unredacted Version of Exhibit 2, #7 Redacted Version of Exhibit 4, #8 Unredacted Version of Exhibit 4, #9 Redacted Version of Exhibit 5, #10 Unredacted Version of Exhibit 5, #11 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 231 Administrative Motion to File Under Seal , Reply in Support of Motion for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion for Partial Summary Judgment, #4 Unedacted Version of Reply in Support of Motion for Partial Summary Judgment, #5 Redacted Version of Steindler Declaration Ex A, #6 Unredacted Version of Steindler Declaration Ex A, #7 Unredacted Version of Steindler Declaration Ex B, #8 Unredacted Version of Steindler Declaration Ex C, #9 Unredacted Version of Steindler Declaration Ex D, #10 Unredacted Version of Steindler Declaration Ex E, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/20/2019)
June 20, 2019	Filing 230 REPLY (re #179 MOTION to Strike Portions of Metzker Expert Report ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 6/20/2019)
June 20, 2019	Filing 229 REPLY (re #175 MOTION for Judgment on the Pleadings ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/20/2019)
June 20, 2019	Filing 228 OPPOSITION/RESPONSE (re #200 MOTION to Exclude Expert Testimony of Michael L. Metzker ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Declaration of Michael L. Metzker, #14 Exhibit A to Declaration of Michael L. Metzker, #15 Exhibit B to Declaration of Michael L. Metzker, #16 Exhibit C to Declaration of Michael L. Metzker, #17 Exhibit D to Declaration of Michael L. Metzker, #18 Exhibit E to Declaration of Michael L. Metzker, #19 Exhibit F to Declaration of Michael L. Metzker, #20 Exhibit G to Declaration of Michael L. Metzker, #21 Exhibit H to Declaration of Michael L. Metzker, #22 Exhibit I to Declaration of Michael L. Metzker, #23 Exhibit J to Declaration of Michael L. Metzker, #24 Exhibit K to Declaration of Michael L. Metzker, #25 Exhibit L to Declaration of Michael L. Metzker, #26 Exhibit M to Declaration of Michael L. Metzker, #27 Exhibit N to Declaration of Michael L. Metzker, #28 Exhibit O to Declaration of Michael L. Metzker, #29 Exhibit P to Declaration of Michael L. Metzker, #30 Exhibit Q to Declaration of Michael L. Metzker, #31 Exhibit R to Declaration of Michael L. Metzker)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 227 OPPOSITION/RESPONSE (re #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 226 Administrative Motion to File Under Seal re Plaintiff's Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff' Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda, #4 Unredacted Version of Plaintiff' Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 2, #9 Redacted Version of Exhibit 3, #10 Unredacted Version of Exhibit 3, #11 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)
June 20, 2019	Filing 225 *DISREGARD, SEE DOCKET ENTRY #325 * OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in Support of Opposition, # 2 REMOVED PER ORDER AT DOCKET NO. #329 Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #3 Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #4 Exhibit 3 to Declaration of Laura E. Miller in Support of Opposition)(Miller, Laura) (Filed on 6/20/2019) Modified on 10/17/2019 (ddkS, COURT STAFF). Modified on 10/25/2019 (cjlS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).
June 20, 2019	Filing 224 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D. filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, # 3REMOVED PER #329 ORDER Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D., #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D., # 5 REMOVED PER #329 ORDER Redacted Version of Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #6 Unredacted Version of Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #7 Redacted Version of Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #8 Unredacted Version of Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #9 Proof of Service)(Miller, Laura) (Filed on 6/20/2019) Modified on 10/17/2019 Locked per filer's request. (ddkS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).
June 17, 2019	Filing 223 Declaration of David Mlaver in Support of #209 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Judgment on the Pleadings filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #209 ) (Steindler, Thomas) (Filed on 6/17/2019)
June 17, 2019	Filing 222 Declaration of Nathanael R. Luman in Support of #211 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Partial Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #211 ) (Luman, Nathanael) (Filed on 6/17/2019)
June 17, 2019	Filing 221 Declaration of Nathanael R. Luman in Support of #207 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Strike Portions of Report of Plaintiffs Expert Michael L. Metzker, Ph.D. filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #207 ) (Luman, Nathanael) (Filed on 6/17/2019)
June 14, 2019	#Electronic filing error. Incorrect filing procedure Re: #212 OPPOSITION/RESPONSE to #177 MOTION for Partial Summary Judgment and Supporting Declarations #213 - #220 filed by P lexxikon Inc. When filing a motion, the Memorandum of Points and Authorities and the Declarations should be filed as attachments to the motion. They are not to be filed separately. No further action is necessary, please comply with all future filings. (cjlS, COURT STAFF) (Filed on 6/14/2019)
June 13, 2019	Filing 220 Declaration of Chai Zhang in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 219 Declaration of Prabha Ibrahim in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 218 Declaration of Wayne Spevak in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 217 Declaration of Alexander J. Bridges in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 216 Declaration of Ted Sweeney in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 215 Declaration of Dr. Susana Ortiz-Urda in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 214 Declaration of Jeffrey Winkler in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 213 Declaration of Michael L. Metzker in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 212 OPPOSITION/RESPONSE (re #177 MOTION for Patial Summary Judgment ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Exhibit 12 to Declaration of Laura E. Miller, #14 Exhibit 13 to Declaration of Laura E. Miller, #15 Exhibit 14 to Declaration of Laura E. Miller, #16 Exhibit 15 to Declaration of Laura E. Miller, #17 Exhibit 16 to Declaration of Laura E. Miller, #18 Exhibit 17 to Declaration of Laura E. Miller, #19 Exhibit 18 to Declaration of Laura E. Miller, #20 Exhibit 19 to Declaration of Laura E. Miller, #21 Exhibit 20 to Declaration of Laura E. Miller, #22 Exhibit 21 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 211 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Partial Summary Judgment filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plexxikon's Opposition to Defendant's Motion for Partial Summary Judgment, #4 Unredacted Version of Plexxikon's Opposition to Defendant's Motion for Partial Summary Judgment, #5 Redacted Version of Exhibit A to Metzker Declaration, #6 Unredacted Version of Exhibit A to Metzker Declaration, #7 Redacted Version of Exhibit B to Metzker Declaration, #8 Unredacted Version of Exhibit B to Metzker Declaration, #9 Redacted Version of Exhibit 12 to Miller Declaration, #10 Unredacted Version of Exhibit 12 to Miller Declaration, #11 Redacted Version of Exhibit 19 to Miller Declaration, #12 Unredacted Version of Exhibit 19 to Miller Declaration, #13 Redacted Version of Exhibit A to Winkler Declaration, #14 Unredacted Version of Exhibit A to Winkler Declaration, #15 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 210 OPPOSITION/RESPONSE (re #175 MOTION for Judgment on the Pleadings ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E Miller, #3 Exhibit 2 to Declaration of Laura E Miller, #4 Exhibit 3 to Declaration of Laura E Miller, #5 Exhibit 4 to Declaration of Laura E Miller, #6 Exhibit 5 to Declaration of Laura E Miller, #7 Exhibit 6 to Declaration of Laura E Miller, #8 Exhibit 7 to Declaration of Laura E Miller, #9 Exhibit 8 to Declaration of Laura E Miller, #10 Exhibit 9 to Declaration of Laura E Miller, #11 Exhibit 10 to Declaration of Laura E Miller, #12 Exhibit 11 to Declaration of Laura E Miller, #13 Exhibit 12 to Declaration of Laura E Miller, #14 Exhibit 13 to Declaration of Laura E Miller, #15 Request for Judicial Notice, #16 Exhibit 1 to Request for Judicial Notice, #17 Exhibit 2 to Request for Judicial Notice, #18 Exhibit 3 to Request for Judicial Notice, #19 Exhibit 4 to Request for Judicial Notice, #20 Exhibit 5 to Request for Judicial Notice, #21 Exhibit 6 to Request for Judicial Notice, #22 Exhibit 7 to Request for Judicial Notice, #23 Exhibit 8 to Request for Judicial Notice, #24 Exhibit 9 to Request for Judicial Notice, #25 Exhibit 10 to Request for Judicial Notice, #26 Exhibit 11 to Request for Judicial Notice, #27 Exhibit 12 to Request for Judicial Notice, #28 Exhibit 13 to Request for Judicial Notice, #29 Exhibit 14 to Request for Judicial Notice, #30 Exhibit 15 to Request for Judicial Notice, #31 Exhibit 16 to Request for Judicial Notice)(Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 209 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Judgment on the Pleadings filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in Support of Administrative Motion to Seal, #2 Proposed Order, #3 Redacted Version of Plexxikon's Opposition to Novartis's Motion for Judgment on the Pleadings, #4 Unredacted Version of Plexxikon's Opposition to Novartis's Motion for Judgment on the Pleadings, #5 Redacted Version of Exhibit 5 to Declaration, #6 Unredacted Version of Exhibit 5 to Declaration, #7 Redacted Version of Exhibit 6 to Declaration, #8 Unredacted Version of Exhibit 6 to Declaration, #9 Redacted Version of Exhibit 7 to Declaration, #10 Unredacted Version of Exhibit 7 to Declaration, #11 Redacted Version of Exhibit 8 to Declaration, #12 Unredacted Version of Exhibit 8 to Declaration, #13 Redacted Version of Exhibit 9 to Declaration, #14 Unredacted Version of Exhibit 9 to Declaration, #15 Redacted Version of Exhibit 10 to Declaration, #16 Unredacted Version of Exhibit 10 to Declaration, #17 Redacted Version of Exhibit 11 to Declaration, #18 Unredacted Version of Exhibit 11 to Declaration, #19 Redacted Version of Exhibit 12 to Declaration, #20 Unredacted Version of Exhibit 12 to Declaration, #21 Redacted Version of Exhibit 13 to Declaration, #22 Unredacted Version of Exhibit 13 to Declaration, #23 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 208 OPPOSITION/RESPONSE (re #179 MOTION to Strike Portions of Metzker Expert Report ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15)(Miller, Laura) (Filed on 6/13/2019)
June 13, 2019	Filing 207 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Strike Portions of Report of Plaintiffs Expert Michael L. Metzker, Ph.D. filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Opposition to Motion to Strike, #4 Unredacted Version of Opposition to Motion to Strike, #5 Redacted Version of Declaration of Laura Miller in Support of Opposition to Motion to Strike, #6 Unredacted Version of Declaration of Laura Miller in Support of Opposition to Motion to Strike, #7 Redacted Version of Exhibit 4 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #8 Unredacted Version of Exhibit 4 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #9 Redacted Version of Exhibit 9 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #10 Unredacted Version of Exhibit 9 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #11 Redacted Version of Exhibit 13 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #12 Unredacted Version of Exhibit 13 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #13 Redacted Version of Exhibit 14 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #14 Unredacted Version of Exhibit 14 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #15 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)
June 6, 2019	Filing 206 MOTION to Exclude Expert Testimony of Ted Sweeney filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 205 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Ted Sweeney filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Ted Sweeney, #4 Unredacted Version of Motion to Exclude Testimony of Ted Sweeney, #5 Unredacted Version of Exhibit 1, #6 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 203 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Ortiz filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Ortiz, #4 Unredacted Version of Motion to Exclude Testimony of Ortiz, #5 Unredacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 2, #7 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 202 MOTION to Exclude Expert Testimony of Gregory Leonard filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 201 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Gregory Leonard filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Leonard, #4 Unredacted Version of Motion to Exclude Testimony of Leonard, #5 Unredacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 2, #7 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 200 MOTION to Exclude Expert Testimony of Michael L. Metzker filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Phil Baran, #2 Declaration of Thomas Steindler, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25, #28 Exhibit 26, #29 Exhibit 27, #30 Exhibit 28, #31 Exhibit 29, #32 Exhibit 30, #33 Exhibit 31, #34 Exhibit 32, #35 Exhibit 33, #36 Exhibit 34, #37 Exhibit 35, #38 Exhibit 36, #39 Exhibit 37, #40 Exhibit 38, #41 Exhibit 39, #42 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 199 Administrative Motion to File Under Seal regarding Motion to Exclude Expert Testimony of Metzker filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Expert Testimony of Metzker, #4 Unredacted Version of Motion to Exclude Expert Testimony of Metzker, #5 Redacted Version of Baran Declaration, #6 Unredacted Version of Baran Declaration, #7 Unredacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 4, #9 Unredacted Version of Exhibit 5, #10 Unredacted Version of Exhibit 6, #11 Unredacted Version of Exhibit 7, #12 Unredacted Version of Exhibit 8, #13 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)
June 6, 2019	Filing 198 CERTIFICATE OF SERVICE by Plexxikon Inc. re #196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts (Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 197 REPLY (re #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts, #4 Unredacted Version of Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts)(Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 195 CERTIFICATE OF SERVICE by Plexxikon Inc. re #193 Administrative Motion to File Under Seal re Reply in Support of Plexxikon's Motion to Exclude Opinions and Testimony of James Malackowski (Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 194 REPLY (re #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 193 Administrative Motion to File Under Seal re Reply in Support of Plexxikon's Motion to Exclude Opinions and Testimony of James Malackowski filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion to Exclude Opinions & Testimony of James Malackowski, #4 Unredacted Version of Reply in Support of Motion to Exclude Opinions & Testimony of James Malackowski)(Miller, Laura) (Filed on 6/6/2019)
June 6, 2019	Filing 192 REPLY (re #167 MOTION for Summary Judgment of No Anticipation ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)
June 3, 2019	Filing 191 Declaration of Marguerite Hutchinson in Support of #187 Administrative Motion to File Under Seal regarding Opposition to Motion to Exclude Opinion and Tesimony of Malackowski filed byPlexxikon Inc.. (Related document(s) #187 ) (Krishnapriyan, Raghav) (Filed on 6/3/2019)
June 3, 2019	Filing 190 Declaration of Nathanael R. Luman in Support of #185 Administrative Motion to File Under Seal regarding Opposition to Motion for Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #185 ) (Luman, Nathanael) (Filed on 6/3/2019)
May 30, 2019	Filing 189 OPPOSITION/RESPONSE (re #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Steindler, Thomas) (Filed on 5/30/2019)
May 30, 2019	Filing 188 OPPOSITION/RESPONSE (re #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Steindler, Thomas) (Filed on 5/30/2019)
May 30, 2019	Filing 187 Administrative Motion to File Under Seal regarding Opposition to Motion to Exclude Opinion and Tesimony of Malackowski filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Opposition to Motion to Exclude Opinion and Testimony of Malackowski, #4 Unredacted Version of Opposition to Motion to Exclude Opinion and Testimony of Malackowski, #5 Unredacted Version of Exhibit A, #6 Unredacted Version of Exhibit B, #7 Unredacted Version of Exhibit C, #8 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/30/2019)
May 30, 2019	Filing 186 OPPOSITION/RESPONSE (re #167 MOTION for Summary Judgment of No Anticipation ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Steindler, Thomas) (Filed on 5/30/2019)
May 30, 2019	Filing 185 Administrative Motion to File Under Seal regarding Opposition to Motion for Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Opposition to Motion for Summary Judgment, #4 Unredacted Version of Opposition to Motion for Summary Judgment, #5 Unredacted Version of Exhibit 2, #6 Redacted Version of Exhibit 3, #7 Unredacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 5, #9 Unredacted Version of Exhibit 7, #10 Unredacted Version of Exhibit 8, #11 Unredacted Version of Exhibit 9, #12 Unredacted Version of Exhibit 10, #13 Unredacted Version of Exhibit 11, #14 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/30/2019)
May 28, 2019	Filing 184 *UNDER SEAL*EXHIBIT 4 (CD) to re #177 -2 Baran Declaration in support of MOTION for Patial Summary Judgment filed byNovartis Pharmaceuticals Corporation. (Related document(s) #177 ) (cpS, COURT STAFF) (Filed on 5/28/2019)
May 28, 2019	Filing 183 ORDER by Judge Haywood S. Gilliam, Jr. Granting #180 Administrative Motion to Extend Time Modifying Summary Judgment Briefing Schedule. (ndrS, COURT STAFF) (Filed on 5/28/2019)
May 28, 2019	Filing 182 Declaration of Nathanael R. Luman in Support of #176 Administrative Motion to File Under Seal regarding Motion for Partial Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #176 ) (Luman, Nathanael) (Filed on 5/28/2019)
May 28, 2019	Filing 181 OPPOSITION/RESPONSE (re #180 ADMINISTRATIVE MOTION Modify Summary Judgment Briefing Schedule re 173 Order on Motion to Shorten Time,, 174 Order, ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler)(Steindler, Thomas) (Filed on 5/28/2019)
May 28, 2019	Reset Deadlines/Hearings as to #175 MOTION for Judgment on the Pleadings , #179 MOTION to Strike Portions of Metzker Expert Report, #177 MOTION for Patial Summary Judgment , See Docket No. #183 : Responses due by 6/13/2019; Replies due by 6/20/2019 and Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/28/2019)
May 28, 2019	Hearing as to #167 MOTION for Summary Judgment of No Anticipation, #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski , #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, See Docket No. #183 : Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/28/2019)
May 24, 2019	Filing 180 ADMINISTRATIVE MOTION to Extend Time Modifying Summary Judgment Briefing Schedule filed by Plexxikon Inc.. Responses due by 5/28/2019. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Declaration of Laura E. Miller, #3 Exhibit 1 to the Decl. of Laura E. Miller, #4 Exhibit 2 to the Decl. of Laura E. Miller, #5 Exhibit 3 to the Decl. of Laura E. Miller, #6 Proposed Order)(Durie, Daralyn) (Filed on 5/24/2019) Modified on 5/28/2019 (cpS, COURT STAFF).
May 23, 2019	Filing 179 MOTION to Strike Portions of Metzker Expert Report filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order, #2 Declaration of David Mlaver, #3 Exhibit Mlaver Ex 1, #4 Exhibit Mlaver Ex 2, #5 Exhibit Mlaver Ex 3, #6 Exhibit Mlaver Ex 4, #7 Exhibit Mlaver Ex 5, #8 Exhibit Mlaver Ex 6, #9 Exhibit Mlaver Ex 7)(Steindler, Thomas) (Filed on 5/23/2019)
May 23, 2019	Filing 178 Administrative Motion to File Under Seal regarding Motion to Strike Portions of Metzker Expert Report filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Strike Portions of Metzker Expert Report, #4 Unredacted Version of Motion to Strike Portions of Metzker Expert Report, #5 Unredacted Version of Mlaver Ex 1, #6 Redacted Version of Mlaver Ex 5, #7 Unredacted Version of Mlaver Ex 5, #8 Unredacted Version of Mlaver Ex 7, #9 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/23/2019)
May 23, 2019	Filing 177 MOTION for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order, #2 Declaration of Phil Baran, #3 Exhibit Baran Ex 1, #4 Exhibit Baran Ex 2, #5 Exhibit Baran Ex 3, #6 Exhibit Baran Ex 4 - NMF, #7 Exhibit Baran Ex 5, #8 Exhibit Baran Ex 6, #9 Exhibit Baran Ex 7, #10 Exhibit Baran Ex 8, #11 Exhibit Baran Ex 9, #12 Exhibit Baran Ex 10, #13 Exhibit Baran Ex 11, #14 Exhibit Baran Ex 12, #15 Exhibit Baran Ex 13, #16 Declaration of Tara Rheault, #17 Exhibit Rheault Ex 1, #18 Exhibit Rheault Ex 2, #19 Declaration of Thomas Steindler, #20 Exhibit Steindler Ex 1, #21 Exhibit Steindler Ex 2, #22 Exhibit Steindler Ex 3)(Steindler, Thomas) (Filed on 5/23/2019) Modified on 5/24/2019 (cpS, COURT STAFF).
May 23, 2019	Filing 176 Administrative Motion to File Under Seal regarding Motion for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion for Partial Summary Judgment, #4 Unredacted Version of Motion for Partial Summary Judgment, #5 Redacted Version of Baran Declaration in Support of Motion for Partial Summary Judgment, #6 Unredacted Version of Baran Declaration in Support of Motion for Partial Summary Judgment, #7 Unredacted Version of Baran Declaration Exhibit 5, #8 Unredacted Version of Baran Declaration Exhibit 6, #9 Unredacted Version of Baran Declaration Exhibit 7, #10 Unredacted Version of Baran Declaration Exhibit 12, #11 Redacted Version of Rheault Declaration in Support of Motion for Partial Summary Judgment, #12 Unredacted Version of Rheault Declaration in Support of Motion for Partial Summary Judgment, #13 Unredacted Version of Rheault Declaration Exhibit 1, #14 Unredacted Version of Rheault Declaration Exhibit 2, #15 Unredacted Version of Steindler Declaration Exhibit 1, #16 Unredacted Version of Steindler Declaration Exhibit 3, #17 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/23/2019)
May 23, 2019	Filing 175 MOTION for Judgment on the Pleadings filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 5/23/2019)
May 22, 2019	Reset Hearing as to Docket Nos. #169 and #165 , See Docket No. 174 : Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/22/2019)
May 22, 2019	Filing 174 ORDER by Hon. Haywood S. Gilliam, Jr. RESCHEDULING the #165 , #169 non-dispositive motion hearings to be heard at the same time as the #167 dispositive motion on August 1, 2019, at 2:00 p.m. in Courtroom 2, Fourth Floor, Oakland. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/22/2019)
May 21, 2019	Filing 173 ORDER by Hon. Haywood S. Gilliam, Jr., GRANTING IN PART and DENYING IN PART #170 motion to shorten time. Due to a previously scheduled full-day jury trial on June 20, the hearing on the dispositive motions is postponed to August 1, 2019, at 2:00 p.m. in Courtroom 2, Fourth Floor, Oakland. Defendant Novartis is DIRECTED to file its dispositive motion by May 23 and the parties are DIRECTED to comply with the briefing schedule set forth in Civil Local Rule 7-3. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/21/2019)
May 20, 2019	Filing 172 OPPOSITION/RESPONSE (re #170 MOTION to Shorten Time to File Dispositive Motions ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Durie, Daralyn) (Filed on 5/20/2019)
May 17, 2019	Filing 171 Declaration of Nathanael R. Luman in Support of #166 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion for Summary Judgment of No Anticipation filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #166 ) (Luman, Nathanael) (Filed on 5/17/2019)
May 17, 2019	Filing 170 MOTION to Shorten Time to File Dispositive Motions filed by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 5/17/2019)
May 16, 2019	Filing 169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Proposed Order)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).
May 16, 2019	Filing 168 Administrative Motion to File Under Seal re Plaintiffs Motion to Exclude the Opinions and Testimony of James E. Malackowski filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit 1, #4 Unredacted Version of Exhibit 1, #5 Redacted Version of Exhibit 2, #6 Unredacted Version of Exhibit 2, #7 Redacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 3, #9 Redacted Version of Plaintiffs Notice of Motion and Motion to Exclude the Opinions and Testimony of James E. Malackowski and Memorandum of Points and Authorities in Support Thereof, #10 Unredacted Version of Plaintiffs Notice of Motion and Motion to Exclude the Opinions and Testimony of James E. Malackowski and Memorandum of Points and Authorities in Support Thereof, #11 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)
May 16, 2019	Filing 167 MOTION for Summary Judgment of No Aticipation filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration of Matthew W. Samuels, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Proposed Order)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).
May 16, 2019	Filing 166 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion for Summary Judgment of No Anticipation filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiffs Plaintiff Plexxikon Inc.s Notice of Motion and Motion for Summary Judgment of No Anticipation; Memorandum of Points and Authorities in Support Thereof, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Notice of Motion and Motion for Summary Judgment of No Anticipation; Memorandum of Points and Authorities in Support Thereof, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 9, #8 Unredacted Version of Exhibit 9, #9 Redacted Version of Exhibit 19, #10 Unredacted Version of Exhibit 19, #11 Redacted Version of Exhibit 20, #12 Unredacted Version of Exhibit 20, #13 Redacted Version of Exhibit 21, #14 Unredacted Version of Exhibit 21, #15 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)
May 16, 2019	Filing 165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).
May 16, 2019	Filing 164 Administrative Motion to File Under Seal Re Plaintiff's Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiffs Notice of Motion and Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts and Memorandum of Points and Authorities in Support Thereof, #4 Unredacted Version of Plaintiffs Notice of Motion and Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts and Memorandum of Points and Authorities in Support Thereof, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 2, #9 Redacted Version of Exhibit 4, #10 Unredacted Version of Exhibit 4, #11 Redacted Version of Exhibit 5, #12 Unredacted Version of Exhibit 5, #13 Redacted Version of Exhibit 7, #14 Unredacted Version of Exhibit 7, #15 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)
May 16, 2019	Filing 163 ORDER on May 15, 2019 Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 5/16/2019)
May 15, 2019	Filing 162 Joint Discovery Letter Brief re the Court's May 3, 2019 Order #161 filed by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Declaration of Dr. Alexander Bridges, #4 Appendix A to Declaration of Dr. Alexander Bridges)(Steindler, Thomas) (Filed on 5/15/2019) Modified on 5/16/2019 (cjlS, COURT STAFF).
May 3, 2019	Filing 161 ORDER on Defendant's Motion to Compel Discovery Regarding Dr. Bridges' Report by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 5/3/2019)
May 1, 2019	Filing 160 ORDER by Judge Haywood S. Gilliam, Jr. Granting #159 Stipulation to Permit Deposition of Malackowski After the Expert Discovery Cutoff Date. (ndrS, COURT STAFF) (Filed on 5/1/2019)
April 30, 2019	Filing 159 STIPULATION WITH PROPOSED ORDER to Permit Deposition of Malackowski After the Expert Discovery Cutoff Date filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Steindler, Thomas) (Filed on 4/30/2019) Modified on 5/1/2019 (jjbS, COURT STAFF).
April 29, 2019	Filing 158 Joint Discovery Letter Brief re Dr. Alexander Bridges filed by Novartis Pharmaceuticals Corporation, and Plexxikon, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 4/29/2019) Modified on 4/30/2019 (jjbS, COURT STAFF).
April 26, 2019	Filing 157 MOTION for leave to appear in Pro Hac Vice for Paul Schoenhard ( Filing fee $ 310, receipt number 0971-13293802.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Schoenhard, Paul) (Filed on 4/26/2019)
April 11, 2019	Filing 156 NOTICE of Appearance by David Floyd McGowan (McGowan, David) (Filed on 4/11/2019)
March 29, 2019	Filing 155 ORDER Denying Plaintiff's Motion to Compel signed by Magistrate Judge Elizabeth D. Laporte: denying #150 Motion. (shyS, COURT STAFF) (Filed on 3/29/2019)
March 22, 2019	Filing 154 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING #89 ADMINISTRATIVE MOTION TO FILE UNDER SEAL.(ndrS, COURT STAFF) (Filed on 3/22/2019)
March 21, 2019	Filing 153 Declaration of Nathanael R. Luman in Support of #149 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #149 ) (Luman, Nathanael) (Filed on 3/21/2019)
March 19, 2019	Filing 152 OPPOSITION/RESPONSE (re #150 Discovery Letter Brief re ruling of the SDNY Court re Christina Schwarz ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 3/19/2019)
March 18, 2019	Filing 151 CERTIFICATE OF SERVICE by Plexxikon Inc. re #149 Administrative Motion to File Under Seal (Durie, Daralyn) (Filed on 3/18/2019)
March 18, 2019	Filing 150 Discovery Letter Brief re ruling of the SDNY Court re Christina Schwarz filed by Plexxikon Inc. (Attachments: #1 Exhibit A)(Durie, Daralyn) (Filed on 3/18/2019) Modified on 3/19/2019 (jjbS, COURT STAFF).
March 18, 2019	Filing 149 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit A, #4 Unredacted Version of Exhibit A)(Durie, Daralyn) (Filed on 3/18/2019)
March 18, 2019	Filing 148 Letter from Thomas P. Steindler regarding Order from Southern District of New York. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 3/18/2019)
March 8, 2019	Filing 147 FURTHER ORDER Regarding Privilege Waiver Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 3/8/2019)
February 28, 2019	Filing 146 Letter from Thomas P. Steindler in Response to Plaintiff's Discovery Letter. (Steindler, Thomas) (Filed on 2/28/2019)
February 27, 2019	Filing 145 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit A, #3 Exhibit B)(Durie, Daralyn) (Filed on 2/27/2019)
February 27, 2019	Filing 144 Letter from Thomas P. Steindler Submitting Declaration of Peter Waibel per D.I. 140. (Attachments: #1 Declaration of Peter Waibel, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D)(Steindler, Thomas) (Filed on 2/27/2019)
February 25, 2019	Filing 143 FURTHER Order Regarding Non-Party Discovery Disputes by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 2/25/2019)
February 25, 2019	Filing 142 NOTICE of Compliance with the Court's #140 Order on Administrative Motion to File Under Seal, Order on Discovery Letter Brief by Plexxikon Inc. (Attachments: #1 Exhibit B [Partially Redacted], #2 Exhibit C)(Krishnapriyan, Raghav) (Filed on 2/25/2019) Modified on 2/26/2019 (jjbS, COURT STAFF).
February 22, 2019	Filing 141 Joint Discovery Letter Brief re Status Update filed by Plexxikon Inc., GlaxoSmithKline PLC, and GlaxoSmithKline LLC (Durie, Daralyn) (Filed on 2/22/2019) Modified on 2/25/2019 (jjbS, COURT STAFF).
February 22, 2019	Filing 140 ORDER on February 13, 2019 Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 2/22/2019)
February 22, 2019	Filing 139 Letter Regarding Redactions from William R. Zimmerman.(Zimmerman, William) (Filed on 2/22/2019) Modified on 2/25/2019 (jjbS, COURT STAFF).
February 22, 2019	Filing 138 Transcript of Proceedings held on 02/19/2019, before Magistrate Judge Elizabeth D. Laporte. Court Reporter/Transcriber Peggy Schuerger/Ad Hoc Reporting, telephone number (619) 228-3774/adhocreporting@aol.com. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #136 Transcript Order ) Redaction Request due 3/15/2019. Redacted Transcript Deadline set for 3/25/2019. Release of Transcript Restriction set for 5/23/2019. (Related documents(s) #136 ) (pls, COURT STAFF) (Filed on 2/22/2019)
February 20, 2019	Filing 136 TRANSCRIPT ORDER for proceedings held on 2/19/19 before Magistrate Judge Elizabeth D. Laporte by GlaxoSmithKline LLC, GlaxoSmithKline PLC, for Court Reporter FTR - San Francisco. (Zimmerman, William) (Filed on 2/20/2019)
February 20, 2019	Filing 135 PDF with attached Audio File. Court Date & Time [ 2/19/2019 11:30:57 AM ]. File Size [ 18277 KB ]. Run Time [ 00:38:05 ]. (courtspeak).
February 19, 2019	Filing 137 Minute Entry for proceedings held on 2/19/2019 before Magistrate Judge Elizabeth D. Laporte. Discussion held regarding the discovery letter brief filed on 2/7/2019. Counsel shall submit an update to the Court by 2/22/2019. Furthermore, Plaintiff and the third-party defendant shall meet and confer regarding the issue raised at the hearing pertaining to redactions. As stated at the hearing, the third-party defendant shall prepare a written explanation for the redactions and share it with Plaintiff; and submit it to the Court for review, unless Plaintiff thinks that would be unnecessary.FTR Time: 11:31 - 12:06 Plaintiff Attorney: Daralyn Durie Third Party Defendant Attorney: William ZimmermanDefendant Attorney: Thomas Steindler (telephonic appearance) Matter transcribed by Peggy Schuerger. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Date Filed: 2/19/2019)
February 19, 2019	Filing 134 Declaration of William R. Zimmerman in Support of #130 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #130 ) (Zimmerman, William) (Filed on 2/19/2019)
February 15, 2019	Filing 133 CLERK'S NOTICE: The parties are hereby notified that a hearing regarding the discovery letter brief filed on 2/7/2019 is set for 2/19/2019 at 11:30 AM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. To the extend counsel need to appear by phone, then counsel must utilize the following call-in information: dial (888) 684-8852 and enter access code 537 9839. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Filed on 2/15/2019)
February 14, 2019	Filing 132 ORDER GRANTING PLAINTIFF PLEXXIKON INC.S ADMINISTRATIVE MOTION TO FILE UNDER SEAL PURSUANT TO CIVIL L.R. 7-11 AND 79-5 by Judge Elizabeth D. Laporte. (mllS, COURT STAFF) (Filed on 2/14/2019)
February 13, 2019	Filing 131 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Durie, Daralyn) (Filed on 2/13/2019)
February 13, 2019	Filing 130 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit B, #4 Unredacted Version of Exhibit B, #5 Redacted Version of Exhibit C, #6 Unredacted Version of Exhibit C, #7 Certificate/Proof of Service)(Durie, Daralyn) (Filed on 2/13/2019)
February 7, 2019	Filing 129 Joint Discovery Letter Brief re Status Update Pursuant to the Courts February 1, 2019 order (ECF No. 125) filed by Plexxikon Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Durie, Daralyn) (Filed on 2/7/2019)
February 7, 2019	Filing 128 Administrative Motion to File Under Seal filed by GlaxoSmithKline LLC. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Ex. 5, #4 Unredacted Version of Ex. 5, #5 Redacted Version of Ex. 6, #6 Unredacted Version of Ex. 6, #7 Redacted Version of Ex. 7, #8 Unredacted Version of Ex. 7, #9 Redacted Version of Ex. 8, #10 Unredacted Version of Ex. 8)(Durie, Daralyn) (Filed on 2/7/2019)
February 5, 2019	Filing 127 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #114 MOTION FOR RELIEF FROM NON-DISPOSITIVE PRETRIAL ORDER.(ndrS, COURT STAFF) (Filed on 2/5/2019)
February 4, 2019	Filing 126 NOTICE of Appearance by Victoria Leigh Weatherford (Weatherford, Victoria) (Filed on 2/4/2019)
February 1, 2019	Filing 125 ORDER ON DISCOVERY DISPUTES WITH NON-PARTY. Signed by Judge Elizabeth D. Laporte on February 1, 2019. (mllS, COURT STAFF) (Filed on 2/1/2019)
February 1, 2019	Filing 124 NOTICE of Change In Counsel by Laura Elizabeth Miller (Miller, Laura) (Filed on 2/1/2019)
January 29, 2019	Filing 123 MOTION for leave to appear in Pro Hac Vice Ian B Brooks ( Filing fee $ 310, receipt number 0971-13043124.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Brooks, Ian) (Filed on 1/29/2019)
January 29, 2019	FILED IN ERROR, DISREGARD** #Electronic filing error. REMINDER TO COUNSEL: In the future, please attach all supporting documents to the Motion. No further action is necessary Re: #122 Declaration in Support filed by GlaxoSmithKline LLC, GlaxoSmithKline PLC (jjbS, COURT STAFF) (Filed on 1/29/2019) Modified on 1/29/2019 (jjbS, COURT STAFF).

February 8, 2022

Filing 609 NOTICE by Novartis Pharmaceuticals Corporation of Withdrawal of Attorney (Steindler, Thomas) (Filed on 2/8/2022)

January 12, 2022

Filing 608 CLERK'S NOTICE RE DOCKET NOS. #582 , #585 , AND #586 . Notice is hereby given that the Court takes the pending motions filings under submission. The hearings previously scheduled for January 20, 2022 at 2:00 p.m. are vacated. The Court will issue a written order. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndr, COURT STAFF) (Filed on 1/12/2022)

January 4, 2022

Filing 607 ORDER by Hon. Haywood S. Gilliam, Jr. The Court has reviewed Dkt. No. #606 Plexxikon's letter, and the parties are advised that each side may have more than one counsel argue at the January 20, 2022 hearing if they believe doing so will aid in the discussion of the issues. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1, COURT STAFF) (Filed on 1/4/2022)

January 4, 2022

Filing 606 Letter from Daralyn Durie, counsel for Plexxikon Inc. concerning the January 20, 2022 hearing on the parties post-trial motions. (Durie, Daralyn) (Filed on 1/4/2022)

December 6, 2021

Filing 605 CLERK'S NOTICE RE DOCKET NOS. #582 , #585 , AND #586 . Notice is hereby given that the hearings on the motions, previously set for December 16, 2021, are continued to January 20, 2022, at 2:00 p.m. These proceedings will be held by AT&T Conference Line. The parties are advised that in the event of an audio problem, counsel should be prepared to attend the hearing via Zoom conference at the Courts direction.The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (This is a text-only entry generated by the court. There is no document associated with this entry.)(ndr, COURT STAFF) (Filed on 12/6/2021)

November 16, 2021

Filing 604 REPLY (re #585 MOTION Enhanced Damages ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Hannah Jiam, #2 Exhibit A to Declaration of Hannah Jiam, #3 Exhibit B to Declaration of Hannah Jiam, #4 Exhibit C to Declaration of Hannah Jiam, #5 Exhibit D to Declaration of Hannah Jiam)(Novikov, Eugene) (Filed on 11/16/2021)

November 16, 2021

Filing 603 REPLY (re #586 MOTION for Ongoing Royalties and Interest ) filed byPlexxikon Inc.. (Davis, Kira) (Filed on 11/16/2021)

November 16, 2021

Filing 602 REPLY (re #582 MOTION for Judgment as a Matter of Law MOTION for New Trial And/Or Remittur ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 11/16/2021)

November 4, 2021

Filing 601 Declaration of Nathanael R. Luman in Support of #596 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #596 ) (Luman, Nathanael) (Filed on 11/4/2021)

November 2, 2021

Filing 600 OPPOSITION/RESPONSE (re #586 MOTION for Ongoing Royalties and Interest ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 11/2/2021)

November 2, 2021

Filing 599 OPPOSITION/RESPONSE (re #585 MOTION Enhanced Damages ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 11/2/2021)

November 2, 2021

Filing 598 OPPOSITION/RESPONSE (re #582 MOTION for Judgment as a Matter of Law MOTION for New Trial And/Or Remittur ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Novikov, Eugene) (Filed on 11/2/2021)

November 2, 2021

Filing 597 CERTIFICATE OF SERVICE by Plexxikon Inc. re #596 Administrative Motion to File Under Seal (Novikov, Eugene) (Filed on 11/2/2021)

November 2, 2021

Filing 596 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Proposed Order, #3 Redacted Version of Exhibit 3, #4 Unredacted Version Exhibit 3)(Novikov, Eugene) (Filed on 11/2/2021)

October 19, 2021

Filing 595 STIPULATION re #587 Bill of Costs,, filed by Novartis Pharmaceuticals Corporation. (Schoenhard, Paul) (Filed on 10/19/2021)

October 13, 2021

Filing 594 ORDER by Judge Haywood S. Gilliam, Jr. Granting #593 Motion for Pro Hac Vice for E. Joshua Rosenkranz. Terminated Docket No. #591 , Re-Filed as Docket No. #593 .(ndrS, COURT STAFF) (Filed on 10/13/2021)

October 13, 2021

Filing 593 MOTION for leave to appear in Pro Hac Vice for E. Joshua Rosenkranz ( Filing fee $ 317, receipt number 0971-16484246.) Filing fee previously paid on 10/11/2021 filed by Plexxikon Inc.. (Rosenkranz, E. Joshua) (Filed on 10/13/2021)

October 13, 2021

Filing 592 CLERK'S NOTICE TO COUNSEL RE DOCKET NO. #591 . Counsel is directed to re-file his/her pro hac vice application along with a true and correct copy of a certificate of good standing or other similar official document issued by the appropriate authority governing attorney admissions for the relevant bar. Said certificate or other document must be dated no more than one year prior to the date of application for admission. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 10/13/2021)

October 11, 2021

Filing 591 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 317, receipt number 0971-16484246.) filed by Plexxikon Inc.. (Rosenkranz, E. Joshua) (Filed on 10/11/2021)

October 11, 2021

Filing 590 ASSOCIATION of Counsel on Plexxikon Inc. by Plexxikon Inc.. (Moulton, Elizabeth) (Filed on 10/11/2021)

October 11, 2021

Filing 589 NOTICE of Appearance by Elizabeth R Moulton (Moulton, Elizabeth) (Filed on 10/11/2021)

October 8, 2021

Filing 588 Declaration of Nathanael R. Luman in Support of #583 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #583 ) (Luman, Nathanael) (Filed on 10/8/2021)

October 5, 2021

Filing 587 BILL OF COSTS by Plexxikon Inc.. Objections due by 10/19/2021. (Attachments: #1 Declaration of Eugene Novikov, #2 Exhibit A to the Declaration of Eugene Novikov, #3 Exhibit B to the Declaration of Eugene Novikov, #4 Declaration of Andy Fredericks, #5 Exhibit A to the Declaration of Andy Fredericks, #6 Declaration of Brian Lee, #7 Declaration of Melanie Antoon, #8 Exhibit A to the Declaration of Melanie Antoon, #9 Exhibit B to the Declaration of Melanie Antoon, #10 Exhibit C to the Declaration of Melanie Antoon)(Novikov, Eugene) (Filed on 10/5/2021)

October 5, 2021

Filing 586 MOTION for Ongoing Royalties and Interest filed by Plexxikon Inc.. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/19/2021. Replies due by 10/26/2021. (Attachments: #1 Declaration of Gregory K. Leonard, #2 Exhibit A, #3 Exhibit B, #4 Proposed Order)(Davis, Kira) (Filed on 10/5/2021)

October 5, 2021

Filing 585 MOTION Enhanced Damages filed by Plexxikon Inc.. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/19/2021. Replies due by 10/26/2021. (Attachments: #1 Declaration of Hannah Jiam, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27, #29 Exhibit 28, #30 Proposed Order)(Novikov, Eugene) (Filed on 10/5/2021)

October 5, 2021

Filing 584 CERTIFICATE OF SERVICE by Plexxikon Inc. re #583 Administrative Motion to File Under Seal (Jiam, Hannah) (Filed on 10/5/2021)

October 5, 2021

Filing 583 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Hannah Jiam, #2 Proposed Order, #3 Redacted version of Plaintiff's Motion for Enhanced Damages, #4 Unredacted version of Plaintiff's Motion for Enhanced Damages, #5 Redacted version of Exhibit 10, #6 Unredacted version of Exhibit 10, #7 Redacted version of Exhibit 12, #8 Unredacted version of Exhibit 12, #9 Redacted version of Exhibit 13, #10 Unredacted version of Exhibit 13, #11 Redacted version of Exhibit 23, #12 Unredacted version of Exhibit 23, #13 Redacted version of Exhibit 27, #14 Unredacted version of Exhibit 27)(Jiam, Hannah) (Filed on 10/5/2021)

October 5, 2021

Filing 582 MOTION for Judgment as a Matter of Law , MOTION for New Trial And/Or Remittur filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 12/16/2021 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 11/2/2021. Replies due by 11/16/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 10/5/2021)

September 17, 2021

Filing 581 ORDER by Judge Haywood S. Gilliam, Jr. Granting #579 Joint Administrative Motion to Exceed Page Limits. (ndrS, COURT STAFF) (Filed on 9/17/2021)

September 17, 2021

Filing 580 JUDGMENT. Signed by Judge Haywood S. Gilliam, Jr. on 9/17/2021. ***Civil Case Terminated.*** (ndrS, COURT STAFF) (Filed on 9/17/2021)

September 16, 2021

Filing 579 Joint ADMINISTRATIVE MOTION to Exceed Page Limits filed by Novartis Pharmaceuticals Corporation. Responses due by 9/20/2021. (Attachments: #1 Stipulation, #2 Proposed Order)(Steindler, Thomas) (Filed on 9/16/2021)

September 15, 2021

Filing 578 NOTICE by Plexxikon Inc. of Proposed Judgment (Attachments: #1 Proposed Judgment)(Novikov, Eugene) (Filed on 9/15/2021)

August 10, 2021

Filing 577 JOINT STIPULATION AND ORDER AS MODIFIED BY THE COURT REGARDING ENTRY OF JUDGMENT AND POST-TRIAL BRIEFING SCHEDULE by Judge Haywood S Gilliam, Jr granting #576 Stipulation. Judgment to be entered on 9/7/2021. Motions due by 10/5/2021. Oppositions due 11/2/2021. Replies due 11/16/2021. Motion Hearing set for 12/16/2021 at 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. (kcS, COURT STAFF) (Filed on 8/10/2021)

August 9, 2021

Filing 576 Joint Stipulation Regarding Entry of Judgment and Post-Trial Briefing Schedule filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Steindler, Thomas) (Filed on 8/9/2021) Modified on 8/10/2021 (bnsS, COURT STAFF).

July 26, 2021

Filing 569 TRANSCRIPT ORDER for proceedings held on July 9-21, 2021 before Judge Haywood S Gilliam, Jr for Court Reporter Raynee Mercado. (oh, COURT STAFF) (Filed on 7/26/2021)

July 23, 2021

Exhibit Location (C-4): Trial Exhibit (1 Envelope). (bnsS, COURT STAFF) (Filed on 7/23/2021)

July 22, 2021

Filing 566 Jury Notes. (ndrS, COURT STAFF) (Filed on 7/22/2021)

July 22, 2021

Filing 565 JURY VERDICT. (ndrS, COURT STAFF) (Filed on 7/22/2021)

July 22, 2021

Filing 564 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial completed on 7/22/2021.(ndrS, COURT STAFF) (Date Filed: 7/22/2021)

July 21, 2021

Filing 563 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/21/2021. Further Jury Trial July 22, 2021 at 09:00 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/21/2021)

July 21, 2021

Filing 562 OPPOSITION/RESPONSE (re #559 MOTION for Judgment as a Matter of Law Under Rule 50(a) ) filed byPlexxikon Inc.. (Novikov, Eugene) (Filed on 7/21/2021)

July 21, 2021

Filing 560 Final Jury Instructions. (hsglc1S, COURT STAFF) (Filed on 7/21/2021)

July 21, 2021

Filing 559 MOTION for Judgment as a Matter of Law Under Rule 50(a) filed by Novartis Pharmaceuticals Corporation. Responses due by 8/4/2021. Replies due by 8/11/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 7/21/2021)

July 20, 2021

Filing 561 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/20/2021. Further Jury Trial July 21, 2021 at 08:00 AM (for counsel) and 8:30 AM (for jury) in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/20/2021)

July 20, 2021

Filing 556 OPPOSITION/RESPONSE (re #554 MOTION for Judgment as a Matter of Law ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/20/2021)

July 20, 2021

Filing 555 RESPONSE re #553 Statement Request regarding Closing Arguments by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/20/2021)

July 19, 2021

Filing 554 MOTION for Judgment as a Matter of Law filed by Plexxikon Inc.. Responses due by 8/2/2021. Replies due by 8/9/2021. (Durie, Daralyn) (Filed on 7/19/2021)

July 19, 2021

Filing 553 Plaintiff Plexxikon Inc.'s Memorandum Regarding Request to Exclude Closing Arguments that are Contrary to Law by Plexxikon Inc.. (Durie, Daralyn) (Filed on 7/19/2021) Modified on 7/20/2021 (bnsS, COURT STAFF).

July 19, 2021

Filing 552 July 19, 2021 Joint Statement by Novartis Pharmaceuticals Corporation and Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 7/19/2021) Modified on 7/20/2021 (bnsS, COURT STAFF).

July 19, 2021

Filing 551 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Jury Trial held on 7/19/2021. Further Jury Trial July 20, 2021 at 08:00 AM (for counsel) and 8:30 AM (for jury) in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (Attachments: #1 Trial Sheet)(ndrS, COURT STAFF) (Date Filed: 7/19/2021) Modified on 7/21/2021 to add date (ndrS, COURT STAFF).

July 16, 2021

Filing 550 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/16/2021, Further Jury Trial Monday, 7/19/2021 at 8:00AM. Jury at 8:30AM.Total Time in Court: 4:40. Court Reporter: Raynee Mercado. (Attachments: #1 Exhibit Trial sheet)(fs, COURT STAFF) (Date Filed: 7/16/2021)

July 15, 2021

Filing 549 OPPOSITION/RESPONSE (re #545 MOTION for Judgment as a Matter of Law on Willfulness ) filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Durie, Daralyn) (Filed on 7/15/2021)

July 15, 2021

Filing 548 July 15, 2021 Joint Statement by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Steindler, Thomas) (Filed on 7/15/2021) Modified on 7/16/2021 (bnsS, COURT STAFF).

July 15, 2021

Filing 547 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/15/2021. Jury trial continued to July 16, 2021 at 8:00 a.m.Total Time in Court: 5 hours 29 minutes. Court Reporter: Raynee Mercado. Attachment: Minute order and Trial/Exhibit Log. (mllS, COURT STAFF) (Date Filed: 7/15/2021)

July 14, 2021

Filing 546 Reply in Support of Proffer re Testimony of Dr. Tara Rheault re #543 Response ( Non Motion ), 544 Order, by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).

July 14, 2021

Filing 545 MOTION for Judgment as a Matter of Law on Willfulness filed by Novartis Pharmaceuticals Corporation. Responses due by 7/28/2021. Replies due by 8/4/2021. (Steindler, Thomas) (Filed on 7/14/2021)

July 14, 2021

Filing 544 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Defendant to file any response to Dkt. No. #543 Plaintiff's Response to Novartis's Proffer of Testimony of Dr. Tara Rheault by 10:00 p.m. PDT tonight. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/14/2021)

July 14, 2021

Filing 543 Plaintiff Plexxikon Inc.'s Response to Novartis's Proffer of Testimony of Dr. Tara Rheault re #541 by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit 1, #3 Exhibit 2 (PUBLIC SLIPSHEET), #4 Exhibit 3 (PUBLIC SLIPSHEET))(Durie, Daralyn) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).

July 14, 2021

Filing 542 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie re Motion to Seal, #2 Proposed Order, #3 Redacted Version of Brief, #4 Unredacted Version of Brief, #5 Sealed Version of Ex. 2, #6 Sealed Version of Ex. 3, #7 Certificate/Proof of Service)(Durie, Daralyn) (Filed on 7/14/2021)

July 14, 2021

Filing 541 Novartis Proffer of Testimony of Dr. Tara Rheault by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/14/2021) Modified on 7/15/2021 (bnsS, COURT STAFF).

July 14, 2021

Filing 540 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial held on 7/14/2021. Further Jury Trial set for 7/15/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr.Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet) (kcS, COURT STAFF) (Date Filed: 7/14/2021)

July 13, 2021

Filing 539 Administrative Motion to File Under Seal re July 13, 2021 Joint Statement filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Daralyn Durie, #2 Joint Statement - Sealed, #3 Joint Statement - Redacted, #4 Exhibit 2, #5 Proposed Order)(Steindler, Thomas) (Filed on 7/13/2021)

July 13, 2021

Filing 538 July 13, 2021 Joint Statement by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Durie Tangri, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Steindler, Thomas) (Filed on 7/13/2021) Modified on 7/14/2021 (bnsS, COURT STAFF).

July 13, 2021

Filing 537 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial (Day 2) held on 7/13/2021. Further Jury Trial set for 7/14/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet) (kcS, COURT STAFF) (Date Filed: 7/13/2021)

July 13, 2021

Filing 536 ORDER REGARDING DEPOSITION DESIGNATIONS re #524 Statement. Signed by Judge Haywood S. Gilliam on 7/13/2021. (fs, COURT STAFF) (Filed on 7/13/2021)

July 12, 2021

Filing 535 ERRATA re #534 Statement by Plexxikon Inc.. (Attachments: #1 TDX1140, #2 TDX1405-06)(Durie, Daralyn) (Filed on 7/12/2021)

July 12, 2021

Filing 534 July 12, 2021 Joint Statement by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 7/12/2021) Modified on 7/13/2021 (bnsS, COURT STAFF).

July 12, 2021

Filing 533 RESPONSE re 532 Order, by Plexxikon Inc.. (O'Byrne, Whitney) (Filed on 7/12/2021)

July 12, 2021

Filing 532 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Plaintiff to identify the next three witnesses that it anticipates calling in its case-in-chief after Dr. Michael Metzker. Plaintiff shall file the list by 6:00 p.m. today, July 12, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/12/2021)

July 12, 2021

Filing 531 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Trial - Day 1 began on 7/12/2021.Total Time in Court: 4 hours 21 minutes. Court Reporter: Raynee Mercado. Plaintiff Attorney: Deralyn Durie. Defendant Attorney: Thomas Steindler. Attachment: Trial Minute and Exhibit Witness List. (jjoS, COURT STAFF) (Date Filed: 7/12/2021)

July 12, 2021

Filing 530 Order by Judge Haywood S Gilliam, Jr granting #528 Joint Stipulation and Proposed Order Regarding Metadata.(mllS, COURT STAFF) (Filed on 7/12/2021)

July 11, 2021

Filing 528 Joint Stipulation and Proposed Order Regarding Metadata filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (O'Byrne, Whitney) (Filed on 7/11/2021) Modified on 7/12/2021 (bnsS, COURT STAFF).

July 9, 2021

Filing 529 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Jury Selection held on 7/9/2021. Jury Trial set for 7/12/2021 at 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Total Time in Court: 4:44. Court Reporter: Raynee Mercado. (Attachments: #1 Trial Sheet)(kcS, COURT STAFF) (Date Filed: 7/9/2021)

July 9, 2021

Filing 527 ORDER by Hon. Haywood S. Gilliam, Jr. OVERRULING Dkt. No. #524 Defendant's objections to the deposition designations for Plaintiff's case-in-chief and DENYING Defendant's request to include the counter-designation. Short written order detailing the Court's reasoning to issue. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/9/2021)

July 9, 2021

#Electronic filing error. REMINDER TO COUNSEL: Incorrect Event Used. In the future, the correct event is Statement. Correct event is found under Civil Events > Other Fil ings > Other Documents. [err101] Corrected by Clerk's Office. No further action is necessary. Re: #519 Response ( Non Motion ), filed by Novartis Pharmaceuticals Corporation (bnsS, COURT STAFF) (Filed on 7/9/2021)

July 8, 2021

Filing 526 Corrected Exhibit C to Joint Statement re Deposition Designations for Plaintiff's Case-in-chief re #524 Statement filed by Plexxikon Inc.. (Attachments: #1 Exhibit C)(Related document(s) #524 ) (Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).

July 8, 2021

Filing 525 ***RE-FILED AT DOCKET NO. #526 *** Exhibit C to Joint Statement re Deposition Designations for Plaintiff's Case-in-chief re #524 Statement filed by Plexxikon Inc.. (Attachments: #1 Exhibit C)(Related document(s) #524 ) (Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF). Modified on 7/9/2021 (bnsS, COURT STAFF).

July 8, 2021

Filing 524 Joint Statement Regarding Deposition Designations for Plaintiff's Case-in-Chief by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B)(Novikov, Eugene) (Filed on 7/8/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).

July 8, 2021

Filing 523 Notice of Withdrawal of Motion to Seal, Dkt 495 (Steindler, Thomas) (Filed on 7/8/2021)

July 8, 2021

Filing 522 ORDER by Haywood S. Gilliam, Jr. granting #518 Joint Stipulation Regarding N.D. Cal. Model Patent Jury Instruction No. A.1. (ig, COURT STAFF) (Filed on 7/8/2021)

July 8, 2021

Filing 521 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Case Management Conference held on 7/8/2021. Total Time in Court: 11 minutes. Not Reported. Plaintiff's Attorney: Daralyn Durie. Defendant's Attorney: Thomas Steindler. Trial issues discussed. Parties intend to provide deposition designations and any objections for Plaintiff's case-in-chief to Court today. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ig, COURT STAFF) (Date Filed: 7/8/2021).

July 8, 2021

CLERKS NOTICE SETTING TELEPHONIC HEARING. See Docket No. 520 Telephone Conference set for 7/8/2021 11:00 AM in Oakland, - Telephonic Only before Judge Haywood S. Gilliam Jr. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. Telephone Conference set for 7/8/2021 11:00 AM in Oakland, - Telephonic Only before Judge Haywood S Gilliam Jr.. (This is a text-only entry generated by the court. There is no document associated with this entry.) (amgS, COURT STAFF) (Filed on 7/8/2021)

July 7, 2021

Filing 520 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a telephonic case management conference on July 8, 2021, at 11:00 a.m. The parties' recent filings reflect that there appear to be a mushrooming number of new disputes and needless problems arising on the eve of trial, including fights over the basic authentication of financial documents and the addition of Defendant's lead counsel to Plaintiff's witness list. This trend is unacceptable. Neither party shall file anything further on the docket until after the case management conference tomorrow. All counsel shall use the following dial-in information to access the call:Dial-In: 888-808-6929;Passcode: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III.Signed by Hon. Haywood S. Gilliam, Jr. on 7/7/2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/7/2021)

July 7, 2021

Filing 519 JOINT STATEMENT REGARDING CHANGES TO PRETRIAL STATEMENT AND EXHIBITS re 516 Order,,,, by Novartis Pharmaceuticals Corporation and Plexxikon, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Steindler, Thomas) (Filed on 7/7/2021) Modified on 7/9/2021 (bnsS, COURT STAFF).

July 7, 2021

Filing 518 Joint Stipulation Regarding N.D. Cal. Model Patent Jury Instruction No. A.1 re 507 Order filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/7/2021) Modified on 7/8/2021 (bnsS, COURT STAFF).

July 7, 2021

Filing 517 ORDER AS MODIFIED by Judge Haywood S Gilliam, Jr Granting #510 STIPULATION REGARDING REQUEST TO BRING IN EQUIPMENT FOR TRIAL.(amgS, COURT STAFF) (Filed on 7/7/2021)

July 7, 2021

Filing 516 ORDER by Hon. Haywood S. Gilliam, Jr. Since the pretrial conference and in the last few days leading up to trial, the parties have filed several revised and unsolicited documents, including another version of their proposed joint pretrial statement. Dkt. No. #502 . As detailed in the Court's Civil Pretrial and Trial Standing Order, the pretrial statement was due 14 days before the pretrial conference. The parties have not explained the need for the revised pretrial statement, nor have they explained what changes, if any, have been made. The parties are therefore DIRECTED to provide a detailed explanation of what has changed in this latest version of the pretrial statement and accompanying exhibits by 5:00 p.m. today, July 7, 2021. The time for amendments to the pretrial filings has passed, and the parties may not file any further revisions before jury selection without obtaining leave of Court and explaining the basis for the request. Any such request for leave should be jointly submitted whenever possible. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/7/2021)

July 6, 2021

Filing 515 Novartis Pharmaceuticals Corp.'s Form Witness List by Novartis Pharmaceuticals Corporation (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 514 Novartis Pharmaceuticals Corp.'s Form Exhibit List by Novartis Pharmaceuticals Corporation.. (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 513 Plexxikon Inc.'s Form Witness List by Plexxikon Inc.. (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 512 Plexxikon Inc.'s Form Exhibit List by Plexxikon Inc... (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 511 ORDER by Hon. Haywood S. Gilliam, Jr. DENYING Dkt. No. #494 motion to preclude Plaintiff from calling Dr. Zuosheng Liu as a witness at trial. (hsglc1S, COURT STAFF) (Filed on 7/6/2021)

July 6, 2021

Filing 510 Joint Stipulation Regarding Request to Bring in Equipment for Trial filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 509 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation - Revised. (Steindler, Thomas) (Filed on 7/6/2021)

July 6, 2021

Filing 508 JOINT CASE MANAGEMENT STATEMENT Regarding Special Verdict Form filed by Novartis Pharmaceuticals Corporation and Plexxikon Inc.. (Steindler, Thomas) (Filed on 7/6/2021) Modified on 7/7/2021 (bnsS, COURT STAFF).

July 6, 2021

Filing 507 ORDER by Hon. Haywood S. Gilliam, Jr. The Court has considered the FJC patent video that the parties propose be shown to the jury after Stipulated Preliminary Instruction No. 2. The Court believes that juror comprehension will be aided by giving an oral instruction that the jurors can follow along with in writing in addition to the video, as this Court and others in this district have done in patent trials. The Court therefore intends to give N.D. Cal. Model Patent Jury Instruction No. A.1 before showing the video, rather than showing the video in lieu of the instruction as the parties propose. The parties may submit any objection to this approach by 5:00 p.m. on Wednesday, July 7, 2021. Regardless of any objections, however, the parties are further DIRECTED to meet and confer on the assumption that the Court will proceed as set out above, and determine whether they can agree on a form of Model Instruction No. A.1. The Court intends to hew directly to the language of the model instruction, and the parties' proposal should do so too (without prejudice to assertion on appeal of any objections, which will be preserved for the record). For example, it would be helpful for the parties to agree on whether the bracketed language in the model instruction should be included or omitted. The parties shall submit the stipulated instruction by 5:00 p.m. on Wednesday, July 7, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 7/6/2021)

July 6, 2021

Filing 506 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation . (Steindler, Thomas) (Filed on 7/6/2021)

July 6, 2021

Filing 505 Proposed Form of Verdict by Plexxikon Inc. . (Novikov, Eugene) (Filed on 7/6/2021)

July 3, 2021

Filing 504 REPLY (re #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further,,,,,, ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 7/3/2021)

July 2, 2021

Filing 503 ADMINISTRATIVE MOTION to Bring in Equipment For Trial filed by Plexxikon Inc.. Responses due by 7/6/2021. (Attachments: #1 Proposed Order)(Novikov, Eugene) (Filed on 7/2/2021)

July 2, 2021

Filing 502 Proposed Joint Pretrial Statement and Order by Plexxikon Inc and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).

July 2, 2021

Filing 501 Joint Trial Stipulation Regarding Undisputed Facts with Proposed Order filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).

July 2, 2021

Filing 500 Third Amended Joint Proposed Jury Instructions by Plexxikon Inc. (Novikov, Eugene) (Filed on 7/2/2021) Modified on 7/6/2021 (bnsS, COURT STAFF).

July 2, 2021

Filing 499 Administrative Motion to File Under Seal re: Plexxikon Opposition to Novartis Motion to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial filed by Plexxikon Inc.. (Attachments: #1 Declaration of Eugene Novikov, #2 Proposed Order, #3 Redacted Version of Opposition, #4 Unredacted Version of Opposition, #5 Certificate/Proof of Service)(Novikov, Eugene) (Filed on 7/2/2021)

July 2, 2021

Filing 498 ADMINISTRATIVE MOTION Regarding Request to Bring in Equipment for Trial filed by Novartis Pharmaceuticals Corporation. Responses due by 7/6/2021. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 7/2/2021)

July 2, 2021

Filing 497 OPPOSITION/RESPONSE (re #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further,,,,,, ) filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Novikov, Eugene) (Filed on 7/2/2021)

July 2, 2021

Filing 496 ORDER REGARDING VERDICT FORM AND EXPERT REPORTS. Signed by Judge Haywood S. Gilliam, Jr. on 7/2/2021. (ndrS, COURT STAFF) (Filed on 7/2/2021)

June 30, 2021

#Electronic filing error. REMINDER TO COUNSEL: Incorrect Event Used. In the future, the correct event is Administrative Motion. Correct event is found under Civil Events &g t; Motion and Related Filings & Motions- General.[err101] Re: #494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further filed by Novartis Pharmaceuticals Corporation (bnsS, COURT STAFF) (Filed on 6/30/2021)

June 29, 2021

Filing 495 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Declaration of David Mlaver, #3 Proposed Order, #4 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/29/2021)

June 29, 2021

Filing 494 MOTION to Preclude Plexxikon from Calling Dr. Zuosheng Liu as a Witness at Trial re 491 Case Management Conference - Further filed by Novartis Pharmaceuticals Corporation. Motion Responses due by 7/2/2021. (Attachments: #1 Exhibit A, #2 Proposed Order)(Steindler, Thomas) (Filed on 6/29/2021) Modified on 6/30/2021 (bnsS, COURT STAFF).

June 28, 2021

Filing 493 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Plexxikon Inc.. (Jones, Andrew) (Filed on 6/28/2021)

June 28, 2021

Filing 492 NOTICE of Appearance by Whitney Rose O'Byrne (O'Byrne, Whitney) (Filed on 6/28/2021)

June 25, 2021

Filing 491 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Further Case Management Conference held on 6/25/2021. Total Time in Court: 10 minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Court gives the attorneys the following updated trial information, in light of the COVID-19 rules, effective July 1st: 1) the jury trial will be held in courtroom 2, 4th floor; 2) everyone in the courtroom will be required to wear a mask at all times except for: witnesses who certify that they are fully vaccinated while testifying and attorneys who certify that they are fully vaccinated during opening, closing, witness examinations, and any sidebar; 3) all 41 prospective jurors will be in the courtroom at one time for jury selection; 4) each side will be given 15 minutes for follow-up questions during voir dire; 5) jury deliberations will occur in the jury deliberation room adjacent to courtroom 2; 6) team size of 7 per side, not including experts, can be accommodated; and 7) trial will be in person in a courtroom open to the public, so no phone access will be available. The Court sets Friday, July 2nd as the deadline for the following to be submitted: trial stipulation, PTO and sample patent, updated jury instructions and definitions. Counsel for defendant is directed to file his motion to exclude plaintiffs witness by close of business on Tuesday, June 29th and counsel for plaintiff has until close of business on Friday, July 2nd to respond. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 6/25/2021)

June 23, 2021

Filing 490 ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS #307 MOTION TO STRIKE AND DEFENDANTS #272 MOTION IN LIMINE NO. 5. Signed by Judge Haywood S. Gilliam, Jr. on 6/23/2021. Further Case Management Conference set for 6/25/2021 01:00 PM. This proceeding will be held by AT&T Conference Line. The parties are advised that in the event of an audio problem, counsel should be prepared to attend the hearing via Zoom conference at the Courts direction. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (ndrS, COURT STAFF) (Filed on 6/23/2021)

June 22, 2021

Filing 489 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/22/2021)

June 12, 2021

Filing 488 Transcript of Proceedings held on June 8, 2021, before Judge Haywood S. Gilliam. Court Reporter Diane E. Skillman, telephone number 925-899-2912, Diane_Skillman@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #484 Transcript Order ) Release of Transcript Restriction set for 9/10/2021. (Related documents(s) #484 ) (Skillman, Diane) (Filed on 6/12/2021)

June 11, 2021

Filing 487 TRANSCRIPT ORDER for proceedings held on 6/8/2021 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Diane Skillman. (Novikov, Eugene) (Filed on 6/11/2021)

June 10, 2021

Filing 486 Minute Entry for proceedings held before Magistrate Judge Susan van Keulen: Settlement Conference held on 6/10/2021 via Zoom.Settlement discussions continue.Time in Court: 6 hours. Court Reporter: Not reported. Pre-Settlement Conference Calls held 6/1/21.50 hours and 6/9/21 2 hours.Total Time in Court: 8.5 hours. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Date Filed: 6/10/2021)

June 9, 2021

Filing 485 TRANSCRIPT ORDER for Future Trial with Daily Transcripts by Plexxikon Inc.. (Novikov, Eugene) (Filed on 6/9/2021)

June 9, 2021

Filing 484 TRANSCRIPT ORDER for proceedings held on 6/8/2021 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Diane Skillman. (Steindler, Thomas) (Filed on 6/9/2021)

June 8, 2021

Filing 483 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Pretrial Conference held on 6/8/2021. Total Time in Court: 1 hour and 3 minutes. Court Reporter: Diane Skillman. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas P. Steindler. The Court DENIES the request for bifurcation. The Court advises the parties that: 1) the telephonic conference line will be used during the trial for public access; 2) July 23rd will be a dark day; 3) 8 jurors will be selected; 4) each side will be allotted 20 hours of trial time; 5) the U.S. Patent and Trademark Office video and sample patent they intend to provide to the jury should be submitted to the Court; and 5) the parties shall meet and confer regarding the disputed jury instructions as discussed on the record. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 6/8/2021)

June 8, 2021

Filing 482 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #206 MOTION TO EXCLUDE EXPERT TESTIMONY OF TED SWEENEY. (ndrS, COURT STAFF) (Filed on 6/8/2021)

June 7, 2021

Filing 481 Submission of Alternative Language for Jury Instruction per June 3, 2021 Order, Dkt 476 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/7/2021) Modified on 6/8/2021 (bnsS, COURT STAFF).

June 4, 2021

Filing 480 CLERK'S NOTICE CHANGE OF TIME FOR 6/9/21 FURTHER PRE-SETTLEMENT CONFERENCE CALLS. Further Pre-Settlement Conference Call with Plaintiff set for 6/9/2021 01:00 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen.Further Pre-Settlement Conference Call with Defendant set for 6/9/2021 02:30 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/4/2021)

June 3, 2021

Filing 479 ORDER REGARDING JUNE 8th PRETRIAL CONFERENCE. Signed by Judge Haywood S. Gilliam, Jr. on 6/3/2021. Pretrial Conference set for 6/8/2021 02:00 PM in Oakland, - Videoconference Only before Judge Haywood S. Gilliam Jr. This proceeding will be held via a Zoom webinar.Webinar Access: All counsel, members of the public, and media may access the webinar information at #https://www.cand.uscourts.gov/hsg General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited.Zoom Guidance and Setup: #https://www.cand.uscourts.gov/zoom/. (ndrS, COURT STAFF) (Filed on 6/3/2021)

June 3, 2021

Filing 478 ORDER by Judge Haywood S. Gilliam, Jr. Granting Amended #477 Motion for Pro Hac Vice as to Nicole M. Jantzi. #474 Motion for Pro Hac Vice Terminated, Re-filed as Docket No. #477 .(ndrS, COURT STAFF) (Filed on 6/3/2021)

June 3, 2021

Filing 477 Amended MOTION for leave to appear in Pro Hac Vice - Nicole M. Jantzi ( Filing fee $ 317, receipt number 0971-16032530.) Filing fee previously paid on 6/2/2021 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Jantzi, Nicole) (Filed on 6/3/2021)

June 3, 2021

Filing 476 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART PLAINTIFFS #264 MOTION IN LIMINE NO. 4 AND DENYING PLAINTIFFS #266 MOTION IN LIMINE NO. 5.(ndrS, COURT STAFF) (Filed on 6/3/2021)

June 2, 2021

Filing 475 ORDER REGARDING PLAINTIFFS MOTION IN LIMINE NO. 1 AND DEFENDANTS MOTIONS IN LIMINE NOS. 2, 3, AND 4. Signed by Judge Haywood S. Gilliam, Jr. on 6/2/2021. (ndrS, COURT STAFF) (Filed on 6/2/2021)

June 2, 2021

Filing 474 MOTION for leave to appear in Pro Hac Vice - Nicole M. Jantzi ( Filing fee $ 317, receipt number 0971-16032530.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Jantzi, Nicole) (Filed on 6/2/2021)

June 1, 2021

Filing 473 Novartis' Trial Time Estimates re 456 Order by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/1/2021) Modified on 6/2/2021 (bnsS, COURT STAFF).

June 1, 2021

Filing 472 Plaintiff Plexxikon, Inc.'s Trial Time Estimates re 456 Order by Plexxikon Inc.. (Krishnapriyan, Raghav) (Filed on 6/1/2021) Modified on 6/2/2021 (bnsS, COURT STAFF).

June 1, 2021

Filing 471 CLERK'S NOTICEBrief joint and confidential settlement statements due 6/3/21.Further Pre-Settlement Conference Call with Plaintiff set for 6/9/2021 01:30 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Further Pre-Settlement Conference Call with Defendant set for 6/9/2021 03:00 PM in San Jose, - Telephonic Only before Magistrate Judge Susan van Keulen. Counsel/parties emailed Judge van Keulen's AT&T Conference Call information.Settlement Conference remains set for 6/10/21 09:30 AM before Magistrate Judge Susan van Keulen. This proceeding will be held via Zoom.Counsel/parties emailed Judge van Keulen's Recurring Zoom Meeting Link.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. Zoom Guidance and Setup: https://www.cand.uscourts.gov/zoom/. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)

June 1, 2021

Filing 470 CLERK'S NOTICE CHANGE OF TIME FOR 6/1/21 PRE-SETTLEMENT CONFERENCE CALL VIA AT&T FROM 11:30AM TO 12:00PM.Pre-Settlement Conference Call set for 6/1/21 at 12:00 PM before Magistrate Judge Susan van Keulen.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)

June 1, 2021

Filing 469 CLERK'S NOTICE CHANGE OF TIME FOR 6/1/21 PRE-SETTLEMENT CONFERENCE CALL VIA AT&T FROM 11:00AM TO 11:30AM.Pre-Settlement Conference Call set for 6/1/21 at 11:30 AM before Magistrate Judge Susan van Keulen.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 6/1/2021)

May 28, 2021

Filing 468 CLERK'S NOTICE: SETTING OF ZOOM SETTLEMENT CONFERENCE.Settlement Conference set for 6/10/21 09:30 AM before Magistrate Judge Susan van Keulen. This proceeding will be held via Zoom.Counsel/parties emailed Judge van Keulen's Recurring Zoom Meeting Link.Settlement conference statements are due by 6/3/21.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. Zoom Guidance and Setup: https://www.cand.uscourts.gov/zoom/. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 5/28/2021)

May 28, 2021

Filing 467 CLERK'S NOTICE RE PRE-SETTLEMENT CONFERENCE CALL VIA AT&T.Pre-Settlement Conference Call set for 6/1/21 at 11:00 AM before Magistrate Judge Susan van Keulen.Settlement conference statements are due 6/3/21.Counsel/parties emailed Judge van Keulen's AT&T Conference Call information.The parties shall familiarize themselves with Judge van Keulen's Standing Order re: Settlement Conference Procedures at http://www.cand.uscourts.gov/svkorders. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhfS, COURT STAFF) (Filed on 5/28/2021)

May 26, 2021

Filing 466 ORDER by Hon. Haywood S. Gilliam, Jr. REFERRING CASE to Magistrate Judge van Keulen for Settlement. Signed by Judge Haywood S. Gilliam, Jr. on 5/26/2021. (hsglc1S, COURT STAFF) (Filed on 5/26/2021)

May 26, 2021

Filing 465 NOTICE of Appearance by Hannah Jiam (Jiam, Hannah) (Filed on 5/26/2021)

May 25, 2021

Filing 464 Proposed Joint Pretrial Statement and Order filed by Plexxikon Inc., and Novartis Pharmaceuticals Corporation (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).

May 25, 2021

Filing 463 TRIAL BRIEF by Plexxikon Inc.. (Novikov, Eugene) (Filed on 5/25/2021)

May 25, 2021

Filing 462 Proposed Joint Statement of the Case by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).

May 25, 2021

Filing 461 Proposed Form of Verdict by Plexxikon Inc. . (Novikov, Eugene) (Filed on 5/25/2021)

May 25, 2021

Filing 460 Joint Proposed Voir Dire Questions by Plexxikon Inc, and Novartis Pharmaceuticals Corporation. (Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).

May 25, 2021

Filing 459 Second Amended Joint Proposed Jury Instructions by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Novikov, Eugene) (Filed on 5/25/2021) Modified on 5/26/2021 (bnsS, COURT STAFF).

May 25, 2021

Filing 458 Proposed Form of Verdict by Novartis Pharmaceuticals Corporation . (Steindler, Thomas) (Filed on 5/25/2021)

May 25, 2021

Filing 457 ORDER by Hon. Haywood S. Gilliam, Jr. ADVANCING the jury selection to July 9, 2021, at 8:30 a.m. Opening statements and the presentation of evidence will still begin as scheduled on July 12, 2021, at 8:30 a.m. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/25/2021)

May 21, 2021

Filing 456 ORDER by Hon. Haywood S. Gilliam, Jr. The Court intends to impose time limits on each party at trial. Each party is therefore DIRECTED to submit (1) the projected duration of the direct examination of each of its witnesses listed in Dkt. No. [313-2] and Dkt. No. [313-3], the Joint Pretrial Statement and related exhibits; (2) the anticipated duration of the cross-examination of each of the other party's disclosed witnesses; and (3) the total number of hours projected (i.e., the sum of categories (1) and (2)). These estimates should be realistic, not padded. The parties shall file their submissions by June 1, 2021, and should be prepared to discuss these estimates during the pretrial conference. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/21/2021)

May 10, 2021

Filing 455 NOTICE of Appearance by Andrew Treloar Jones (Jones, Andrew) (Filed on 5/10/2021)

May 10, 2021

Filing 454 NOTICE of Appearance by Katherine E. McNutt (McNutt, Katherine) (Filed on 5/10/2021)

April 7, 2021

Filing 453 Notice of Compliance with Court Order Dated March 31, 2021 by Plexxikon Inc. re #452 Order on Administrative Motion per Civil Local Rule 7-11 (Attachments: #1 Exhibit 1 to Miller Declaration (Dkt. No. 169-2/ (Dkt. No. 168-4)), #2 Exhibit 2 to Steindler Declaration (Dkt. No. 202-3/ (Dkt. No. 201-6)))(Krishnapriyan, Raghav) (Filed on 4/7/2021) Modified on 4/8/2021 (bnsS, COURT STAFF).

March 31, 2021

Filing 452 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING Dkt. No. #394 Plaintiff's Administrative Motion for Leave to Move for Reconsideration of Motions to Seal. (hsglc1S, COURT STAFF) (Filed on 3/31/2021)

March 26, 2021

Filing 451 ORDER by Judge Haywood S. Gilliam, Jr. DENYING PLAINITFFS ( #262 , #260 ) MOTIONS IN LIMINE NO. 2 AND 3 AND GRANTING DEFENDANTS #268 MOTION IN LIMINE NO. 1. (ndrS, COURT STAFF) (Filed on 3/26/2021)

March 15, 2021

Filing 450 ORDER by Judge Haywood S. Gilliam, Jr. DENYING DEFENDANT'S #177 MOTION FOR SUMMARY JUDGMENT. (ndrS, COURT STAFF) (Filed on 3/15/2021)

February 23, 2021

Filing 449 ORDER by Judge Haywood S. Gilliam, Jr. Granting Plexxikon Inc.s #167 Motion for Summary Judgment of no Anticipation. (ndrS, COURT STAFF) (Filed on 2/23/2021)

January 15, 2021

Filing 448 ORDER by Judge Haywood S. Gilliam, Jr. Granting #447 Stipulation Regarding Trial Re Docket No. 446 . Pretrial Conference set for 6/8/2021 03:00 PM before Judge Haywood S. Gilliam Jr. and Jury Selection /Jury Trial (2-week) set for 7/12/2021 08:30 AM before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 1/15/2021)

January 14, 2021

Filing 447 STIPULATION WITH PROPOSED ORDER Regarding Trial re 446 Terminate Hearings, Status Conference, Set Deadlines filed by Novartis Pharmaceuticals Corporation, and Plexxikon Inc.. (Steindler, Thomas) (Filed on 1/14/2021) Modified on 1/15/2021 (bnsS, COURT STAFF).

January 12, 2021

Filing 446 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Status Conference held on 1/12/2021. Status Report due by 1/15/2021.Total Time in Court: 13 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Court directs the parties to confer with their teams and witnesses to determine if July 12th would work as a trial date. If July 12th works, the pretrial conference would be set on June 8th at 3:00 p.m. Counsel for plaintiff is directed to confer with her client to determine if a bench trial is a possibility. Parties are directed to update the Court regarding these two issues by Friday, January 15th. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 1/12/2021)

January 12, 2021

Filing 445 ORDER by Judge Haywood S. Gilliam, Jr. REGARDING ( #169 , #202 ) MOTIONS TO EXCLUDE DAMAGES EXPERTS OPINIONS. (ndrS, COURT STAFF) (Filed on 1/12/2021)

January 7, 2021

Filing 444 RESPONSE re #443 Order Regarding Motion to Exclude Expert Testimony of Dr. Gregory K. Leonard, Ph.D by Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Durie, Daralyn) (Filed on 1/7/2021)

January 7, 2021

Filing 443 ORDER REGARDING #202 MOTION TO EXCLUDE EXPERT TESTIMONY OF DR. GREGORY K. LEONARD, PH.D. Signed by Judge Haywood S. Gilliam, Jr. on 1/7/2021. (ndrS, COURT STAFF) (Filed on 1/7/2021)

January 6, 2021

Filing 442 ORDER Granting #441 Joint Motion for Hearing Re Status Conference Re Trial Date. Telephonic Status Conference set for 1/12/2021 02:00 PM in Oakland before Judge Haywood S. Gilliam Jr. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III.. Signed by Judge Haywood S. Gilliam, Jr. on 1/6/2021 (ndrS, COURT STAFF) (Filed on 1/6/2021)

January 5, 2021

Filing 441 Joint MOTION for Hearing re Status Conference re Trial Date filed by Plexxikon Inc., and Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Durie, Daralyn) (Filed on 1/5/2021) Modified on 1/6/2021 (bnsS, COURT STAFF).

December 8, 2020

Filing 440 NOTICE by Novartis Pharmaceuticals Corporation re #438 Order on Administrative Motion to File Under Seal, (Attachments: #1 Proposed Motion for Summary Judgment, #2 Exhibit C-04, #3 Exhibit C-10, #4 Exhibit C-11, #5 Exhibit C-12, #6 Exhibit C-13, #7 Exhibit C-14, #8 Exhibit C-15, #9 Exhibit C-16, #10 Exhibit C, #11 Exhibit D, #12 Exhibit F, #13 Exhibit G, #14 Exhibit I, #15 Exhibit J, #16 Exhibit K, #17 Exhibit L)(Steindler, Thomas) (Filed on 12/8/2020)

November 30, 2020

Filing 439 ORDER by Hon. Haywood S. Gilliam, Jr. DENYING Dkt. No. #383 Defendant's motion to file a reply brief regarding Plaintiff's Motion in Limine No. 1. Although the Court directed the parties to file proffers related to Motion in Limine No. 1, this was not an invitation to brief the issues anew. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 11/30/2020)

November 30, 2020

Filing 438 ORDER by Judge Haywood S. Gilliam, Jr. DENYING ( #344 , #390 )MOTIONS TO SEAL. (ndrS, COURT STAFF) (Filed on 11/30/2020)

September 16, 2020

Filing 437 ORDER by Judge Haywood S. Gilliam, Jr. Granting #436 Motion for Pro Hac Vice as to Columbia, Sarah. (ndrS, COURT STAFF) (Filed on 9/16/2020)

September 15, 2020

Filing 436 MOTION for leave to appear in Pro Hac Vice re Sarah Chapin Columbia ( Filing fee $ 310, receipt number 0971-14943938.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Certificate of Good Standing, #2 Proposed Order)(Columbia, Sarah) (Filed on 9/15/2020) Modified on 9/16/2020 (bnsS, COURT STAFF).

August 31, 2020

Filing 435 ORDER by Judge Haywood S. Gilliam, Jr. Granting #433 Motion for Pro Hac Vice Re: Kira Alexis Davis. (ndrS, COURT STAFF) (Filed on 8/31/2020)

August 24, 2020

Filing 434 Declaration of Kira A. Davis in Support of #433 MOTION for leave to appear in Pro Hac Vice Re: Kira Alexis Davis filed byPlexxikon Inc.. (Related document(s) #433 ) (Davis, Kira) (Filed on 8/24/2020)

August 17, 2020

Filing 433 MOTION for leave to appear in Pro Hac Vice Re: Kira Alexis Davis(Filing fee $ 310, receipt number 0971-14825848) filed by Plexxikon Inc. (Attachments: #1 Certificate/Proof of Service Certificate of Good Standing)(Davis, Kira) (Filed on 8/17/2020) Modified on 8/17/2020 (cjlS, COURT STAFF).

August 12, 2020

Filing 432 REVISED SCHEDULING ORDER: Pretrial Conference set for 3/2/2021 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. and Jury Selection / Jury Trial (10 day) set for 4/5/2021 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. Signed by Judge Haywood S. Gilliam, Jr. on 8/12/2020. (ndrS, COURT STAFF) (Filed on 8/12/2020)

August 10, 2020

Filing 431 Joint Notice Re: Proposed Trial Dates re 430 Order, 428 Status Conference by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 8/10/2020) Modified on 8/11/2020 (bnsS, COURT STAFF).

August 10, 2020

Filing 430 ORDER by Hon. Haywood S. Gilliam, Jr. GRANTING Dkt. No. #429 the parties' request to extend the deadline to file a joint statement advising the Court as to their preferred new trial date. The parties shall file their joint statement by August 10, 2020. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 8/10/2020)

August 7, 2020

Filing 429 Joint Notice Re: Proposed Trial Dates by Plexxikon Inc. (Durie, Daralyn) (Filed on 8/7/2020) Modified on 8/10/2020 (cjlS, COURT STAFF).

August 4, 2020

Filing 428 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Telephonic Status Conference held on 8/4/2020. Total Time in Court: 10 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. Counsel are directed to meet and confer with the clients and witnesses by Friday, August 7, 2020, and e-file a joint statement advising the Court which of the proposed trial dates they agree to. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 8/4/2020)

August 4, 2020

Filing 427 NOTICE of Withdrawal of Laura E. Miller by Eugene Novikov. (Novikov, Eugene) (Filed on 8/4/2020) Modified on 8/5/2020 (cjlS, COURT STAFF).

July 30, 2020

Filing 426 ORDER GRANTING #425 Joint MOTION for Hearing Re Status Conference Re Trial Date. Telephonic Status Conference set for 8/4/2020 02:00 PM before Judge Haywood S. Gilliam Jr. Signed by Judge Haywood S. Gilliam, Jr. on 7/30/2020. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: 888-808-6929Access Code: 6064255The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. (ndrS, COURT STAFF) (Filed on 7/30/2020)

July 29, 2020

Filing 425 Joint MOTION for Hearing re Status Conference re Trial Date filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Durie, Daralyn) (Filed on 7/29/2020) Modified on 7/30/2020 (jmlS, COURT STAFF).

June 8, 2020

Filing 424 NOTICE of Withdrawal of Counsel by Plexxikon Inc. (Durie, Daralyn) (Filed on 6/8/2020) Modified on 6/8/2020 (cjlS, COURT STAFF).

May 29, 2020

Filing 423 NOTICE for Withdrawal of Counsel by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 5/29/2020) Modified on 6/1/2020 (cjlS, COURT STAFF).

May 26, 2020

Filing 422 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART #204 MOTION TO EXCLUDE THE EXPERT TESTIMONY OF SUSANA ORTIZ-URDA. (ndrS, COURT STAFF) (Filed on 5/26/2020)

May 8, 2020

Filing 421 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #165 MOTION TO EXCLUDE CERTAIN OPINIONS AND TESTIMONY OF DEFENDANT'S TECHNICAL EXPERTS. (ndrS, COURT STAFF) (Filed on 5/8/2020)

April 20, 2020

Filing 420 ORDER by Hon. Haywood S. Gilliam, Jr. CONTINUING the case schedule as follows: September 8, 2020, at 3:00 p.m. for pretrial conference, and October 5, 2020, at 8:30 a.m. for 10-day jury trial. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 4/20/2020)

April 20, 2020

Reset Hearing, See Docket No. 420 : Pretrial Conference set for 9/8/2020 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. and Jury Selection \Jury Trial (10- day) set for 10/5/2020 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 4/20/2020)

April 17, 2020

Filing 419 Statement of Joint Availability re Trial by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 4/17/2020) Modified on 4/20/2020 (cjlS, COURT STAFF).

April 14, 2020

Filing 418 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 4/14/2020. Total Time in Court: 8 Minutes. Not Reported. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler and David Mlaver. Parties are directed meet with their clients and witnesses and e-file a short statement indicating whether a September 8th pretrial conference and an October 5th jury trial will work. The Court is alternatively available for trial beginning on November 2nd or December 7th if necessary, though would prefer to set trial as early as possible. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 4/14/2020)

April 10, 2020

Set Hearing, See Docket No. 415 : Telephonic Further Case Management Conference set for 4/14/2020 02:00 PM. (ndrS, COURT STAFF) (Filed on 4/10/2020)

April 10, 2020

Filing 417 Document Sealed. ORDER GRANTING #179 MOTION TO STRIKE PORTIONS OF EXPERTREPORT. ***UNREDACTED VERSION*** Signed by Judge Haywood S. Gilliam, Jr. on 4/10/2020. (ndrS, COURT STAFF) (Filed on 4/10/2020) (Additional attachment(s) added on 4/15/2020: #1 Certificate/Proof of Service) (ndrS, COURT STAFF).

April 10, 2020

Filing 416 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING #179 MOTION TOSTRIKE PORTIONS OF EXPERT REPORT. **REDACTED VERSION** (ndrS, COURT STAFF) (Filed on 4/10/2020)

April 10, 2020

Filing 415 ORDER by Hon. Haywood S. Gilliam, Jr. GRANTING Dkt. No. #414 the parties' joint request for a status conference. The Court SETS a telephonic case management conference on April 14, 2020, at 2:00 p.m. All counsel shall use the following dial-in information to access the case management conference: Dial-In: 888-808-6929; and Passcode: 6064255. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 4/10/2020)

April 10, 2020

#Electronic filing error. REMINDER: Incorrect event used. [err101] Proper event to use is a motion. Additionally, future request should be accompanied by a proposed order. Correc ted by Clerk's Office. No further action is necessary. Re: #414 Joint Request for Status Conference Regarding Trial Date filed by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (cjlS, COURT STAFF) (Filed on 4/10/2020)

April 9, 2020

Filing 414 Joint Request for Status Conference Regarding Trial Date by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (Steindler, Thomas) (Filed on 4/9/2020) Modified on 4/10/2020 (cjlS, COURT STAFF).

March 26, 2020

Filing 413 Transcript of Proceedings held on 03/25/2020, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #412 Transcript Order ) Redaction Request due 4/16/2020. Redacted Transcript Deadline set for 4/27/2020. Release of Transcript Restriction set for 6/24/2020. (Related documents(s) #412 ) (Batalo, Pam) (Filed on 3/26/2020)

March 26, 2020

Filing 412 TRANSCRIPT ORDER for proceedings held on 3/25/2020 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Miller, Laura) (Filed on 3/26/2020)

March 26, 2020

Filing 411 TRANSCRIPT ORDER for proceedings held on 3/25/2020 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 3/26/2020)

March 25, 2020

Filing 410 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Telephonic Case Management Conference held on 3/25/2020. Total Time in Court: 12 minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Judge advises the parties that he's not inclined to vacate the trial date at this time. Parties are advised that no oral argument will be needed on the pending motions unless advised otherwise. Parties are advised that lead counsel will be the only counsel permitted to argue any issue presented to the Court beginning now through trial (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 3/25/2020) Modified on 3/26/2020 to correct typo(ndrS, COURT STAFF).

March 25, 2020

Filing 409 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #200 MOTION TO EXCLUDE TESTIMONY OF DR. MICHAEL L. METZKER. (ndrS, COURT STAFF) (Filed on 3/25/2020)

March 24, 2020

Filing 408 ORDER by Judge Haywood S. Gilliam, Jr. Granting #407 Motion for Extension of Time to File Public Versions of Documents.(ndrS, COURT STAFF) (Filed on 3/24/2020)

March 23, 2020

Filing 407 MOTION for Extension of Time to File Public Versions of Documents filed by Plexxikon Inc.. (Attachments: #1 Declaration of Matthew W. Samuels In Support of Plaintiff Plexxikon Inc.'s Unopposed Motion and [Proposed] Order to Extend Time to Submit Public Versions of Documents)(Samuels, Matthew) (Filed on 3/23/2020)

March 23, 2020

Filing 406 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a case management conference on March 25, 2020, at 1:00 p.m., to be held in lieu of the pretrial conference and hearing on the motions in limine that day. In light of the evolving circumstances with the COVID-19 outbreak, the Court does not need argument on the motions in limine at this time, and would instead like to prioritize discussing whether the case may proceed under the current case schedule. The Court's inclination is to proceed for now under the assumption that trial will proceed on June 15, 2020, as planned. However, the parties should be prepared to discuss how this case may proceed realistically under the circumstances. The Court is exploring whether video conference will be available, but for now, all counsel shall use the following dial-in information to access the case management conference: Dial-In: 888-808-6929; and Passcode: 6064255. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 3/23/2020)

March 23, 2020

Filing 405 EXHIBITS 9 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 367-2/(366-7) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: Novartis's MIL No. 3, #2 Exhibit Dkt. No. 367-3/(366-9) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 3, #3 Exhibit Dkt. No. 367-4/(366-11) Exhibit 3 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL NO. 3, #4 Exhibit Dkt. No. 367-5/(366-13) Exhibit 4 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 3, #5 Dkt. No. 369/(368-4) Plaintiff's Offer of Proof Re: Novartis's MIL No. 4, #6 Exhibit Dkt. No. 369-2/(368-6) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 4, #7 Exhibit Dkt. No. 369-3/(368-8) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 4)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 404 EXHIBITS 8 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Dkt. No. 333/(332-4) Opposition to Novartis's Motion to Strike Second Supplemental Report of Leonard, #2 Exhibit Dkt. No. 333-6/(332-10) Exhibit 5 to Miller Declaration ISO Opposition to Novartis's MTS, #3 Exhibit Dkt. No. 333-7/(332-12) Exhibit 6 to Miller Declaration ISO Opposition to Novartis's MTS, #4 Dkt. No. 364/(363-4) Plaintiff's Offer of Proof Re: Novartis's MIL No. 2, #5 Exhibit Dkt. No. 364-2/(363-6) Exhibit 1 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #6 Exhibit Dkt. No. 364-3/(363-8) Exhibit 2 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #7 Exhibit Dkt. No. 364-7/(363-12) Exhibit 6 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2, #8 Exhibit Dkt. No. 364-10/(363-14) Exhibit 9 to Miller Declaration ISO Plaintiff's Offer of Proof Re: MIL No. 2)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 403 EXHIBITS 7 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 298-7/(297-16) Exhibit 6 to Miller Declaration ISO Opposition to Novartis's MIL No. 4, #2 Exhibit Dkt. No. 298-8/(297-18) Exhibit 7 to Miller Declaration ISO Opposition to Novartis's MIL No. 4, #3 Exhibit Dkt. No. 327-4/(299-4) Exhibit 3 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #4 Exhibit Dkt. No. 327-5/(299-6) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #5 Dkt. No. 325/(314-5) Plaintiff's Opposition to Motion to Exclude Leonard Testimony, #6 Exhibit Dkt. No. 325-2/(314-7) Exhibit 1 to Miller Declaration ISO Opposition to Motion to Exclude Leonard Testimony, #7 Exhibit Dkt. No. 327-4/(314-15) Exhibit 3 to Miller Declaration ISO Opposition to Novartis's MIL No. 5, #8 Exhibit Dkt. No. 327-5/(314-17) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 5)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 402 EXHIBITS 6 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 292-6/(291-5) Exhibit 5 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #2 Exhibit Dkt. No. 292-8/(291-7) Exhibit 7 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #3 Exhibit Dkt. No. 292-9/(291-9) Exhibit 8 to Miller Declaration ISO Opposition to Novartis's MIL No. 1, #4 Dkt. No. 294/(293-3) Opposition to Novartis's MIL No. 2, #5 Exhibit Dkt. No. 294-3/(293-5) Exhibit 2 to Miller Declaration ISO Opposition to Novartis's MIL No. 2, #6 Exhibit Dkt. No. 294-5/(293-7) Exhibit 4 to Miller Declaration ISO Opposition to Novartis's MIL No. 2, #7 Exhibit Dkt. No. 296-2/(295-3) Exhibit 1 to Miller Declaration ISO Opposition to Novartis's MIL No. 3, #8 Exhibit Dkt. No. 296-3/(295-5) Exhibit 2 to Miller Declaration ISO Opposition to Novartis's MIL No. 3)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 401 EXHIBITS 5 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 262-2/(261-6) Exhibit 1 to Miller Declaration ISO MIL No. 3, #2 Exhibit Dkt. No. 262-3/(261-8) Exhibit 2 to Miller Declaration ISO MIL No. 3, #3 Exhibit Dkt. No. 262-4/(261-10) Exhibit 3 to Miller Declaration ISO MIL No. 3, #4 Exhibit Dkt. No. 262-5/(261-12) Exhibit 4 to Miller Declaration ISO MIL No. 3, #5 Exhibit Dkt. No. 262-6/(261-14) Exhibit 5 to Miller Declaration ISO MIL No. 3, #6 Dkt. No. 264/(263-4) Plaintiff's MIL No. 4, #7 Declaration Dkt. No. 264-1/(263-6) Miller Declaration ISO MIL No. 4, #8 Exhibit Dkt. No. 264-6/(263-8) Exhibit 5 to Miller Declaration ISO MIL No. 4, #9 Exhibit Dkt. No. 264-7/(263-10) Exhibit 6 to Miller Declaration ISO MIL No. 4)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 400 EXHIBITS 4 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 234-3/(232-6) Exhibit 2 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #2 Exhibit Dkt. No. 234-5/(232-8) Exhibit 4 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #3 Exhibit Dkt. No. 234-6/(232-10) Exhibit 5 to Miller Declaration ISO Opposition to Motion to Exclude Sweeney Testimony, #4 Dkt. No. 236/(235-4) Plaintiff's Motion to Strike Daubert Motions Filed June 6, 2019, #5 Exhibit Dkt. No. 236-2/(235-6) Exhibit 1 to Miller Declaration ISO MTS Daubert Motions, #6 Exhibit Dkt. No. 236-3/(235-8) Exhibit 2 to Miller Declaration ISO MTS Daubert Motions, #7 Dkt. No. 259/(258-4) Plaintiff's MIL No. 1, #8 Exhibit Dkt. No. 259-2/(258-6) Exhibit 1 to Miller Declaration ISO MIL No. 1, #9 Exhibit Dkt. No. 295-3/(258-8) Exhibit 2 to Miller Declaration ISO MIL No. 1)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 399 EXHIBITS 3 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 213-1/(211-6) Exhibit A to Metzker Declaration ISO Opposition to Motion for Partial Summary Judgment, #2 Exhibit Dkt. No. 213-2/(211-8) Exhibit B to Metzker Declaration ISO Opposition to Motion for Partial Summary Judgment, #3 Exhibit Dkt. No. 212-13/(211-10) Exhibit 12 to Miller Declaration ISO Opposition to Motion for Partial Summary Judgment, #4 Exhibit Dkt. No. 212-20/(211-12) Exhibit 19 to Miller Declaration ISO Opposition to Motion for Partial Summary Judgment, #5 Exhibit Dkt. No. 214-1/(211-14) Exhibit A to Winkler Declaration ISO Opposition to Motion for Partial Summary Judgment, #6 Exhibit Dkt. No. 325-3/(224-8) Exhibit 2 to Miller Declaration ISO Opposition to Defendant's Motion to Exclude Leonard Testimony, #7 Dkt. No. 227/(226-4) Plaintiff's Opposition to Motion to Preclude Certain Testimony of Ortiz-Urda Under Daubert, #8 Exhibit Dkt. No. 227-2/(226-6) Exhibit 1 to Miller Declaration ISO Opposition to Motion to Preclude Certain Testimony of Ortiz-Urda, #9 Exhibit Dkt. No. 227-3/(226-8) Exhibit 2 to Miller Declaration ISO Opposition to Motion to Preclude Testimony of Ortiz-Urda)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 398 EXHIBITS 2 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Dkt. No. 197/(196-4) Plaintiff's Reply ISO Motion to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #2 Exhibit Dkt. No. 208-15/(207-14) Exhibit 14 to Miller Declaration, #3 Dkt. No. 210/(209-4) Plaintiff's Opposition to Novartis's Motion for Judgment on the Pleadings, #4 Exhibit Dkt. No. 210-10/(209-14) Exhibit 9 to Miller Declaration, #5 Exhibit Dkt. No. 210-11/(209-16) Exhibit 10 to Miller Declaration, #6 Exhibit Dkt. No. 210-12/(209-18) Exhibit 11 to Miller Declaration, #7 Exhibit Dkt. No. 210-13/(209-20) Exhibit 12 to Miller Declaration, #8 Exhibit Dkt. No. 210-14/(209-22) Exhibit 13 to Miller Declaration)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 397 EXHIBITS 1 of 9 re #396 Notice of Compliance with Court Dated March 13, 2020 (DKT. NO. #386 ) filed by Plexxikon Inc. (Attachments: #1 Exhibit Dkt. No. 167-2/(166-6) Exhibit 1 to Samuels Declaration, #2 Exhibit Dkt. No. 167-10/(166-8) Exhibit 9 to Samuels Declaration, #3 Exhibit Dkt. No. 167-20/(166-10) Exhibit 19 to Samuels Declaration, #4 Dkt. No. 169/(168-10) Plaintiff's Motion to Exclude the Opinions and Testimony of Malackowski, #5 Exhibit Dkt. No. 169-3/(168-8) Exhibit 2 to Miller Declaration, #6 Exhibit Dkt. No. 169-4/(168-8) Exhibit 3 to Miller Declaration)(Related document(s) #396 ) (Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 396 NOTICE OF COMPLIANCE WITH COURT ORDER DATED MARCH 13, 2020 (DKT. NO. #386 ) by Plexxikon Inc. (Attachments: #1 Dkt. No. 165/(164-4) Plaintiff's Motion to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #2 Exhibit Dkt. No. 165-2(164-6) Exhibit 1 to Miller Declaration, #3 Exhibit Dkt. No. 165-3(164-8) Exhibit 2 to Miller Declaration, #4 Exhibit Dkt. No. 165-5(164-10) Exhibit 4 to Miller Declaration, #5 Exhibit Dkt. No. 165-6(164-12) Exhibit 5 to Miller Declaration, #6 Exhibit Dkt. No. 165-8(164-14) Exhibit 7 to Miller Declaration)(Samuels, Matthew) (Filed on 3/23/2020) Modified on 3/24/2020 (cjlS, COURT STAFF).

March 23, 2020

Filing 395 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING a telephonic hearing for Monday, March 23, 2020, at 12:30 p.m., regarding logistics for the pretrial conference currently scheduled for March 25, 2020. All counsel shall use the following dial-in information to access the call today: Dial-In: 888-808-6929; and Passcode: 6064255. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines. The parties are further advised to ensure that the Court can hear and understand them clearly before speaking at length. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 3/23/2020)

March 23, 2020

Reset Hearings, See Docket No. 406 : Telephonic Case Management Conference set for 3/25/2020 01:00 PM in Oakland, Courtroom 2, 4th Floor. (ndrS, COURT STAFF) (Filed on 3/23/2020)

March 20, 2020

Filing 394 PLAINTIFF PLEXXIKON INC.S MOTION FOR ADMINISTRATIVE RELIEF PURSUANT TO CIVIL L.R. 7-11 AND 79-5 AND MOTION FOR LEAVE TO MOVE FOR RECONSIDERATION PURSUANT TO CIVIL L.R. 7-9 filed by Plexxikon Inc. Responses due by 3/24/2020. (Attachments: #1 Declaration of Marguerite Hutchinson in Support of Plaintiff Plexxikon Inc.'s Motion for Administrative Relief, #2 Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.'s Motion for Administrative Relief, #3 Proposed Order Granting Plaintiff Plexxikon Inc.'s Motion for Administrative Relief)(Miller, Laura) (Filed on 3/20/2020) Modified on 3/23/2020 (cjlS, COURT STAFF).

March 20, 2020

Filing 393 NOVARTISS NOTICE OF COMPLIANCE WITH COURT ORDER DATED MARCH 20, 2020 (Dkt. No. #386 ) by Novartis Pharmaceuticals Corporation. (Attachments: #1 Dkt. No. 177 / (176-4) - Public Version of Partial SJ Motion, #2 Dkt. No. 177-14 / (176-10) - Public Version of Ex 12 to Baran Dec ISO Partial SJ Motion, #3 Dkt. No. 177-20 / (176-15) - Public Version of Ex 1 to Steindler Dec ISO Partial SJ Motion, #4 Dkt. No. 177-22 / (176-16) - Public Version of Ex 3 to Steindler Dec ISO Partial SJ Motion, #5 Dkt. No. 179 / (178-4) - Public Version of Motion to Strike - Metzker, #6 Dkt. No. 179-3 / (178-5) - Public Version of Ex 1 to Motion to Strike - Metzker, #7 Dkt. No. 179-7 / (178-7) - Public Version of Ex 5 to Motion to Strike - Metzker, #8 Dkt. No. 179-9 / (178-8) - Public Version of Ex 7 to Motion to Strike - Metzker, #9 Dkt. No. 186 / (185-4) - Public Version of Opp to Plex SJ Motion, #10 Dkt. No. 186-3 / (185-5) - Public Version of Ex 2 to Opp to Plex SJ Motion, #11 Dkt. No. 186-4 / (185-7) - Public Version of Ex 3 to Opp to Plex SJ Motion, #12 Dkt. No. 186-6 / (185-8) - Public Version of Ex 5 to Opp to Plex SJ Motion, #13 Dkt. No. 186-8 / (185-9) - Public Version of Ex 7 to Opp to Plex SJ Motion, #14 Dkt. No. 186-11 / (185-12) - Public Version of Ex 10 to Opp to Plex SJ Motion, #15 Dkt. No. 186-12 / (185-13) - Public Version of Ex 11 to Opp to Plex SJ Motion, #16 Dkt. No. 188 / (187-4) - Public Version of Opp to Plex Motion to Exclude - Malackowski, #17 Dkt. No. 188-2 / (187-5) - Public Version of Ex A to Opp to Plex Motion to Exclude - Malackowski, #18 Dkt. No. 188-3 / (187-6) - Public Version of Ex B to Opp to Plex Motion to Exclude - Malackowski, #19 Dkt. No. 188-4 / (187-7) - Public Version of Ex C to Opp to Plex Motion to Exclude - Malackowski, #20 Dkt. No. 200 / (199-4) - Public Version of Motion to Exclude - Metzker, #21 Dkt. No. 200-1 / (199-6) - Public Version of Baran Dec ISO Motion to Exclude - Metzker, #22 Dkt. No. 200-5 / (199-7) - Public Version of Ex 3 to Motion to Exclude - Metzker, #23 Dkt. No. 200-6 / (199-8) - Public Version of Ex 4 to Motion to Exclude - Metzker, #24 Dkt. No. 200-7 / (199-9) - Public Version of Ex 5 to Motion to Exclude - Metzker, #25 Dkt. No. 200-8 / (199-10) - Public Version of Ex 6 to Motion to Exclude - Metzker, #26 Dkt. No. 200-9 / (199-11) - Public Version of Ex 7 to Motion to Exclude - Metzker, #27 Dkt. No. 200-10 / (199-12) - Public Version of Ex 8 to Motion to Exclude - Metzker, #28 Dkt. No. 202 / (201-4) - Public Version of Motion to Exclude - Leonard, #29 Dkt. No. 202-2 / (201-5) - Public Version of Ex 1 to Motion to Exclude - Leonard, #30 Dkt. No. 202-3 / (201-6) - Public Version of Ex 2 to Motion to Exclude - Leonard, #31 Dkt. No. 204 / (203-4) - Public Version of Motion to Exclude - Ortiz, #32 Dkt. No. 204-2 / (203-5) - Public Version of Ex 1 to Motion to Exclude - Ortiz, #33 Dkt. No. 204-3 / (203-6) - Public Version of Ex 2 to Motion to Exclude - Ortiz, #34 Dkt. No. 206 / (205-4) - Public Version of Motion to Exclude - Sweeney, #35 Dkt. No. 206-2 / (205-5) - Public Version of Ex 1 to Motion to Exclude - Sweeney, #36 Dkt. No. 233 / (231-4) - Public Version of Reply ISO Partial SJ Motion, #37 Dkt. No. 233-2 / (231-6) - Public Version of Ex A ISO Reply ISO Partial SJ Motion, #38 Dkt. No. 233-3 / (231-7) - Public Version of Ex B ISO Reply ISO Partial SJ Motion, #39 Dkt. No. 233-4 / (231-8) - Public Version of Ex C ISO Reply ISO Partial SJ Motion, #40 Dkt. No. 233-5 / (231-9) - Public Version of Ex D ISO Reply ISO Partial SJ Motion, #41 Dkt. No. 233-6 / (231-10) - Public Version of Ex E ISO Reply ISO Partial SJ Motion, #42 Dkt. No. 272 / (267-4) - Public Version of MIL No. 5, #43 Dkt. No. 273-6 / (267-7) - Public Version of Ex F to Steindler Dec ISO MILs, #44 Dkt. No. 273-7 / (267-9) - Public Version of Ex G to Steindler Dec ISO MILs, #45 Dkt. No. 273-11 / (267-10) - Public Version of Ex K to Steindler Dec ISO MILs, #46 Dkt. No. 283 / (282-4) - Public Version of Opp to Plex MIL No. 1, #47 Dkt. No. 286-2 / (285-4) - Public Version of Ex A to Opp to Plex MIL No. 3, #48 Dkt. No. 286-7 / (285-6) - Public Version of Ex F to Opp to Plex MIL No. 3, #49 Dkt. No. 286-9 / (285-8) - Public Version of Ex H to Opp to Plex MIL No. 3, #50 Dkt. No. 286-10 / (285-10) - Public Version of Ex I to Opp to Plex MIL No. 3, #51 Dkt. No. 288-3 / (287-3) - Public Version of Ex B to Opp to Plex MIL No. 4, #52 Dkt. No. 288-4 / (287-4) - Public Version of Ex C to Opp to Plex MIL No. 4, #53 Dkt. No. 290-2 / (289-5) - Public Version of Ex A to Opp to Plex Mil No. 5, #54 Dkt. No. 307 / (306-4) - Public Version of Motion to Strike 2d Supp Leonard Report, #55 Dkt. No. 307-2 / (306-5) - Public Version of Ex 1 to Motion to Strike 2d Supp Leonard Report, #56 Dkt. No. 307-4 / (306-8) - Public Version of Ex 3 to Motion to Strike 2d Supp Leonard Report, #57 Dkt. No. 319 / (314-19) - Public Version of Ex 4 to Motion to Strike 2d Supp Leonard Report)(Steindler, Thomas) (Filed on 3/20/2020) Modified on 3/23/2020 (cjlS, COURT STAFF).

March 20, 2020

Filing 392 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART #236 MOTION TO STRIKE DEFENDANTS DAUBERT MOTIONS. (ndrS, COURT STAFF) (Filed on 3/20/2020)

March 18, 2020

Filing 390 Administrative Motion to File Under Seal re Objections to Special Master's Recommendation for Order re Plaintiff's Motion in Limine No. 4 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Exhibit C-4, #4 Exhibit C-10, #5 Exhibit C-11, #6 Exhibit C-12, #7 Exhibit C-13, #8 Exhibit C-14, #9 Exhibit C-15, #10 Exhibit C-16, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 3/18/2020)

March 18, 2020

Filing 389 OBJECTIONS to #388 Special Masters Order - Recommendation for Order on Plaintiff's Motion in Limine No. 4 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit C-1, #6 Exhibit C-2, #7 Exhibit C-3, #8 Exhibit C-4, #9 Exhibit C-5, #10 Exhibit C-6, #11 Exhibit C-7, #12 Exhibit C-8, #13 Exhibit C-9, #14 Exhibit C-10, #15 Exhibit C-11, #16 Exhibit C-12, #17 Exhibit C-13, #18 Exhibit C-14, #19 Exhibit C-15, #20 Exhibit C-16, #21 Exhibit C-17 - Part 1 of 2, #22 Exhibit C-17 - Part 2 of 2, #23 Exhibit D, #24 Exhibit E, #25 Exhibit E-1, #26 Exhibit F)(Steindler, Thomas) (Filed on 3/18/2020) Modified on 3/19/2020 (cjlS, COURT STAFF).

March 18, 2020

Filing 388 Special Masters Order - Recommendation for Order Regarding Plaintiff's Motion in Limine No. 4. (Steindler, Thomas) (Filed on 3/18/2020)

March 16, 2020

Filing 387 ORDER REGARDING MOTIONS TO SEAL. Signed by Judge Haywood S. Gilliam, Jr. on 3/16/2020. (ndrS, COURT STAFF) (Filed on 3/16/2020)

March 13, 2020

Filing 386 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING IN PART AND DENYING IN PART ( #363 ; #366 ; #368 ; #374 ; #149 ; #164 ; #235 ; #242 ; #258 ; #261 ; #263 ; #265 ; #267 ; #282 ; #285 ; #287 ; #289 ; #291 ; #293 ; #295 ; #297 ; #299 ; #306 ; #314 and #332 ) MOTIONS TO SEAL. (ndrS, COURT STAFF) (Filed on 3/13/2020)

March 12, 2020

Filing 385 ORDER by Judge Haywood S. Gilliam, Jr. Granting #157 Motion for Pro Hac Vice as to Schoenhard, Paul. (ndrS, COURT STAFF) (Filed on 3/12/2020)

February 27, 2020

Filing 384 OPPOSITION/RESPONSE (re #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Opposition, #2 Exhibit 1, #3 Exhibit 2)(Miller, Laura) (Filed on 2/27/2020)

February 13, 2020

Set Hearing as to #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1: Motion Hearing set for 3/25/2020 01:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 2/13/2020)

February 13, 2020

Filing 383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Reply)(Steindler, Thomas) (Filed on 2/13/2020)

February 13, 2020

#Electronic filing error. Proposed order was not included with the Motion in compliance with Local Rule 7-2(c). In the future, please include a proposed order as an attachment to t he motion. No further action is necessary. Re: #383 MOTION for Leave to File Reply Regarding Plexxikon's Motion in Limine No. 1 filed by Novartis Pharmaceuticals Corporation (jjbS, COURT STAFF) (Filed on 2/13/2020)

February 6, 2020

Filing 382 RESPONSE re #375 Offer of Proof by Plexxikon Inc.. (Miller, Laura) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).

February 6, 2020

Filing 381 RESPONSE re #369 Offer of Proof by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).

February 6, 2020

Filing 380 RESPONSE re #367 Offer of Proof by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).

February 6, 2020

Filing 379 RESPONSE re #364 Offer of Proof by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1)(Steindler, Thomas) (Filed on 2/6/2020) Modified on 2/7/2020 (jjbS, COURT STAFF).

February 3, 2020

Filing 378 ORDER REASSIGNING CASE. IT IS ORDERED that this case is reassigned to the Honorable Magistrate Judge Alex G. Tse in the San Francisco division as the referral judge. Any discovery related hearings and motions remain as scheduled. Existing discovery briefing schedules for motions remain unchanged. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ecgS, COURT STAFF) (Filed on 2/3/2020)

February 3, 2020

Case Reassigned to Magistrate Judge Alex G Tse. Chief Magistrate Judge Joseph C. Spero no longer assigned to the case. (ecgS, COURT STAFF) (Filed on 2/3/2020)

January 29, 2020

Filing 377 Declaration of Nathanael R. Luman in Support of #374 Administrative Motion to File Under Seal re Offer of Proof re Plexxikon's MIL #1 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #374 ) (Luman, Nathanael) (Filed on 1/29/2020)

January 28, 2020

Filing 376 ORDER by Judge Haywood S. Gilliam, Jr. Granting #373 Motion to Remove Incorrectly Filed Document. (ndrS, COURT STAFF) (Filed on 1/28/2020)

January 27, 2020

Filing 375 Offer of Proof re Plexxikon's MIL #1 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/27/2020) Modified on 1/28/2020 (jjbS, COURT STAFF).

January 27, 2020

Filing 374 Administrative Motion to File Under Seal re Offer of Proof re Plexxikon's MIL #1 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Offer of Proof, #4 Unredacted Version of Offer of Proof, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 1/27/2020)

January 27, 2020

Filing 373 MOTION to Remove Incorrectly Filed Document filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 1/27/2020)

January 27, 2020

Filing 372 Declaration of Nathanael R. Luman in Support of #368 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #368 ) (Luman, Nathanael) (Filed on 1/27/2020)

January 27, 2020

Filing 371 Declaration of Nathanael R. Luman in Support of #366 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #366 ) (Luman, Nathanael) (Filed on 1/27/2020)

January 27, 2020

Filing 370 Declaration of Nathanael R. Luman in Support of #363 Administrative Motion to File Under Seal Plaintiff Plexxikon's Offer of Proof re: Novartis's Motion in Limine No. 2 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #363 ) (Luman, Nathanael) (Filed on 1/27/2020)

January 23, 2020

Filing 369 Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 by Plexxikon Inc. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #2 Exhibit 1, #3 Exhibit 2)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).

January 23, 2020

Filing 368 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Administrative Motion to Seal, #2 Proposed Order, #3 Redacted version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #4 Unredacted version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 4, #5 Redacted version of Exhibit 1, #6 Unredacted version of Exhibit 1, #7 Redacted version of Exhibit 2, #8 Unredacted version of Exhibit 2, #9 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)

January 23, 2020

Filing 367 Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 by Plexxikon Inc. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).

January 23, 2020

Filing 366 Administrative Motion to File Under Seal Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Marguerite Hutchinson in support of Plexxikon's Administrative Motion to Seal, #2 Declaration of Laura Miller in support of Plexxikon's Administrative Motion to Seal, #3 Proposed Order, #4 Redacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #5 Unredacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 3, #6 Redacted Version of Ex. 1 to the declaration, #7 Unredacted Version of Ex. 1, #8 Redacted Version of Ex. 2, #9 Unredacted Version of Ex. 2, #10 Redacted Version of Ex. 3, #11 Unredacted Version of Ex. 3, #12 Redacted Version of Ex. 4, #13 Unredacted Version of Ex. 4, #14 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)

January 23, 2020

Filing 365 *** REMOVED PER ORDER AT DOCKET NO. #376 *** Offer of Proof re Plexxikon's Motion In Limine #1 by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF). Modified on 1/27/2020 (fff, COURT STAFF). (jjbS, COURT STAFF). Modified on 1/29/2020 (jjbS, COURT STAFF).

January 23, 2020

Filing 364 Offer of Proof by Plexxikon Inc. re: Novartis's Motion in Limine No. 2 (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10)(Miller, Laura) (Filed on 1/23/2020) Modified on 1/24/2020 (jjbS, COURT STAFF).

January 23, 2020

Filing 363 Administrative Motion to File Under Seal Plaintiff Plexxikon's Offer of Proof re: Novartis's Motion in Limine No. 2 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura Miller in support of Plexxikon's Motion to file under seal, #2 Proposed Order, #3 Redacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #4 Unredacted Version of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #9 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #10 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #11 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #12 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #13 Redacted Version of Exhibit 9 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #14 Unredacted Version of Exhibit 9 to the Declaration of Laura E. Miller in support of Plexxikon's Offer of Proof re Novartis's Motion in Limine No. 2, #15 Proof of Service)(Miller, Laura) (Filed on 1/23/2020)

January 23, 2020

Filing 362 NOTICE re #361 Order on Motion for Leave to File Second Summary Judgment Motion by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/23/2020) Modified on 1/23/2020 (jjbS, COURT STAFF).

January 16, 2020

Filing 361 ORDER by Judge Haywood S. Gilliam, Jr. DENYING DEFENDANTS #345 MOTION FOR LEAVE TO FILE SECOND SUMMARY JUDGMENT MOTION.(ndrS, COURT STAFF) (Filed on 1/16/2020)

January 14, 2020

Filing 360 ORDER by Hon. Haywood S. Gilliam, Jr. VACATING the hearing previously scheduled for January 16, 2020, at 2:00 p.m. The Court takes Dkt. No. #345 , Defendant's motion for leave to file a second summary judgment motion, under submission. The Court will issue a written order. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 1/14/2020)

January 3, 2020

Filing 359 ORDER by Judge Haywood S. Gilliam, Jr. Granting #358 Stipulation re Leave to File Amended Joint Proposed Jury Instructions. (ndrS, COURT STAFF) (Filed on 1/3/2020)

December 31, 2019

Filing 358 STIPULATION WITH PROPOSED ORDER re Leave to File Amended Joint Proposed Jury Instructions filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 12/31/2019) Modified on 1/2/2020 (jjbS, COURT STAFF).

December 20, 2019

Filing 357 Proposed Jury Instructions by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Steindler, Thomas) (Filed on 12/20/2019) Modified on 12/20/2019 (jjbS, COURT STAFF).

December 17, 2019

Filing 356 ORDER by Judge Haywood S. Gilliam, Jr. Granting #354 Motion for Extension of Time to File Response/Reply. (ndrS, COURT STAFF) (Filed on 12/17/2019)

December 17, 2019

Filing 355 Statement of Non-Opposition re #354 MOTION for Extension of Time to File Response/Reply to Defendant's Motion for Leave to File Second Summary Judgment Motion filed byNovartis Pharmaceuticals Corporation. (Related document(s) #354 ) (Steindler, Thomas) (Filed on 12/17/2019)

December 16, 2019

Filing 354 MOTION for Extension of Time to File Response/Reply re #345 Motion for Leave to File Second Summary Judgment Motion filed by Plexxikon Inc. (Attachments: #1 Declaration of Eugene Novikov in support of Motion, #2 Exhibit A, #3 Exhibit B)(Novikov, Eugene) (Filed on 12/16/2019) Modified on 12/17/2019 (jjbS, COURT STAFF).

December 13, 2019

Filing 353 REPLY (re #345 MOTION for Leave to File Second Summary Judgment Motion ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 12/13/2019)

December 11, 2019

Filing 352 Transcript of Proceedings held on December 3, 2019, before Judge Haywood S. Gilliam. Court Reporter Diane E. Skillman, telephone number 925-899-2812, Diane_Skillman@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #348 Transcript Order ) Release of Transcript Restriction set for 3/10/2020. (Related documents(s) #348 ) (Skillman, Diane) (Filed on 12/11/2019)

December 10, 2019

Filing 351 OPPOSITION/RESPONSE (re #345 MOTION for Leave to File Second Summary Judgment Motion ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to the declaration of Laura E. Miller)(Miller, Laura) (Filed on 12/10/2019)

December 5, 2019

Filing 350 ORDER APPOINTING SPECIAL MASTER. Signed by Judge Haywood S. Gilliam, Jr. on 12/5/2019. (ndrS, COURT STAFF) (Filed on 12/5/2019)

December 4, 2019

Filing 349 TRANSCRIPT ORDER for proceedings held on 12/03/2019 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Diane Skillman. (Miller, Laura) (Filed on 12/4/2019)

December 4, 2019

Filing 348 TRANSCRIPT ORDER for proceedings held on 12/3/2019 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Diane Skillman. (Steindler, Thomas) (Filed on 12/4/2019)

December 3, 2019

Filing 347 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 12/3/2019. Total Time in Court: 38 Minutes. Court Reporter: Diane Skillman. Plaintiff Attorney: Eugene Novikov; Daralyn Duri and David McGowan. Defendant Attorney: Thomas Steindler. Parties are directed to meet and confer regarding substantive jury instructions and e-file by December 20th a revised set of complete jury instructions including any agreed upon instructions. The Court sets January 23rd as the deadline for Plaintiff to submit offer of proof regarding what they plan to introduce as it pertains to Defendants motions in limine nos. 2, 3 and 4, and Defendant to submit offer of proof regarding what they plan to introduce as it pertains to Plaintiffs motion in limine no. 1. Each side has until February 6th to respond to the other sides offer of proof. The Court shall appoint former Magistrate Judge Laporte as a special master to provide a report and recommendation regarding Plaintiffs motion in limine no. 4. The Court resets the case schedule as follows: January 16, 2020 at 2:00 p.m. for hearing on motion for leave to file second summary judgment motion (docket no. #345 ); March 25, 2020 at 1:00 p.m. for hearing on jury instructions and remaining motions in limine; May 19, 2020 at 3:00 p.m. for pretrial conference and June 15, 2020 at 8:30 a.m. for 10-day-jury trial. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 12/3/2019)

December 3, 2019

Reset Hearing as to #345 MOTION for Leave to File Second Summary Judgment Motion, See Docket No. 347 : Motion Hearing set for 1/16/2020 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 12/3/2019)

November 27, 2019

Filing 346 ORDER SETTING CASE MANAGEMENT CONFERENCE. Further Case Management Conference set for 12/3/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor. Signed by Judge Haywood S. Gilliam, Jr. on 11/27/2019. (ndrS, COURT STAFF) (Filed on 11/27/2019)

November 25, 2019

Set Hearing as to #345 MOTION for Leave to File Second Summary Judgment Motion : Motion Hearing set for 1/9/2020 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 11/25/2019)

November 25, 2019

Filing 345 MOTION for Leave to File Second Summary Judgment Motion filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order, #2 Motion for Summary Judgement, #3 Motion for Summary Judgment - Proposed Order, #4 Declaration of Thomas P. Steindler, #5 Exhibit Steindler Dec Ex A, #6 Exhibit Steindler Dec Ex B, #7 Exhibit Steindler Dec Ex C, #8 Exhibit Steindler Dec Ex D, #9 Exhibit Steindler Dec Ex E, #10 Exhibit Steindler Dec Ex F, #11 Exhibit Steindler Dec Ex G, #12 Exhibit Steindler Dec Ex H, #13 Exhibit Steindler Dec Ex I, #14 Exhibit Steindler Dec Ex J, #15 Exhibit Steindler Dec Ex K, #16 Exhibit Steindler Dec Ex L, #17 Declaration of Phil S. Baran, #18 Exhibit Baran Dec Ex A, #19 Exhibit Baran Dec Ex B, #20 Exhibit Baran Dec Ex C, #21 Declaration of Andy Jennings, #22 Exhibit Jennings Dec Ex A, #23 Exhibit Jennings Dec Ex B)(Steindler, Thomas) (Filed on 11/25/2019)

November 25, 2019

Filing 344 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion for Summary Judgment, #4 Unredacted Version of Motion for Summary Judgment, #5 Unredacted Version of Exhibit C, #6 Unredacted Version of Exhibit D, #7 Unredacted Version of Exhibit F, #8 Unredacted Version of Exhibit G, #9 Unredacted Version of Exhibit I, #10 Unredacted Version of Exhibit J, #11 Unredacted Version of Exhibit K, #12 Unredacted Version of Exhibit L, #13 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 11/25/2019) Modified on 11/26/2019 (jjbS, COURT STAFF).

November 20, 2019

Filing 343 TRANSCRIPT ORDER for proceedings held on 11/1/2019 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 11/20/2019)

November 15, 2019

Filing 342 CLERK'S NOTICE. Notice is hereby given that the #307 motion to strike Second Supplemental Report of Expert Gregory K. Leonard, previously set for December 3rd, will be held on that date before Judge Haywood S. Gilliam, Jr., at 3:00 p.m. in Courtroom 2, 4th Floor, 1301 Clay Street, Oakland, CA. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 11/15/2019)

November 8, 2019

Filing 341 Transcript of Proceedings held on 11/01/19, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #338 Transcript Order ) Redaction Request due 11/29/2019. Redacted Transcript Deadline set for 12/9/2019. Release of Transcript Restriction set for 2/6/2020. (Related documents(s) #338 ) (Batalo, Pam) (Filed on 11/8/2019)

November 6, 2019

Filing 340 STATEMENT OF RECENT DECISION pursuant to Civil Local Rule 7-3.d filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #309 ) (Steindler, Thomas) (Filed on 11/6/2019)

November 5, 2019

Filing 339 REPLY (re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 5)(Steindler, Thomas) (Filed on 11/5/2019)

November 5, 2019

Filing 338 TRANSCRIPT ORDER for proceedings held on 11/1/19 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Krishnapriyan, Raghav) (Filed on 11/5/2019)

November 4, 2019

Filing 336 STATEMENT OF RECENT DECISION pursuant to Civil Local Rule 7-3.d filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #268 ) (Steindler, Thomas) (Filed on 11/4/2019)

November 1, 2019

Filing 337 Minute Entry for proceedings held before Judge Haywood S Gilliam, Jr: Motions Hearings held on 11/1/2019. Total Time in Court: 2 hours and 31 minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Matt Samuels; David McGowan; Raghav Krishnapriyan; Daralyn Durie and Eugene Novokov. Defendant Attorney: Thomas Steindler; Paul Schoenhard; K. Nicole Clouse. Defendants motion for judgment on pleadings (docket no. #175 ) is argued and submitted by the parties and DENIED on the record by the Court. Plaintiffs motions for miscellaneous relief (docket nos. #165 and #169 ), motion for summary judgment (docket no. #167 ) and Defendants motion for summary judgment (docket no. #177 ), motion to strike (docket no. 179) and motions for miscellaneous relief (docket nos. #200 , #202 and #204 ) are argued and submitted by the parties and taken under submission by the Court. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 11/1/2019)

October 31, 2019

Filing 335 NOTICE of Supplemental Authority by Plexxikon Inc. (Samuels, Matthew) (Filed on 10/31/2019) Modified on 11/1/2019 (jjbS, COURT STAFF).

October 30, 2019

Filing 334 Declaration of Nathanael R. Luman in Support of #332 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #332 ) (Luman, Nathanael) (Filed on 10/30/2019)

October 29, 2019

Filing 333 OPPOSITION/RESPONSE (re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to the Declaration of Laura E. Miller, #3 Exhibit 2 to the Declaration of Laura E. Miller, #4 Exhibit 3 to the Declaration of Laura E. Miller, #5 Exhibit 4 to the Declaration of Laura E. Miller, #6 Exhibit 5 to the Declaration of Laura E. Miller, #7 Exhibit 6 to the Declaration of Laura E. Miller, #8 Exhibit 7 to the Declaration of Laura E. Miller, #9 Exhibit 8 to the Declaration of Laura E. Miller, #10 Exhibit 9 to the Declaration of Laura E. Miller, #11 Exhibit 10 to the Declaration of Laura E. Miller, #12 Exhibit 11 to the Declaration of Laura E. Miller)(Miller, Laura) (Filed on 10/29/2019)

October 29, 2019

Filing 332 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Marguerite Hutchinson in support of Plexxikon's Administrative Motion to File Under Seal, #2 Declaration of Laura E. Miller in support of Plexxikon's Administrative Motion to File Under Seal, #3 REDACTED version of Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #4 UNREDACTED version of Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #5 REDACTED version of Ex. 3 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #6 UNREDACTED version of Ex. 3 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #7 REDACTED version of Ex. 4 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #8 UNREDACTED version of Ex. 4 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #9 REDACTED version of Ex. 5 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #10 UNREDACTED version of Ex. 5 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #11 REDACTED version of Ex. 6 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #12 UNREDACTED version of Ex. 6 to the Decl. of Laura Miller ISO Plexxikon's Opposition to Novartis's Motion to Strike the Second Supplemental Report of Dr. Gregory K. Leonard, #13 Proposed Order, #14 Proof of Service)(Miller, Laura) (Filed on 10/29/2019)

October 29, 2019

Filing 331 ORDER REASSIGNING CASE. Signed by the Clerk on 10/29/2019. (ecgS-adi, COURT STAFF) (Filed on 10/29/2019)

October 29, 2019

Case Reassigned to Magistrate Judge Joseph C. Spero. Magistrate Judge Elizabeth D. Laporte no longer assigned to the case. (ecgS-adi, COURT STAFF) (Filed on 10/29/2019)

October 28, 2019

Filing 330 Declaration of Nathanael R. Luman in Support of #314 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #314 ) (Luman, Nathanael) (Filed on 10/28/2019)

October 25, 2019

Filing 329 ORDER by Judge Haywood S. Gilliam, Jr. Granting #324 Motion to Remove Incorrectly Filed Document. (ndrS, COURT STAFF) (Filed on 10/25/2019)

October 24, 2019

Filing 328 NOTICE of Corrected Documents re #326 Opposition/Response to Motion, #327 Opposition/Response to Motion, #325 Opposition/Response to Motion by Plexxikon Inc. (Krishnapriyan, Raghav) (Filed on 10/24/2019) Modified on 10/25/2019 (cjlS, COURT STAFF).

October 24, 2019

Filing 327 OPPOSITION/RESPONSE (re #272 MOTION in Limine Number 5 re Damages ) CORRECTION OF DOCKET #300 filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Krishnapriyan, Raghav) (Filed on 10/24/2019)

October 24, 2019

Filing 326 OPPOSITION/RESPONSE (re #271 MOTION in Limine Number 4 re Alleged Copying ) CORRECTION OF DOCKET #298 filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Errata 3)(Krishnapriyan, Raghav) (Filed on 10/24/2019)

October 24, 2019

Filing 325 OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) CORRECTION OF DOCKET #225 filed byPlexxikon Inc.. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3)(Krishnapriyan, Raghav) (Filed on 10/24/2019)

October 24, 2019

Filing 324 MOTION to Remove Incorrectly Filed Document filed by Plexxikon Inc.. (Attachments: #1 Proposed Order)(Krishnapriyan, Raghav) (Filed on 10/24/2019)

October 24, 2019

Filing 323 OPPOSITION/RESPONSE (re #322 MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Steindler, Thomas) (Filed on 10/24/2019)

October 24, 2019

#Electronic filing error. Motion did not include a proposed order. Please re-file the motion in its entirety with the proposed order as an attachment. Re: #322 MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 filed by Plexxikon Inc. (jjbS, COURT STAFF) (Filed on 10/24/2019)

October 23, 2019

Filing 322 **RE-FILED AT DOCKET NO. #324 ** MOTION to Remove Incorrectly Filed Document ECF Nos. 225-, 225-2, 300-2, 300-3, & 307-5 filed by Plexxikon Inc.. (Krishnapriyan, Raghav) (Filed on 10/23/2019) Modified on 10/24/2019 (jjbS, COURT STAFF).

October 23, 2019

Filing 321 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING Plaintiff to re-file any corrections it has to motions or other filings on the docket in their entirety. Plaintiff is further DIRECTED to file a separate summary document explaining which documents or selections within those documents have been corrected, and the reason for each correction. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 10/23/2019)

October 23, 2019

Filing 320 NOTICE by Plexxikon Inc. of Withdrawal of Counsel for Victoria L. Weatherford (Samuels, Matthew) (Filed on 10/23/2019)

October 22, 2019

Filing 319 EXHIBITS re #307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard CORRECTION OF DOCKET # [307-5] filed byPlexxikon Inc.. (Related document(s) #307 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 22, 2019

Filing 318 EXHIBITS re #301 Declaration in Support, #300 Opposition/Response to Motion,, CORRECTION OF DOCKET # [300-2] and [300-3] filed byPlexxikon Inc.. (Attachments: #1 Exhibit 2)(Related document(s) #301 , #300 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 22, 2019

Filing 317 EXHIBITS re #300 Opposition/Response to Motion,, #299 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018 CORRECTION OF DOCKET # [299-4] and [299-6] filed byPlexxikon Inc.. (Attachments: #1 Exhibit 4)(Related document(s) #300 , #299 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 22, 2019

Filing 316 EXHIBITS re #298 Opposition/Response to Motion,, #297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying CORRECTION OF DOCKET # [297-10] filed byPlexxikon Inc.. (Related document(s) #298 , #297 ) (Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 22, 2019

Filing 315 OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) CORRECTION OF DOCKET #225 and [225-2] filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 22, 2019

Filing 314 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration of Raghav Krishnapriyan, #2 Declaration of Marguerite Hutchinson, #3 Proposed Order, #4 Redaacted Version of 225-00, #5 Unredaacted Version of 225-00, #6 Redaacted Version of 225-2, #7 Unredaacted Version of 225-2, #8 Redacted Version of 297-10, #9 Unredacted Version of 297-10, #10 Redacted Version of 300-02, #11 Unredacted Version of 300-02, #12 Redacted Version of 300-03, #13 Unredacted Version of 300-03, #14 Redacted Version of 299-04, #15 Unredacted Version of 299-04, #16 Redacted Version of 299-06, #17 Unredacted Version of 299-06, #18 Redacted Version of 307-05, #19 Unredacted Version of 307-05)(Krishnapriyan, Raghav) (Filed on 10/22/2019)

October 18, 2019

Filing 313 Joint Proposed Pretrial Statement and Order by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).

October 18, 2019

Filing 312 Declaration of Marguerite Hutchinson in Support of #306 Administrative Motion to File Under Seal re Motion to Strike Second Supplemental Report of Expert Gregory K. Leonard filed byPlexxikon Inc.. (Related document(s) #306 ) (Krishnapriyan, Raghav) (Filed on 10/18/2019)

October 18, 2019

Filing 311 Proposed Joint Statement of the Case by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).

October 18, 2019

Filing 310 Joint Proposed Voir Dire Questions by Plexxikon Inc. and Novartis Pharmaceuticals Corporation (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF). Modified on 10/21/2019 (jjbS, COURT STAFF).

October 18, 2019

Filing 309 Joint Proposed Jury Instructions by Plexxikon Inc. and Novartis Pharmaceuticals Corporation (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).

October 18, 2019

Filing 308 Joint Proposed Verdict Form by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Durie, Daralyn) (Filed on 10/18/2019) Modified on 10/21/2019 (jjbS, COURT STAFF).

October 15, 2019

Filing 307 MOTION to Strike Second Supplemental Report of Expert Gregory K. Leonard filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 12/3/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 10/29/2019. Replies due by 11/5/2019. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, # 5**REMOVED PER #329 ORDER** Exhibit 4)(Steindler, Thomas) (Filed on 10/15/2019) Modified on 10/18/2019 (jjbS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).

October 15, 2019

Filing 306 Administrative Motion to File Under Seal re Motion to Strike Second Supplemental Report of Expert Gregory K. Leonard filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Strike, #4 Unredacted Version of Motion to Strike, #5 Unredacted Version of Exhibit 1, #6 Redacted Version of Exhibit 2, #7 Unredacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 3, #9 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 10/15/2019)

October 1, 2019

Filing 305 NOTICE of Appearance by Eugene Novikov (Novikov, Eugene) (Filed on 10/1/2019)

September 19, 2019

Filing 304 ORDER Granting Non-Party Glaxosmithklien's Administrative Motion to File Under Seal Exhibits to Joint Report to the Court Regarding Discovery Disputes by Magistrate Judge Elizabeth D. Laporte: granting #128 Administrative Motion. (shyS, COURT STAFF) (Filed on 9/19/2019)

September 9, 2019

Filing 303 Order by Magistrate Judge Elizabeth D. Laporte granting #250 Plaintiff's Motion to Strike Novartis's Supplemental Initial Disclosures.(tmiS, COURT STAFF) (Filed on 9/9/2019)

September 9, 2019

Filing 302 Declaration of Nathanael R. Luman in Support of #297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #297 ) (Luman, Nathanael) (Filed on 9/9/2019)

September 9, 2019

Filing 301 Declaration of Nathanael R. Luman in Support of #289 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #289 ) (Luman, Nathanael) (Filed on 9/9/2019)

September 6, 2019

Filing 300 ***DISREGARD, SEE DOCKET ENTRY #327 *** OPPOSITION/RESPONSE (re #272 MOTION in Limine Number 5 re Damages ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, # 2 **REMOVED PER #329 ORDER** Exhibit 1 to Declaration of Laura E. Miller, # 3 **REMOVED PER #329 ORDER** Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019) Modified on 10/17/2019 (ddkS, COURT STAFF). Modified on 10/25/2019 (cjlS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).

September 6, 2019

Filing 299 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2018, #4 Unredacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #5 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #6 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 5 Re: Evidence or Argument Suggesting Damages Should be Awarded for Any Period After December 2, #7 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 298 ***DISREGARD, SEE DOCKET ENTRY #326 *** OPPOSITION/RESPONSE (re #271 MOTION in Limine Number 4 re Alleged Copying ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019) Modified on 10/25/2019 (cjlS, COURT STAFF).

September 6, 2019

Filing 297 Administrative Motion to File Under Seal Re: Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying filed by Plexxikon Inc.. (Attachments: #1 Declaration Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #9 Redacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #10 Unredacted Version of Exhibit 3 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #11 Redacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #12 Unredacted Version of Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #13 Redacted Version of Exhibit 5 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #14 Unredacted Version of Exhibit 5 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #15 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #16 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #17 Redacted Version of Exhibit 7 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #18 Unredacted Version of Exhibit 7 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 4 Re: Alleged Copying, #19 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 296 OPPOSITION/RESPONSE (re #270 MOTION in Limine Number 3 re Scope of Patent Rights ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 295 Administrative Motion to File Under Seal re Plexxikon Inc Opposition to Novartis Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #4 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #5 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #6 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 3 re: Evidence or Argument Mischaracterizing or Having a Tendency to Mislead as to the Scope of Plexxikons Patent Rights, #7 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 294 OPPOSITION/RESPONSE (re #269 MOTION in Limine Number 2 re Unasserted Patents ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 293 Administrative Motion to File Under Seal re Plexxikon Opposition to Novartis Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #5 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #6 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #7 Redacted Version Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #8 Unredacted Version Exhibit 4 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Opposition to Novartiss Motion in Limine No. 2 re: Unasserted Patents as Evidence of the Validity of the Asserted Patents, #9 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 292 OPPOSITION/RESPONSE (re #268 MOTION in Limine Number 1 re PTAB Proceedings ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 291 Administrative Motion to File Under Seal Plaintiff Plexxikon Inc.'s Opposition to Novartis's Motion in Limine No. 1 re: PTAB Proceedings filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Opposition to Novartis MIL No 1, #4 Unredacted Version of Opposition to Novartis MIL No 1, #5 Redacted Version of Exhibit 5 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #6 Unredacted Version of Exhibit 5 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #7 Redacted Version of Exhibit 7 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #8 Unredacted Version of Exhibit 7 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #9 Redacted Version of Exhibit 8 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #10 Unredacted Version of Exhibit 8 to Declaration of Laure E. Miller in Support of Opposition to Novartis's MIL No. 1, #11 Proof of Service)(Miller, Laura) (Filed on 9/6/2019)

September 6, 2019

Filing 290 OPPOSITION/RESPONSE (re #266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 289 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #4 Unredacted Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #5 Unredacted Version of Exhibit A to Opposition to Plexxikons Motion In Limine No. 5 Re: Excluding Hidden Hearsay Testimony, #6 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 288 OPPOSITION/RESPONSE (re #264 MOTION in Limine No. 4 re: Excluding Withheld Evidence ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit A to Steindler Declaration, #3 Exhibit B to Steindler Declaration, #4 Exhibit C to Steindler Declaration, #5 Exhibit D to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 287 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Unredacted Version of Exhibit B to Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence, #4 Unredacted Version of Exhibit C to Opposition to Plexxikons Motion In Limine No. 4 Re: Excluding Withheld Evidence, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 286 OPPOSITION/RESPONSE (re #262 MOTION in Limine No. 3 re: Cumulative Expert Testimony ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit A to Steindler Declaration, #3 Exhibit B to Steindler Declaration, #4 Exhibit C to Steindler Declaration, #5 Exhibit D to Steindler Declaration, #6 Exhibit E to Steindler Declaration, #7 Exhibit F to Steindler Declaration, #8 Exhibit G to Steindler Declaration, #9 Exhibit H to Steindler Declaration, #10 Exhibit I to Steindler Declaration)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 285 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit A Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #4 Unredacted Version of Exhibit A Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #5 Redacted Version of Exhibit F Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #6 Unredacted Version of Exhibit F Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #7 Redacted Version of Exhibit H Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #8 Unredacted Version of Exhibit H Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #9 Redacted Version of Exhibit I Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #10 Unredacted Version of Exhibit I Opposition to Plexxikons Motion In Limine No. 3 Re: Cumulative Expert Testimony, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 284 OPPOSITION/RESPONSE (re #260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 283 OPPOSITION/RESPONSE (re #259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 9/6/2019)

September 6, 2019

Filing 282 Administrative Motion to File Under Seal Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges, #4 Unredacted Version of Opposition to Plexxikons Motion In Limine No. 1 Re: Excluding Undisclosed Validity Challenges, #5 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 9/6/2019)

September 5, 2019

Filing 281 Transcript of Proceedings held on August 27, 2019, before Judge Elizabeth D. Laporte. Court Reporter/Transcriber Joan Marie Columbini, CSR, RPR, telephone number (510) 367-3043, joan.columbini.csr@gmail.com. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #278 Transcript Order ) Redaction Request due 9/26/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/4/2019. (Related documents(s) #278 ) (Columbini, Joan) (Filed on 9/5/2019)

September 5, 2019

Filing 280 Transcript of Proceedings held on 08/29/19, before Judge Gilliam. Court Reporter Pamela Batalo Hebel, telephone number 626-688-7509; pamela_batalo-hebel@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #277 Transcript Order ) Redaction Request due 9/26/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/4/2019. (Related documents(s) #277 ) (Batalo, Pam) (Filed on 9/5/2019)

September 4, 2019

Filing 279 TRANSCRIPT ORDER for proceedings held on 8/29/19 before Judge Haywood S Gilliam, Jr by Novartis Pharmaceuticals Corporation, for Court Reporter Pam Batalo. (Steindler, Thomas) (Filed on 9/4/2019)

September 4, 2019

Filing 278 TRANSCRIPT ORDER for proceedings held on 8/27/2019 before Magistrate Judge Elizabeth D. Laporte by Novartis Pharmaceuticals Corporation, for Court Reporter FTR - San Francisco. (Steindler, Thomas) (Filed on 9/4/2019)

September 3, 2019

Filing 277 TRANSCRIPT ORDER for proceedings held on 8/29/2019 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter Pam Batalo. (Miller, Laura) (Filed on 9/3/2019)

August 29, 2019

Filing 276 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 8/29/2019. Total Time in Court: 13 Minutes. Court Reporter: Pamela Batalo-Hebel. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The judge reset the following dates: November 1, 2019, at 2:00 p.m. for hearing on motions (docket nos. #165 , #167 , #169 , #175 , #177 , #179 , #200 , #202 and #204 ); December 3, 2019, at 3:00 p.m. for pretrial conference/hearing on motions in limine (docket nos. #259 , #260 , #262 , #264 , #266 , #268 , #269 , #270 , #271 and #272 ) and January 21, 2020, at 8:30 a.m. for jury trial. Parties are directed to meet and confer regarding any discovery dispute, consistent with the discovery magistrate judges procedures. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 8/29/2019)

August 29, 2019

Filing 274 Declaration of Nathanael R. Luman in Support of #265 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 5 filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #265 ) (Luman, Nathanael) (Filed on 8/29/2019)

August 29, 2019

#Electronic filing error. In the future, please be sure to set the correct opposition deadlines when filing your Motion in Limine pursuant to number 8 on page 4 of the Judge's Pre-trial Standing order. Corrected by Clerk's Office. No further action is necessary. Re: #264 MOTION in Limine No. 4 re: Excluding Withheld Evidence filed by Plexxikon Inc., #260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office filed by Plexxikon Inc., #266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony filed by Plexxikon Inc., #262 MOTION in Limine No. 3 re: Cumulative Expert Testimony filed by Plexxikon Inc., #259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges filed by Plexxikon Inc. (jjbS, COURT STAFF) (Filed on 8/29/2019)

August 28, 2019

#Electronic filing error. REMINDER TO COUNSEL: In the future, please attach all supporting document and to the Motion. No further action is necessary. Re: #273 Declarati on in Support, filed by Novartis Pharmaceuticals Corporation (jjbS, COURT STAFF) (Filed on 8/28/2019)

August 27, 2019

Filing 275 Minute Entry for proceedings held on 8/27/2019 before Magistrate Judge Elizabeth D. Laporte regarding the motion to strike. Hearing held The Court takes the motion under submission. FTR Time: 2:09 - 2:23. Plaintiff Attorney: Luara Miller. Defendant Attorney: Jennifer Routh. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Date Filed: 8/27/2019) Modified on 9/4/2019: Matter transcribed by Joan Columbini. (rjdS, COURT STAFF).

August 27, 2019

Filing 273 Declaration of Thomas P. Steindler in Support of #272 MOTION in Limine Number 5 re Damages, #271 MOTION in Limine Number 4 re Alleged Copying, #268 MOTION in Limine Number 1 re PTAB Proceedings, #269 MOTION in Limine Number 2 re Unasserted Patents, #270 MOTION in Limine Number 3 re Scope of Patent Rights filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K)(Related document(s) #272 , #271 , #268 , #269 , #270 ) (Steindler, Thomas) (Filed on 8/27/2019)

August 27, 2019

Filing 272 MOTION in Limine Number 5 re Damages filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 271 MOTION in Limine Number 4 re Alleged Copying filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 270 MOTION in Limine Number 3 re Scope of Patent Rights filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 269 MOTION in Limine Number 2 re Unasserted Patents filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 268 MOTION in Limine Number 1 re PTAB Proceedings filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Steindler, Thomas) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 267 Administrative Motion to File Under Seal filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of MIL #5, #4 Unredacted Version of MIL #5, #5 Unredacted Version of Exhibit E, #6 Redacted Version of Exhibit F, #7 Unredacted Version of Exhibit F, #8 Redacted Version of Exhibit G, #9 Unredacted Version of Exhibit G, #10 Unredacted Version of Exhibit K, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 8/27/2019)

August 27, 2019

Filing 266 MOTION in Limine 5 re: Excluding Hidden Hearsay Testimony filed by Plexxikon Inc. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/28/2019 (jjbS, COURT STAFF). Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 265 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 5 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in support of Plaintiff Plexxikon Inc.s Motion in Limine No. 5 re: Excluding Hidden Hearsay Testimony, #7 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)

August 27, 2019

Filing 264 MOTION in Limine No. 4 re: Excluding Withheld Evidence filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 263 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 4 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #5 Redacted Version of Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #6 Unredacted Version of Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #7 Redacted Version of Exhibit 5 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #8 Unredacted Version of Exhibit 5 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #9 Redacted Version of Exhibit 6 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #10 Unredacted Version of Exhibit 6 to the Declaration of Laura E. Miller In Support of Plaintiff Plexxikon Inc.s Motion In Limine No. 4 re Excluding Withheld Evidence, #11 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)

August 27, 2019

Filing 262 MOTION in Limine No. 3 re: Cumulative Expert Testimony filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 261 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 3 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #5 Redacted Version of Exhibit 1 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #6 Unredacted Version of Exhibit 1 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #7 Redacted Version of Exhibit 2 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #8 Unredacted Version of Exhibit 2 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #9 Redacted Version of Exhibit 3 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #10 Unredacted Version of Exhibit 3 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #11 Redacted Version of Exhibit 4 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #12 Unredacted Version of Exhibit 4 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #13 Redacted Version of Exhibit 5 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #14 Unredacted Version of Exhibit 5 of the Declaration Of Laura E. Miller In Support Of Plaintiff Plexxikon Inc.s Motion In Limine No. 3 Re: Cumulative Expert Testimony, #15 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)

August 27, 2019

Filing 260 MOTION in Limine No.2 re: Precluding Denigration of Patent Office filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 259 MOTION in Limine No. 1 re: Excluding Undisclosed Validity Challenges filed by Plexxikon Inc.. Motion Hearing set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 9/3/2019. (Attachments: #1 Declaration of Laura Miller, #2 Exhibit 1 to the Declaration of Laura Miller, #3 Exhibit 2 to the Declaration of Laura Miller, #4 Proposed Order)(Miller, Laura) (Filed on 8/27/2019) Modified on 8/29/2019 (jjbS, COURT STAFF).

August 27, 2019

Filing 258 Administrative Motion to File Under Seal Plexxikon Inc.'s Motion in Limine No. 1 filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plexxikon's MIL 1, #4 Unredacted version of Plexxikon's MIL 1, #5 Redacted Version of Exhibit 1 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #6 Unredacted Version of Exhibit 1 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #7 Redacted Version of Exhibit 2 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #8 Unredacted Version of Exhibit 2 to Declaration of Laura Miller in support of Plexxikon's MIL 1, #9 Proof of Service)(Miller, Laura) (Filed on 8/27/2019)

August 26, 2019

Set Hearing, See Docket No. #257 : Further Case Management Conference set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor. (ndrS, COURT STAFF) (Filed on 8/26/2019)

August 26, 2019

Filing 257 ORDER by Hon. Haywood S. Gilliam, Jr. SETTING case management conference on August 29, 2019, at 2:00 p.m. (hsglc1S, COURT STAFF) (Filed on 8/26/2019)

August 19, 2019

Filing 256 ORDER by Judge Haywood S. Gilliam, Jr. Granting #255 Motion for Pro Hac Vice as to Jennifer B. Routh. (ndrS, COURT STAFF) (Filed on 8/19/2019)

August 16, 2019

Filing 255 MOTION for leave to appear in Pro Hac Vice for Jennifer B. Routh ( Filing fee $ 310, receipt number 0971-13620000.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Proposed Order)(Routh, Jennifer) (Filed on 8/16/2019)

August 13, 2019

Filing 254 REPLY (re #250 MOTION to Strike Novartis's Supplemental Initial Disclosures ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit A to the declaration of Laura E. Miller)(Miller, Laura) (Filed on 8/13/2019)

August 6, 2019

Filing 253 OPPOSITION/RESPONSE (re #250 MOTION to Strike Novartis's Supplemental Initial Disclosures ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Steindler, Thomas) (Filed on 8/6/2019)

July 31, 2019

Filing 252 ORDER by Judge Haywood S. Gilliam, Jr. Granting #249 Motion for Pro Hac Vice as to Michael S. Nadel. (ndrS, COURT STAFF) (Filed on 7/31/2019)

July 26, 2019

Filing 251 CLERK'S NOTICE: The parties are hereby notified that the hearing on Plaintiff's motion to strike #250 is rescheduled to 8/27/2019 at 2:00 PM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Filed on 7/26/2019)

July 23, 2019

Filing 250 MOTION to Strike Novartis's Supplemental Initial Disclosures filed by Plexxikon Inc.. Motion Hearing set for 8/27/2019 09:00 AM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. Responses due by 8/6/2019. Replies due by 8/13/2019. (Attachments: #1 Declaration of Laura E. Miller in support of Plexxikon Inc.'s Motion to Strike, #2 Exhibit A to the Declaration of Laura E. Miller, #3 Exhibit B to the Declaration of Laura E. Miller, #4 Exhibit C to the Declaration of Laura E. Miller, #5 Exhibit D to the Declaration of Laura E. Miller, #6 Proposed Order)(Miller, Laura) (Filed on 7/23/2019)

July 23, 2019

Filing 249 MOTION for leave to appear in Pro Hac Vice - Michael S. Nadel ( Filing fee $ 310, receipt number 0971-13543679.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Nadel, Michael) (Filed on 7/23/2019)

July 11, 2019

Filing 248 REPLY (re #236 MOTION to Strike #206 MOTION to Exclude Expert Testimony of Ted Sweeney , #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda , #200 MOTION to Exclude Expert Testimony of Michael L. Metzker , [20 ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 7/11/2019)

July 3, 2019

Filing 247 OPPOSITION/RESPONSE (re #236 Motion to Strike #206 Motion to Exclude Expert Testimony of Ted Sweeney, #204 Motion to Exclude the Expert Testimony of Susana Ortiz-Urda, #200 Motion to Exclude Expert Testimony of Michael L. Metzker), filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2)(Steindler, Thomas) (Filed on 7/3/2019) Modified on 7/5/2019 (jlmS, COURT STAFF).

June 28, 2019

Filing 391 **SEALED DOCUMENT** EXHIBIT 5 (CD) to #243 REPLY (re 204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byNovartis Pharmaceuticals Corporation. (jjbS, COURT STAFF) (Filed on 6/28/2019)

June 27, 2019

Filing 246 REPLY (re #206 MOTION to Exclude Expert Testimony of Ted Sweeney ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/27/2019)

June 27, 2019

Filing 245 REPLY (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/27/2019)

June 27, 2019

Filing 244 REPLY (re #200 MOTION to Exclude Expert Testimony of Michael L. Metzker ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Steindler, Thomas) (Filed on 6/27/2019)

June 27, 2019

Filing 243 REPLY (re #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5 (NMF), #7 Exhibit 6)(Steindler, Thomas) (Filed on 6/27/2019)

June 27, 2019

Filing 242 Administrative Motion to File Under Seal - Exhibit to Steindler Dec in Support of Reply in Support of Daubert Motion - Dr. Ortiz filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Exhibit Notice of Manual Filing of Steindler Dec Ex 5, #4 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/27/2019)

June 27, 2019

Filing 241 ORDER by Judge Haywood S. Gilliam, Jr. Granting #239 Motion for Pro Hac Vice for Ian B. Brooks. (ndrS, COURT STAFF) (Filed on 6/27/2019)

June 27, 2019

Filing 240 ORDER by Judge Haywood S. Gilliam, Jr. Granting #238 Motion for Pro Hac Vice for Paul Schoenhard. (ndrS, COURT STAFF) (Filed on 6/27/2019)

June 27, 2019

Filing 239 Amended MOTION for leave to appear in Pro Hac Vice for Ian B. Brooks ( Filing fee $ 310, receipt number 0971-13043124.) Filing fee previously paid on 1/29/2019 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Brooks, Ian) (Filed on 6/27/2019) Modified on 6/28/2019 (cjlS, COURT STAFF).

June 27, 2019

Filing 238 Amended MOTION for leave to appear in Pro Hac Vice for Paul Schoenhard ( Filing fee $ 310, receipt number 0971-13293802.) Filing fee previously paid on 4/26/2019 filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Schoenhard, Paul) (Filed on 6/27/2019) Modified on 6/28/2019 (cjlS, COURT STAFF).

June 24, 2019

Filing 237 Declaration of Nathanael R. Luman in Support of #224 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D. filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #224 ) (Luman, Nathanael) (Filed on 6/24/2019)

June 20, 2019

Filing 236 MOTION to Strike #206 MOTION to Exclude Expert Testimony of Ted Sweeney , #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda , #200 MOTION to Exclude Expert Testimony of Michael L. Metzker , #202 MOTION to Exclude Expert Testimony of Gregory Leonard filed by Plexxikon Inc.. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 7/5/2019. Replies due by 7/12/2019. (Attachments: #1 Declaration Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Proposed Order)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 235 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019 filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order Proposed Order, #3 Redacted Version of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #5 Redacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #6 Unredacted Version of Exhibit 1 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #7 Redacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #8 Unredacted Version of Exhibit 2 to the Declaration of Laura E. Miller in Support of Plaintiff Plexxikon Inc.s Motion to Strike Defendant Novartis Pharmaceuticals Corp.s Daubert Motions Filed June 6, 2019, #9 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 234 OPPOSITION/RESPONSE (re #206 MOTION to Exclude Expert Testimony of Ted Sweeney ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 233 REPLY (re #177 MOTION for Patial Summary Judgment ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit Steindler Dec Ex A, #3 Exhibit Steindler Dec Ex B, #4 Exhibit Steindler Dec Ex C, #5 Exhibit Steindler Dec Ex D, #6 Exhibit Steindler Dec Ex E, #7 Exhibit Steindler Dec Ex F)(Steindler, Thomas) (Filed on 6/20/2019)

June 20, 2019

Filing 232 Administrative Motion to File Under Seal Re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Ted Sweeney filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff's Opposition to Defendant's Motion to Exclude Expert Testimony of Ted Sweeney, #4 Unredacted Version of Plaintiff's Opposition to Defendant's Motion to Exclude Expert Testimony of Ted Sweeney, #5 Redacted Version of Exhibit 2, #6 Unredacted Version of Exhibit 2, #7 Redacted Version of Exhibit 4, #8 Unredacted Version of Exhibit 4, #9 Redacted Version of Exhibit 5, #10 Unredacted Version of Exhibit 5, #11 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 231 Administrative Motion to File Under Seal , Reply in Support of Motion for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion for Partial Summary Judgment, #4 Unedacted Version of Reply in Support of Motion for Partial Summary Judgment, #5 Redacted Version of Steindler Declaration Ex A, #6 Unredacted Version of Steindler Declaration Ex A, #7 Unredacted Version of Steindler Declaration Ex B, #8 Unredacted Version of Steindler Declaration Ex C, #9 Unredacted Version of Steindler Declaration Ex D, #10 Unredacted Version of Steindler Declaration Ex E, #11 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/20/2019)

June 20, 2019

Filing 230 REPLY (re #179 MOTION to Strike Portions of Metzker Expert Report ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 6/20/2019)

June 20, 2019

Filing 229 REPLY (re #175 MOTION for Judgment on the Pleadings ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 6/20/2019)

June 20, 2019

Filing 228 OPPOSITION/RESPONSE (re #200 MOTION to Exclude Expert Testimony of Michael L. Metzker ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Declaration of Michael L. Metzker, #14 Exhibit A to Declaration of Michael L. Metzker, #15 Exhibit B to Declaration of Michael L. Metzker, #16 Exhibit C to Declaration of Michael L. Metzker, #17 Exhibit D to Declaration of Michael L. Metzker, #18 Exhibit E to Declaration of Michael L. Metzker, #19 Exhibit F to Declaration of Michael L. Metzker, #20 Exhibit G to Declaration of Michael L. Metzker, #21 Exhibit H to Declaration of Michael L. Metzker, #22 Exhibit I to Declaration of Michael L. Metzker, #23 Exhibit J to Declaration of Michael L. Metzker, #24 Exhibit K to Declaration of Michael L. Metzker, #25 Exhibit L to Declaration of Michael L. Metzker, #26 Exhibit M to Declaration of Michael L. Metzker, #27 Exhibit N to Declaration of Michael L. Metzker, #28 Exhibit O to Declaration of Michael L. Metzker, #29 Exhibit P to Declaration of Michael L. Metzker, #30 Exhibit Q to Declaration of Michael L. Metzker, #31 Exhibit R to Declaration of Michael L. Metzker)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 227 OPPOSITION/RESPONSE (re #204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 226 Administrative Motion to File Under Seal re Plaintiff's Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiff' Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda, #4 Unredacted Version of Plaintiff' Opposition to Defendant's Motion to Preclude Certain Testimony of Dr. Ortiz-Urda, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 2, #9 Redacted Version of Exhibit 3, #10 Unredacted Version of Exhibit 3, #11 Certificate/Proof of Service)(Miller, Laura) (Filed on 6/20/2019)

June 20, 2019

Filing 225 ***DISREGARD, SEE DOCKET ENTRY #325 *** OPPOSITION/RESPONSE (re #202 MOTION to Exclude Expert Testimony of Gregory Leonard ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in Support of Opposition, # 2 **REMOVED PER ORDER AT DOCKET NO. #329 ** Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #3 Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #4 Exhibit 3 to Declaration of Laura E. Miller in Support of Opposition)(Miller, Laura) (Filed on 6/20/2019) Modified on 10/17/2019 (ddkS, COURT STAFF). Modified on 10/25/2019 (cjlS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).

June 20, 2019

Filing 224 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D. filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, # 3**REMOVED PER #329 ORDER** Redacted Version of Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D., #4 Unredacted Version of Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Exclude Expert Testimony of Gregory K. Leonard, Ph.D., # 5 **REMOVED PER #329 ORDER** Redacted Version of Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #6 Unredacted Version of Exhibit 1 to Declaration of Laura E. Miller in Support of Opposition, #7 Redacted Version of Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #8 Unredacted Version of Exhibit 2 to Declaration of Laura E. Miller in Support of Opposition, #9 Proof of Service)(Miller, Laura) (Filed on 6/20/2019) Modified on 10/17/2019 **Locked per filer's request.** (ddkS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF). Modified on 10/28/2019 (jjbS, COURT STAFF).

June 17, 2019

Filing 223 Declaration of David Mlaver in Support of #209 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Judgment on the Pleadings filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Related document(s) #209 ) (Steindler, Thomas) (Filed on 6/17/2019)

June 17, 2019

Filing 222 Declaration of Nathanael R. Luman in Support of #211 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Partial Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #211 ) (Luman, Nathanael) (Filed on 6/17/2019)

June 17, 2019

Filing 221 Declaration of Nathanael R. Luman in Support of #207 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Strike Portions of Report of Plaintiffs Expert Michael L. Metzker, Ph.D. filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #207 ) (Luman, Nathanael) (Filed on 6/17/2019)

June 14, 2019

#Electronic filing error. Incorrect filing procedure Re: #212 OPPOSITION/RESPONSE to #177 MOTION for Partial Summary Judgment and Supporting Declarations #213 - #220 filed by P lexxikon Inc. When filing a motion, the Memorandum of Points and Authorities and the Declarations should be filed as attachments to the motion. They are not to be filed separately. No further action is necessary, please comply with all future filings. (cjlS, COURT STAFF) (Filed on 6/14/2019)

June 13, 2019

Filing 220 Declaration of Chai Zhang in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 219 Declaration of Prabha Ibrahim in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 218 Declaration of Wayne Spevak in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 217 Declaration of Alexander J. Bridges in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 216 Declaration of Ted Sweeney in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 215 Declaration of Dr. Susana Ortiz-Urda in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 214 Declaration of Jeffrey Winkler in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 213 Declaration of Michael L. Metzker in Support of #212 Opposition/Response to Motion,,,,, filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Related document(s) #212 ) (Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 212 OPPOSITION/RESPONSE (re #177 MOTION for Patial Summary Judgment ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E. Miller, #3 Exhibit 2 to Declaration of Laura E. Miller, #4 Exhibit 3 to Declaration of Laura E. Miller, #5 Exhibit 4 to to Declaration of Laura E. Miller, #6 Exhibit 5 to Declaration of Laura E. Miller, #7 Exhibit 6 to Declaration of Laura E. Miller, #8 Exhibit 7 to Declaration of Laura E. Miller, #9 Exhibit 8 to Declaration of Laura E. Miller, #10 Exhibit 9 to Declaration of Laura E. Miller, #11 Exhibit 10 to Declaration of Laura E. Miller, #12 Exhibit 11 to Declaration of Laura E. Miller, #13 Exhibit 12 to Declaration of Laura E. Miller, #14 Exhibit 13 to Declaration of Laura E. Miller, #15 Exhibit 14 to Declaration of Laura E. Miller, #16 Exhibit 15 to Declaration of Laura E. Miller, #17 Exhibit 16 to Declaration of Laura E. Miller, #18 Exhibit 17 to Declaration of Laura E. Miller, #19 Exhibit 18 to Declaration of Laura E. Miller, #20 Exhibit 19 to Declaration of Laura E. Miller, #21 Exhibit 20 to Declaration of Laura E. Miller, #22 Exhibit 21 to Declaration of Laura E. Miller)(Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 211 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Partial Summary Judgment filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Proposed Order, #3 Redacted Version of Plexxikon's Opposition to Defendant's Motion for Partial Summary Judgment, #4 Unredacted Version of Plexxikon's Opposition to Defendant's Motion for Partial Summary Judgment, #5 Redacted Version of Exhibit A to Metzker Declaration, #6 Unredacted Version of Exhibit A to Metzker Declaration, #7 Redacted Version of Exhibit B to Metzker Declaration, #8 Unredacted Version of Exhibit B to Metzker Declaration, #9 Redacted Version of Exhibit 12 to Miller Declaration, #10 Unredacted Version of Exhibit 12 to Miller Declaration, #11 Redacted Version of Exhibit 19 to Miller Declaration, #12 Unredacted Version of Exhibit 19 to Miller Declaration, #13 Redacted Version of Exhibit A to Winkler Declaration, #14 Unredacted Version of Exhibit A to Winkler Declaration, #15 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 210 OPPOSITION/RESPONSE (re #175 MOTION for Judgment on the Pleadings ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1 to Declaration of Laura E Miller, #3 Exhibit 2 to Declaration of Laura E Miller, #4 Exhibit 3 to Declaration of Laura E Miller, #5 Exhibit 4 to Declaration of Laura E Miller, #6 Exhibit 5 to Declaration of Laura E Miller, #7 Exhibit 6 to Declaration of Laura E Miller, #8 Exhibit 7 to Declaration of Laura E Miller, #9 Exhibit 8 to Declaration of Laura E Miller, #10 Exhibit 9 to Declaration of Laura E Miller, #11 Exhibit 10 to Declaration of Laura E Miller, #12 Exhibit 11 to Declaration of Laura E Miller, #13 Exhibit 12 to Declaration of Laura E Miller, #14 Exhibit 13 to Declaration of Laura E Miller, #15 Request for Judicial Notice, #16 Exhibit 1 to Request for Judicial Notice, #17 Exhibit 2 to Request for Judicial Notice, #18 Exhibit 3 to Request for Judicial Notice, #19 Exhibit 4 to Request for Judicial Notice, #20 Exhibit 5 to Request for Judicial Notice, #21 Exhibit 6 to Request for Judicial Notice, #22 Exhibit 7 to Request for Judicial Notice, #23 Exhibit 8 to Request for Judicial Notice, #24 Exhibit 9 to Request for Judicial Notice, #25 Exhibit 10 to Request for Judicial Notice, #26 Exhibit 11 to Request for Judicial Notice, #27 Exhibit 12 to Request for Judicial Notice, #28 Exhibit 13 to Request for Judicial Notice, #29 Exhibit 14 to Request for Judicial Notice, #30 Exhibit 15 to Request for Judicial Notice, #31 Exhibit 16 to Request for Judicial Notice)(Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 209 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.'s Opposition to Defendant Novartis's Motion for Judgment on the Pleadings filed by Plexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller in Support of Administrative Motion to Seal, #2 Proposed Order, #3 Redacted Version of Plexxikon's Opposition to Novartis's Motion for Judgment on the Pleadings, #4 Unredacted Version of Plexxikon's Opposition to Novartis's Motion for Judgment on the Pleadings, #5 Redacted Version of Exhibit 5 to Declaration, #6 Unredacted Version of Exhibit 5 to Declaration, #7 Redacted Version of Exhibit 6 to Declaration, #8 Unredacted Version of Exhibit 6 to Declaration, #9 Redacted Version of Exhibit 7 to Declaration, #10 Unredacted Version of Exhibit 7 to Declaration, #11 Redacted Version of Exhibit 8 to Declaration, #12 Unredacted Version of Exhibit 8 to Declaration, #13 Redacted Version of Exhibit 9 to Declaration, #14 Unredacted Version of Exhibit 9 to Declaration, #15 Redacted Version of Exhibit 10 to Declaration, #16 Unredacted Version of Exhibit 10 to Declaration, #17 Redacted Version of Exhibit 11 to Declaration, #18 Unredacted Version of Exhibit 11 to Declaration, #19 Redacted Version of Exhibit 12 to Declaration, #20 Unredacted Version of Exhibit 12 to Declaration, #21 Redacted Version of Exhibit 13 to Declaration, #22 Unredacted Version of Exhibit 13 to Declaration, #23 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 208 OPPOSITION/RESPONSE (re #179 MOTION to Strike Portions of Metzker Expert Report ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15)(Miller, Laura) (Filed on 6/13/2019)

June 13, 2019

Filing 207 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Opposition to Defendants Motion to Strike Portions of Report of Plaintiffs Expert Michael L. Metzker, Ph.D. filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Opposition to Motion to Strike, #4 Unredacted Version of Opposition to Motion to Strike, #5 Redacted Version of Declaration of Laura Miller in Support of Opposition to Motion to Strike, #6 Unredacted Version of Declaration of Laura Miller in Support of Opposition to Motion to Strike, #7 Redacted Version of Exhibit 4 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #8 Unredacted Version of Exhibit 4 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #9 Redacted Version of Exhibit 9 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #10 Unredacted Version of Exhibit 9 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #11 Redacted Version of Exhibit 13 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #12 Unredacted Version of Exhibit 13 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #13 Redacted Version of Exhibit 14 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #14 Unredacted Version of Exhibit 14 to Declaration of Laura Miller in Support of Opposition to Motion to Strike, #15 Proof of Service)(Miller, Laura) (Filed on 6/13/2019)

June 6, 2019

Filing 206 MOTION to Exclude Expert Testimony of Ted Sweeney filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 205 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Ted Sweeney filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Ted Sweeney, #4 Unredacted Version of Motion to Exclude Testimony of Ted Sweeney, #5 Unredacted Version of Exhibit 1, #6 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 204 MOTION to Exclude the Expert Testimony of Susana Ortiz-Urda filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 203 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Ortiz filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Ortiz, #4 Unredacted Version of Motion to Exclude Testimony of Ortiz, #5 Unredacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 2, #7 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 202 MOTION to Exclude Expert Testimony of Gregory Leonard filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 201 Administrative Motion to File Under Seal regarding Motion to Exclude Testimony of Gregory Leonard filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Testimony of Leonard, #4 Unredacted Version of Motion to Exclude Testimony of Leonard, #5 Unredacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 2, #7 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 200 MOTION to Exclude Expert Testimony of Michael L. Metzker filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/20/2019. Replies due by 6/27/2019. (Attachments: #1 Declaration of Phil Baran, #2 Declaration of Thomas Steindler, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25, #28 Exhibit 26, #29 Exhibit 27, #30 Exhibit 28, #31 Exhibit 29, #32 Exhibit 30, #33 Exhibit 31, #34 Exhibit 32, #35 Exhibit 33, #36 Exhibit 34, #37 Exhibit 35, #38 Exhibit 36, #39 Exhibit 37, #40 Exhibit 38, #41 Exhibit 39, #42 Proposed Order)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 199 Administrative Motion to File Under Seal regarding Motion to Exclude Expert Testimony of Metzker filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Exclude Expert Testimony of Metzker, #4 Unredacted Version of Motion to Exclude Expert Testimony of Metzker, #5 Redacted Version of Baran Declaration, #6 Unredacted Version of Baran Declaration, #7 Unredacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 4, #9 Unredacted Version of Exhibit 5, #10 Unredacted Version of Exhibit 6, #11 Unredacted Version of Exhibit 7, #12 Unredacted Version of Exhibit 8, #13 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 6/6/2019)

June 6, 2019

Filing 198 CERTIFICATE OF SERVICE by Plexxikon Inc. re #196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts (Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 197 REPLY (re #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, #196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 196 Administrative Motion to File Under Seal Re Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts, #4 Unredacted Version of Reply in Support of Motion to Exclude Certain Opinions and Testimony of Technical Experts)(Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 195 CERTIFICATE OF SERVICE by Plexxikon Inc. re #193 Administrative Motion to File Under Seal re Reply in Support of Plexxikon's Motion to Exclude Opinions and Testimony of James Malackowski (Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 194 REPLY (re #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 193 Administrative Motion to File Under Seal re Reply in Support of Plexxikon's Motion to Exclude Opinions and Testimony of James Malackowski filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Reply in Support of Motion to Exclude Opinions & Testimony of James Malackowski, #4 Unredacted Version of Reply in Support of Motion to Exclude Opinions & Testimony of James Malackowski)(Miller, Laura) (Filed on 6/6/2019)

June 6, 2019

Filing 192 REPLY (re #167 MOTION for Summary Judgment of No Anticipation ) filed byPlexxikon Inc.. (Miller, Laura) (Filed on 6/6/2019)

June 3, 2019

Filing 191 Declaration of Marguerite Hutchinson in Support of #187 Administrative Motion to File Under Seal regarding Opposition to Motion to Exclude Opinion and Tesimony of Malackowski filed byPlexxikon Inc.. (Related document(s) #187 ) (Krishnapriyan, Raghav) (Filed on 6/3/2019)

June 3, 2019

Filing 190 Declaration of Nathanael R. Luman in Support of #185 Administrative Motion to File Under Seal regarding Opposition to Motion for Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #185 ) (Luman, Nathanael) (Filed on 6/3/2019)

May 30, 2019

Filing 189 OPPOSITION/RESPONSE (re #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Steindler, Thomas) (Filed on 5/30/2019)

May 30, 2019

Filing 188 OPPOSITION/RESPONSE (re #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Steindler, Thomas) (Filed on 5/30/2019)

May 30, 2019

Filing 187 Administrative Motion to File Under Seal regarding Opposition to Motion to Exclude Opinion and Tesimony of Malackowski filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Opposition to Motion to Exclude Opinion and Testimony of Malackowski, #4 Unredacted Version of Opposition to Motion to Exclude Opinion and Testimony of Malackowski, #5 Unredacted Version of Exhibit A, #6 Unredacted Version of Exhibit B, #7 Unredacted Version of Exhibit C, #8 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/30/2019)

May 30, 2019

Filing 186 OPPOSITION/RESPONSE (re #167 MOTION for Summary Judgment of No Anticipation ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas Steindler, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Steindler, Thomas) (Filed on 5/30/2019)

May 30, 2019

Filing 185 Administrative Motion to File Under Seal regarding Opposition to Motion for Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Opposition to Motion for Summary Judgment, #4 Unredacted Version of Opposition to Motion for Summary Judgment, #5 Unredacted Version of Exhibit 2, #6 Redacted Version of Exhibit 3, #7 Unredacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 5, #9 Unredacted Version of Exhibit 7, #10 Unredacted Version of Exhibit 8, #11 Unredacted Version of Exhibit 9, #12 Unredacted Version of Exhibit 10, #13 Unredacted Version of Exhibit 11, #14 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/30/2019)

May 28, 2019

Filing 184 ***UNDER SEAL***EXHIBIT 4 (CD) to re #177 -2 Baran Declaration in support of MOTION for Patial Summary Judgment filed byNovartis Pharmaceuticals Corporation. (Related document(s) #177 ) (cpS, COURT STAFF) (Filed on 5/28/2019)

May 28, 2019

Filing 183 ORDER by Judge Haywood S. Gilliam, Jr. Granting #180 Administrative Motion to Extend Time Modifying Summary Judgment Briefing Schedule. (ndrS, COURT STAFF) (Filed on 5/28/2019)

May 28, 2019

Filing 182 Declaration of Nathanael R. Luman in Support of #176 Administrative Motion to File Under Seal regarding Motion for Partial Summary Judgment filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #176 ) (Luman, Nathanael) (Filed on 5/28/2019)

May 28, 2019

Filing 181 OPPOSITION/RESPONSE (re #180 ADMINISTRATIVE MOTION Modify Summary Judgment Briefing Schedule re 173 Order on Motion to Shorten Time,, 174 Order, ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of Thomas P. Steindler)(Steindler, Thomas) (Filed on 5/28/2019)

May 28, 2019

Reset Deadlines/Hearings as to #175 MOTION for Judgment on the Pleadings , #179 MOTION to Strike Portions of Metzker Expert Report, #177 MOTION for Patial Summary Judgment , See Docket No. #183 : Responses due by 6/13/2019; Replies due by 6/20/2019 and Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/28/2019)

May 28, 2019

Hearing as to #167 MOTION for Summary Judgment of No Anticipation, #169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski , #165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts, See Docket No. #183 : Motion Hearing set for 8/29/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/28/2019)

May 24, 2019

Filing 180 ADMINISTRATIVE MOTION to Extend Time Modifying Summary Judgment Briefing Schedule filed by Plexxikon Inc.. Responses due by 5/28/2019. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Declaration of Laura E. Miller, #3 Exhibit 1 to the Decl. of Laura E. Miller, #4 Exhibit 2 to the Decl. of Laura E. Miller, #5 Exhibit 3 to the Decl. of Laura E. Miller, #6 Proposed Order)(Durie, Daralyn) (Filed on 5/24/2019) Modified on 5/28/2019 (cpS, COURT STAFF).

May 23, 2019

Filing 179 MOTION to Strike Portions of Metzker Expert Report filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order, #2 Declaration of David Mlaver, #3 Exhibit Mlaver Ex 1, #4 Exhibit Mlaver Ex 2, #5 Exhibit Mlaver Ex 3, #6 Exhibit Mlaver Ex 4, #7 Exhibit Mlaver Ex 5, #8 Exhibit Mlaver Ex 6, #9 Exhibit Mlaver Ex 7)(Steindler, Thomas) (Filed on 5/23/2019)

May 23, 2019

Filing 178 Administrative Motion to File Under Seal regarding Motion to Strike Portions of Metzker Expert Report filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion to Strike Portions of Metzker Expert Report, #4 Unredacted Version of Motion to Strike Portions of Metzker Expert Report, #5 Unredacted Version of Mlaver Ex 1, #6 Redacted Version of Mlaver Ex 5, #7 Unredacted Version of Mlaver Ex 5, #8 Unredacted Version of Mlaver Ex 7, #9 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/23/2019)

May 23, 2019

Filing 177 MOTION for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order, #2 Declaration of Phil Baran, #3 Exhibit Baran Ex 1, #4 Exhibit Baran Ex 2, #5 Exhibit Baran Ex 3, #6 Exhibit Baran Ex 4 - NMF, #7 Exhibit Baran Ex 5, #8 Exhibit Baran Ex 6, #9 Exhibit Baran Ex 7, #10 Exhibit Baran Ex 8, #11 Exhibit Baran Ex 9, #12 Exhibit Baran Ex 10, #13 Exhibit Baran Ex 11, #14 Exhibit Baran Ex 12, #15 Exhibit Baran Ex 13, #16 Declaration of Tara Rheault, #17 Exhibit Rheault Ex 1, #18 Exhibit Rheault Ex 2, #19 Declaration of Thomas Steindler, #20 Exhibit Steindler Ex 1, #21 Exhibit Steindler Ex 2, #22 Exhibit Steindler Ex 3)(Steindler, Thomas) (Filed on 5/23/2019) Modified on 5/24/2019 (cpS, COURT STAFF).

May 23, 2019

Filing 176 Administrative Motion to File Under Seal regarding Motion for Partial Summary Judgment filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Declaration of David Mlaver, #2 Proposed Order, #3 Redacted Version of Motion for Partial Summary Judgment, #4 Unredacted Version of Motion for Partial Summary Judgment, #5 Redacted Version of Baran Declaration in Support of Motion for Partial Summary Judgment, #6 Unredacted Version of Baran Declaration in Support of Motion for Partial Summary Judgment, #7 Unredacted Version of Baran Declaration Exhibit 5, #8 Unredacted Version of Baran Declaration Exhibit 6, #9 Unredacted Version of Baran Declaration Exhibit 7, #10 Unredacted Version of Baran Declaration Exhibit 12, #11 Redacted Version of Rheault Declaration in Support of Motion for Partial Summary Judgment, #12 Unredacted Version of Rheault Declaration in Support of Motion for Partial Summary Judgment, #13 Unredacted Version of Rheault Declaration Exhibit 1, #14 Unredacted Version of Rheault Declaration Exhibit 2, #15 Unredacted Version of Steindler Declaration Exhibit 1, #16 Unredacted Version of Steindler Declaration Exhibit 3, #17 Certificate/Proof of Service)(Steindler, Thomas) (Filed on 5/23/2019)

May 23, 2019

Filing 175 MOTION for Judgment on the Pleadings filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/6/2019. Replies due by 6/13/2019. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 5/23/2019)

May 22, 2019

Reset Hearing as to Docket Nos. #169 and #165 , See Docket No. 174 : Motion Hearing set for 8/1/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 5/22/2019)

May 22, 2019

Filing 174 ORDER by Hon. Haywood S. Gilliam, Jr. RESCHEDULING the #165 , #169 non-dispositive motion hearings to be heard at the same time as the #167 dispositive motion on August 1, 2019, at 2:00 p.m. in Courtroom 2, Fourth Floor, Oakland. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/22/2019)

May 21, 2019

Filing 173 ORDER by Hon. Haywood S. Gilliam, Jr., GRANTING IN PART and DENYING IN PART #170 motion to shorten time. Due to a previously scheduled full-day jury trial on June 20, the hearing on the dispositive motions is postponed to August 1, 2019, at 2:00 p.m. in Courtroom 2, Fourth Floor, Oakland. Defendant Novartis is DIRECTED to file its dispositive motion by May 23 and the parties are DIRECTED to comply with the briefing schedule set forth in Civil Local Rule 7-3. (This is a text-only entry generated by the court. There is no document associated with this entry.) (hsglc1S, COURT STAFF) (Filed on 5/21/2019)

May 20, 2019

Filing 172 OPPOSITION/RESPONSE (re #170 MOTION to Shorten Time to File Dispositive Motions ) filed byPlexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Durie, Daralyn) (Filed on 5/20/2019)

May 17, 2019

Filing 171 Declaration of Nathanael R. Luman in Support of #166 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion for Summary Judgment of No Anticipation filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #166 ) (Luman, Nathanael) (Filed on 5/17/2019)

May 17, 2019

Filing 170 MOTION to Shorten Time to File Dispositive Motions filed by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 5/17/2019)

May 16, 2019

Filing 169 MOTION to Exclude the Opinions and Testimony of James E. Malackowski filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration of Laura E. Miller, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Proposed Order)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).

May 16, 2019

Filing 168 Administrative Motion to File Under Seal re Plaintiffs Motion to Exclude the Opinions and Testimony of James E. Malackowski filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit 1, #4 Unredacted Version of Exhibit 1, #5 Redacted Version of Exhibit 2, #6 Unredacted Version of Exhibit 2, #7 Redacted Version of Exhibit 3, #8 Unredacted Version of Exhibit 3, #9 Redacted Version of Plaintiffs Notice of Motion and Motion to Exclude the Opinions and Testimony of James E. Malackowski and Memorandum of Points and Authorities in Support Thereof, #10 Unredacted Version of Plaintiffs Notice of Motion and Motion to Exclude the Opinions and Testimony of James E. Malackowski and Memorandum of Points and Authorities in Support Thereof, #11 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)

May 16, 2019

Filing 167 MOTION for Summary Judgment of No Aticipation filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration of Matthew W. Samuels, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Proposed Order)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).

May 16, 2019

Filing 166 Administrative Motion to File Under Seal re Plaintiff Plexxikon Inc.s Motion for Summary Judgment of No Anticipation filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiffs Plaintiff Plexxikon Inc.s Notice of Motion and Motion for Summary Judgment of No Anticipation; Memorandum of Points and Authorities in Support Thereof, #4 Unredacted Version of Plaintiff Plexxikon Inc.s Notice of Motion and Motion for Summary Judgment of No Anticipation; Memorandum of Points and Authorities in Support Thereof, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 9, #8 Unredacted Version of Exhibit 9, #9 Redacted Version of Exhibit 19, #10 Unredacted Version of Exhibit 19, #11 Redacted Version of Exhibit 20, #12 Unredacted Version of Exhibit 20, #13 Redacted Version of Exhibit 21, #14 Unredacted Version of Exhibit 21, #15 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)

May 16, 2019

Filing 165 MOTION to Exclude Certain Opinions and Testimony of Novartis's Technical Experts filed by Plexxikon Inc.. Motion Hearing set for 6/20/2019 02:00 PM before Judge Haywood S Gilliam Jr.. Responses due by 5/30/2019. Replies due by 6/6/2019. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Miller, Laura) (Filed on 5/16/2019) Modified on 5/17/2019 (cpS, COURT STAFF).

May 16, 2019

Filing 164 Administrative Motion to File Under Seal Re Plaintiff's Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Plaintiffs Notice of Motion and Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts and Memorandum of Points and Authorities in Support Thereof, #4 Unredacted Version of Plaintiffs Notice of Motion and Motion to Exclude Certain Opinions and Testimony of Novartiss Technical Experts and Memorandum of Points and Authorities in Support Thereof, #5 Redacted Version of Exhibit 1, #6 Unredacted Version of Exhibit 1, #7 Redacted Version of Exhibit 2, #8 Unredacted Version of Exhibit 2, #9 Redacted Version of Exhibit 4, #10 Unredacted Version of Exhibit 4, #11 Redacted Version of Exhibit 5, #12 Unredacted Version of Exhibit 5, #13 Redacted Version of Exhibit 7, #14 Unredacted Version of Exhibit 7, #15 Proof of Service)(Miller, Laura) (Filed on 5/16/2019)

May 16, 2019

Filing 163 ORDER on May 15, 2019 Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 5/16/2019)

May 15, 2019

Filing 162 Joint Discovery Letter Brief re the Court's May 3, 2019 Order #161 filed by Novartis Pharmaceuticals Corporation, Plexxikon Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Declaration of Dr. Alexander Bridges, #4 Appendix A to Declaration of Dr. Alexander Bridges)(Steindler, Thomas) (Filed on 5/15/2019) Modified on 5/16/2019 (cjlS, COURT STAFF).

May 3, 2019

Filing 161 ORDER on Defendant's Motion to Compel Discovery Regarding Dr. Bridges' Report by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 5/3/2019)

May 1, 2019

Filing 160 ORDER by Judge Haywood S. Gilliam, Jr. Granting #159 Stipulation to Permit Deposition of Malackowski After the Expert Discovery Cutoff Date. (ndrS, COURT STAFF) (Filed on 5/1/2019)

April 30, 2019

Filing 159 STIPULATION WITH PROPOSED ORDER to Permit Deposition of Malackowski After the Expert Discovery Cutoff Date filed by Novartis Pharmaceuticals Corporation and Plexxikon, Inc. (Steindler, Thomas) (Filed on 4/30/2019) Modified on 5/1/2019 (jjbS, COURT STAFF).

April 29, 2019

Filing 158 Joint Discovery Letter Brief re Dr. Alexander Bridges filed by Novartis Pharmaceuticals Corporation, and Plexxikon, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 4/29/2019) Modified on 4/30/2019 (jjbS, COURT STAFF).

April 26, 2019

Filing 157 MOTION for leave to appear in Pro Hac Vice for Paul Schoenhard ( Filing fee $ 310, receipt number 0971-13293802.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Schoenhard, Paul) (Filed on 4/26/2019)

April 11, 2019

Filing 156 NOTICE of Appearance by David Floyd McGowan (McGowan, David) (Filed on 4/11/2019)

March 29, 2019

Filing 155 ORDER Denying Plaintiff's Motion to Compel signed by Magistrate Judge Elizabeth D. Laporte: denying #150 Motion. (shyS, COURT STAFF) (Filed on 3/29/2019)

March 22, 2019

Filing 154 ORDER by Judge Haywood S. Gilliam, Jr. GRANTING #89 ADMINISTRATIVE MOTION TO FILE UNDER SEAL.(ndrS, COURT STAFF) (Filed on 3/22/2019)

March 21, 2019

Filing 153 Declaration of Nathanael R. Luman in Support of #149 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #149 ) (Luman, Nathanael) (Filed on 3/21/2019)

March 19, 2019

Filing 152 OPPOSITION/RESPONSE (re #150 Discovery Letter Brief re ruling of the SDNY Court re Christina Schwarz ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A)(Steindler, Thomas) (Filed on 3/19/2019)

March 18, 2019

Filing 151 CERTIFICATE OF SERVICE by Plexxikon Inc. re #149 Administrative Motion to File Under Seal (Durie, Daralyn) (Filed on 3/18/2019)

March 18, 2019

Filing 150 Discovery Letter Brief re ruling of the SDNY Court re Christina Schwarz filed by Plexxikon Inc. (Attachments: #1 Exhibit A)(Durie, Daralyn) (Filed on 3/18/2019) Modified on 3/19/2019 (jjbS, COURT STAFF).

March 18, 2019

Filing 149 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit A, #4 Unredacted Version of Exhibit A)(Durie, Daralyn) (Filed on 3/18/2019)

March 18, 2019

Filing 148 Letter from Thomas P. Steindler regarding Order from Southern District of New York. (Attachments: #1 Exhibit A, #2 Exhibit B)(Steindler, Thomas) (Filed on 3/18/2019)

March 8, 2019

Filing 147 FURTHER ORDER Regarding Privilege Waiver Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 3/8/2019)

February 28, 2019

Filing 146 Letter from Thomas P. Steindler in Response to Plaintiff's Discovery Letter. (Steindler, Thomas) (Filed on 2/28/2019)

February 27, 2019

Filing 145 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Declaration of Daralyn J. Durie, #2 Exhibit A, #3 Exhibit B)(Durie, Daralyn) (Filed on 2/27/2019)

February 27, 2019

Filing 144 Letter from Thomas P. Steindler Submitting Declaration of Peter Waibel per D.I. 140. (Attachments: #1 Declaration of Peter Waibel, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D)(Steindler, Thomas) (Filed on 2/27/2019)

February 25, 2019

Filing 143 FURTHER Order Regarding Non-Party Discovery Disputes by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 2/25/2019)

February 25, 2019

Filing 142 NOTICE of Compliance with the Court's #140 Order on Administrative Motion to File Under Seal, Order on Discovery Letter Brief by Plexxikon Inc. (Attachments: #1 Exhibit B [Partially Redacted], #2 Exhibit C)(Krishnapriyan, Raghav) (Filed on 2/25/2019) Modified on 2/26/2019 (jjbS, COURT STAFF).

February 22, 2019

Filing 141 Joint Discovery Letter Brief re Status Update filed by Plexxikon Inc., GlaxoSmithKline PLC, and GlaxoSmithKline LLC (Durie, Daralyn) (Filed on 2/22/2019) Modified on 2/25/2019 (jjbS, COURT STAFF).

February 22, 2019

Filing 140 ORDER on February 13, 2019 Discovery Dispute by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 2/22/2019)

February 22, 2019

Filing 139 Letter Regarding Redactions from William R. Zimmerman.(Zimmerman, William) (Filed on 2/22/2019) Modified on 2/25/2019 (jjbS, COURT STAFF).

February 22, 2019

Filing 138 Transcript of Proceedings held on 02/19/2019, before Magistrate Judge Elizabeth D. Laporte. Court Reporter/Transcriber Peggy Schuerger/Ad Hoc Reporting, telephone number (619) 228-3774/adhocreporting@aol.com. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #136 Transcript Order ) Redaction Request due 3/15/2019. Redacted Transcript Deadline set for 3/25/2019. Release of Transcript Restriction set for 5/23/2019. (Related documents(s) #136 ) (pls, COURT STAFF) (Filed on 2/22/2019)

February 20, 2019

Filing 136 TRANSCRIPT ORDER for proceedings held on 2/19/19 before Magistrate Judge Elizabeth D. Laporte by GlaxoSmithKline LLC, GlaxoSmithKline PLC, for Court Reporter FTR - San Francisco. (Zimmerman, William) (Filed on 2/20/2019)

February 20, 2019

Filing 135 PDF with attached Audio File. Court Date & Time [ 2/19/2019 11:30:57 AM ]. File Size [ 18277 KB ]. Run Time [ 00:38:05 ]. (courtspeak).

February 19, 2019

Filing 137 Minute Entry for proceedings held on 2/19/2019 before Magistrate Judge Elizabeth D. Laporte. Discussion held regarding the discovery letter brief filed on 2/7/2019. Counsel shall submit an update to the Court by 2/22/2019. Furthermore, Plaintiff and the third-party defendant shall meet and confer regarding the issue raised at the hearing pertaining to redactions. As stated at the hearing, the third-party defendant shall prepare a written explanation for the redactions and share it with Plaintiff; and submit it to the Court for review, unless Plaintiff thinks that would be unnecessary.FTR Time: 11:31 - 12:06 Plaintiff Attorney: Daralyn Durie Third Party Defendant Attorney: William ZimmermanDefendant Attorney: Thomas Steindler (telephonic appearance) Matter transcribed by Peggy Schuerger. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Date Filed: 2/19/2019)

February 19, 2019

Filing 134 Declaration of William R. Zimmerman in Support of #130 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #130 ) (Zimmerman, William) (Filed on 2/19/2019)

February 15, 2019

Filing 133 CLERK'S NOTICE: The parties are hereby notified that a hearing regarding the discovery letter brief filed on 2/7/2019 is set for 2/19/2019 at 11:30 AM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. To the extend counsel need to appear by phone, then counsel must utilize the following call-in information: dial (888) 684-8852 and enter access code 537 9839. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Filed on 2/15/2019)

February 14, 2019

Filing 132 ORDER GRANTING PLAINTIFF PLEXXIKON INC.S ADMINISTRATIVE MOTION TO FILE UNDER SEAL PURSUANT TO CIVIL L.R. 7-11 AND 79-5 by Judge Elizabeth D. Laporte. (mllS, COURT STAFF) (Filed on 2/14/2019)

February 13, 2019

Filing 131 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Durie, Daralyn) (Filed on 2/13/2019)

February 13, 2019

Filing 130 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit B, #4 Unredacted Version of Exhibit B, #5 Redacted Version of Exhibit C, #6 Unredacted Version of Exhibit C, #7 Certificate/Proof of Service)(Durie, Daralyn) (Filed on 2/13/2019)

February 7, 2019

Filing 129 Joint Discovery Letter Brief re Status Update Pursuant to the Courts February 1, 2019 order (ECF No. 125) filed by Plexxikon Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Durie, Daralyn) (Filed on 2/7/2019)

February 7, 2019

Filing 128 Administrative Motion to File Under Seal filed by GlaxoSmithKline LLC. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Ex. 5, #4 Unredacted Version of Ex. 5, #5 Redacted Version of Ex. 6, #6 Unredacted Version of Ex. 6, #7 Redacted Version of Ex. 7, #8 Unredacted Version of Ex. 7, #9 Redacted Version of Ex. 8, #10 Unredacted Version of Ex. 8)(Durie, Daralyn) (Filed on 2/7/2019)

February 5, 2019

Filing 127 ORDER by Judge Haywood S. Gilliam, Jr. DENYING #114 MOTION FOR RELIEF FROM NON-DISPOSITIVE PRETRIAL ORDER.(ndrS, COURT STAFF) (Filed on 2/5/2019)

February 4, 2019

Filing 126 NOTICE of Appearance by Victoria Leigh Weatherford (Weatherford, Victoria) (Filed on 2/4/2019)

February 1, 2019

Filing 125 ORDER ON DISCOVERY DISPUTES WITH NON-PARTY. Signed by Judge Elizabeth D. Laporte on February 1, 2019. (mllS, COURT STAFF) (Filed on 2/1/2019)

February 1, 2019

Filing 124 NOTICE of Change In Counsel by Laura Elizabeth Miller (Miller, Laura) (Filed on 2/1/2019)

January 29, 2019

Filing 123 MOTION for leave to appear in Pro Hac Vice Ian B Brooks ( Filing fee $ 310, receipt number 0971-13043124.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Brooks, Ian) (Filed on 1/29/2019)

January 29, 2019

FILED IN ERROR, DISREGARD** #Electronic filing error. REMINDER TO COUNSEL: In the future, please attach all supporting documents to the Motion. No further action is necessary Re: #122 Declaration in Support filed by GlaxoSmithKline LLC, GlaxoSmithKline PLC (jjbS, COURT STAFF) (Filed on 1/29/2019) Modified on 1/29/2019 (jjbS, COURT STAFF).

January 28, 2019

Filing 122 Declaration of William R. Zimmerman in Support of #119 Administrative Motion to File Under Seal filed byGlaxoSmithKline LLC, GlaxoSmithKline PLC. (Related document(s) #119 ) (Zimmerman, William) (Filed on 1/28/2019)

January 24, 2019

Filing 121 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Exhibit M, #15 Exhibit N, #16 Exhibit O, #17 Exhibit P)(Durie, Daralyn) (Filed on 1/24/2019)

January 24, 2019

Filing 120 CERTIFICATE OF SERVICE by Plexxikon Inc. re #119 Administrative Motion to File Under Seal (Samuels, Matthew) (Filed on 1/24/2019)

January 24, 2019

Filing 119 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit E, #4 Unredacted Version of Exhibit E, #5 Redacted Version of Exhibit F, #6 Unredacted Version of Exhibit F, #7 Redacted Version of Exhibit G, #8 Unredacted Version of Exhibit G, #9 Redacted Version of Exhibit H, #10 Unredacted Version of Exhibit H, #11 Redacted Version of Exhibit I, #12 Unredacted Version of Exhibit I, #13 Redacted Version of Exhibit J, #14 Unredacted Version of Exhibit J)(Samuels, Matthew) (Filed on 1/24/2019)

January 14, 2019

Filing 118 ORDER by Judge Haywood S. Gilliam, Jr. Granting #117 Stipulation to Permit Depositions After the Fact Discovery Cutoff Date. (ndrS, COURT STAFF) (Filed on 1/14/2019)

January 11, 2019

Filing 117 STIPULATION WITH PROPOSED ORDER to Permit Depositions After the Fact Discovery Cutoff Date filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Samuels, Matthew) (Filed on 1/11/2019) Modified on 1/11/2019 (jjbS, COURT STAFF).

December 21, 2018

Filing 116 ORDER granting Letter of Request for International Judicial Assistance Pursuant to Hague Convention of 18 March 1970 on the Taking of Evidence Abroad in Civil or Commercial Matters signed by Magistrate Judge Elizabeth D. Laporte: granting as modified as to January 4, 2019 Response Date [106-2] Request. The deputy clerk hereby certifies that on 12/21/2018 three copies of this order was served by sending it via first-class mail to the Plaintiff's counsel. (shyS, COURT STAFF) (Filed on 12/21/2018)

December 21, 2018

Filing 115 ORDER granting Letter of Request for International Judicial Assistance Pursuant to Hague Convention of 18 March 1970 on the Taking of Evidence Abroad in Civil or Commercial Matters signed by Magistrate Judge Elizabeth D. Laporte: granting as modified as to January 4, 2019 Response Date [106-1] Request. The deputy clerk hereby certifies that on 12/21/2018 three copies of this order was served by sending it via first-class mail to the Plaintiff's counsel. (shyS, COURT STAFF) (Filed on 12/21/2018)

December 21, 2018

Filing 114 MOTION for Relief from Non-Dispositive Pretrial Amended Order of Magistrate Judge Conditionally Granting Request for Issuance of Letters of Request re #112 Order filed by Novartis Pharmaceuticals Corporation. Responses due by 1/4/2019. Replies due by 1/11/2019. (Attachments: #1 Exhibit 1 - Part 1, #2 Exhibit 1 - Part 2, #3 Exhibit 2, #4 Exhibit 3, #5 Proposed Order)(Steindler, Thomas) (Filed on 12/21/2018) Modified on 12/26/2018 (cpS, COURT STAFF).

December 20, 2018

Filing 113 Letter from Daralyn J. Durie to The Honorable Elizabeth D. Laporte. (Durie, Daralyn) (Filed on 12/20/2018)

December 19, 2018

Filing 112 AMENDED ORDER Conditionally Granting Request for Issuance of Letters of Request by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 12/19/2018)

December 18, 2018

Filing 111 ORDER Regarding Plaintiff's Motion to Remove DKT. NOS. 106-10 and 109 by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 12/18/2018)

December 14, 2018

Filing 110 MOTION to Remove Incorrectly Filed Document Dkt. Nos. 106-10 & 109 filed by Plexxikon Inc.. (Attachments: #1 Proposed Order)(Krishnapriyan, Raghav) (Filed on 12/14/2018)

December 13, 2018

Filing 109 ORDER CONDITIONALLY GRANTING REQUEST FOR ISSUANCE OF LETTERS OF REQUEST re #106 Discovery Letter Brief filed by Plexxikon Inc. Signed by Judge Elizabeth D. Laporte on December 13, 2018. (mllS, COURT STAFF) (Filed on 12/13/2018) (Main Document 109 replaced on 12/19/2018) (rcsS, COURT STAFF).

December 13, 2018

Filing 108 Transcript of Proceedings held on 11/29/2018, before Magistrate Judge Elizabeth D. Laporte. Court Reporter/Transcriber Leo T. Mankiewicz, CSR, CRR, RMR, telephone number (415) 722-7045; email: leomank@gmail.com. FTR 10:47 a.m. - 11:29 a.m. = 42 minutes. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #101 Transcript Order, #102 Transcript Order ) Redaction Request due 1/3/2019. Redacted Transcript Deadline set for 1/14/2019. Release of Transcript Restriction set for 3/13/2019. (Related documents(s) #101 , #102 ) (Mankiewicz, Leo) (Filed on 12/13/2018)

December 11, 2018

Filing 107 ORDER ON DISCOVERY DISPUTE REGARDING LAB NOTEBOOKS. Signed by Judge Elizabeth D. Laporte on December 11, 2018. (mllS, COURT STAFF) (Filed on 12/11/2018)

December 6, 2018

Filing 106 Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, *** #10 Exhibit J DOCUMENT LOCKED AT FILER'S REQUEST. DOCUMENT TO BE REFILED LATER. *** , #11 Proposed Order)(Durie, Daralyn) (Filed on 12/6/2018) Modified on 12/13/2018 (ewn, COURT STAFF).

December 5, 2018

Filing 105 Brief Regarding Relevance of Lab Notebooks re #100 Order on Discovery Letter Brief filed byNovartis Pharmaceuticals Corporation. (Related document(s) #100 ) (Steindler, Thomas) (Filed on 12/5/2018) Modified on 12/6/2018 (jjbS, COURT STAFF).

December 5, 2018

Filing 104 Discovery Letter Brief per Court's Order Dated November 30, 2018 filed by Plexxikon Inc.. (Durie, Daralyn) (Filed on 12/5/2018)

December 4, 2018

Filing 103 AUDIO RECORDINGS ORDER (re: 99 Discovery Hearing,, ), by Novartis Pharmaceuticals Corporation. Court will send to Lisa Marth at lmarth@mwe.com a link to the files requested in this order. ( Filing fee $ 31, receipt number 0971-12895999). (Steindler, Thomas) (Filed on 12/4/2018)

December 3, 2018

Filing 102 TRANSCRIPT ORDER for proceedings held on 11/29/2018 before Magistrate Judge Elizabeth D. Laporte by Plexxikon Inc., for Court Reporter FTR - San Francisco. (Krishnapriyan, Raghav) (Filed on 12/3/2018)

December 3, 2018

Filing 101 TRANSCRIPT ORDER for proceedings held on 11/29/2018 before Magistrate Judge Elizabeth D. Laporte by Novartis Pharmaceuticals Corporation, for Court Reporter FTR - San Francisco. (Steindler, Thomas) (Filed on 12/3/2018)

November 30, 2018

Filing 100 ORDER on Discovery Dispute Over Requests Relating to the "Core Molecular Structure" by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 11/30/2018)

November 29, 2018

Filing 99 Minute Entry for proceedings held on 11/29/2018 before Magistrate Judge Elizabeth D. Laporte regarding the parties pending discovery dispute. Hearing held. The Court shall issue an order memorializing the rulings made during the hearing. FTR Time: 10:47 - 11:29 Plaintiff Attorneys: Daralyn Durie and Matt Samuels Defendant Attorney: Thomas Steindler (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Date Filed: 11/29/2018) Modified on 12/3/2018: Matter transcribed by Leo Mankiewicz. (rjdS, COURT STAFF).

November 27, 2018

Filing 98 ORDER Regarding November 29, 2018 Discovery Hearing by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 11/27/2018)

November 26, 2018

Filing 97 CLERK'S NOTICE: The parties are hereby notified that a hearing regarding the 11/9/2018 joint discovery letter is set for 11/29/2018 at 10:30 AM in San Francisco, Courtroom E, 15th Floor before Magistrate Judge Elizabeth D. Laporte. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shyS, COURT STAFF) (Filed on 11/26/2018)

November 9, 2018

Filing 96 Joint Discovery Letter Brief filed by Plexxikon Inc.. (Attachments: #1 Exhibit Plexxikon Ex. A, #2 Exhibit Plexxikon Ex. B, #3 Exhibit Plexxikon Ex. C, #4 Exhibit Novartis Ex. 1, #5 Exhibit Novartis Ex. 2, #6 Exhibit Novartis Ex. 3)(Durie, Daralyn) (Filed on 11/9/2018)

October 25, 2018

Filing 95 NOTICE of Appearance by Matthew Walter Samuels (Samuels, Matthew) (Filed on 10/25/2018)

October 15, 2018

Filing 94 NOTICE of Appearance by Stephen J Elkind (Elkind, Stephen) (Filed on 10/15/2018)

October 4, 2018

Filing 93 ORDER by Judge Haywood S. Gilliam, Jr. Granting #92 Stipulation.(ndrS, COURT STAFF) (Filed on 10/4/2018)

October 2, 2018

Filing 92 STIPULATION WITH PROPOSED ORDER RE DISCOVERY re #90 MOTION for Leave to File Third Amended Complaint, #63 Order on Stipulation, filed by Plexxikon Inc., GlaxoSmithKline PLC, GlaxoSmithKline LLC. (Attachments: #1 Exhibit Exhibit A)(Krishnapriyan, Raghav) (Filed on 10/2/2018) Modified on 10/3/2018 (jlmS, COURT STAFF).

August 24, 2018

Filing 91 Declaration of William R. Zimmerman in Support of #89 Administrative Motion to File Under Seal filed byGlaxoSmithKline PLC, GlaxoSmithKline LLC. (Related document(s) #89 ) (Zimmerman, William) (Filed on 8/24/2018)

August 20, 2018

Set Deadlines/Hearing as to #90 MOTION for Leave to File Third Amended Complaint:. Responses due by 9/4/2018; Replies due by 9/11/2018 and Motion Hearing set for 11/8/2018 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 8/20/2018)

August 20, 2018

Filing 90 MOTION for Leave to File Third Amended Complaint filed by Plexxikon Inc.. (Attachments: #1 Exhibit A to Motion, #2 Declaration of Laura E. Miller, #3 Exhibit 1 to Declaration of Laura E. Miller, #4 Exhibit 2 to Declaration of Laura E. Miller, #5 Exhibit 3 to Declaration of Laura E. Miller, #6 Exhibit 4 to Declaration of Laura E. Miller, #7 Exhibit 5 to Declaration of Laura E. Miller, #8 Exhibit 6 to Declaration of Laura E. Miller, #9 Exhibit 7 to Declaration of Laura E. Miller, #10 Exhibit 8 to Declaration of Laura E. Miller, #11 Exhibit 9 to Declaration of Laura E. Miller, #12 Exhibit 10 to Declaration of Laura E. Miller, #13 Exhibit 11 to Declaration of Laura E. Miller, #14 Exhibit 12 to Declaration of Laura E. Miller, #15 Exhibit 13 to Declaration of Laura E. Miller, #16 Exhibit 14 to Declaration of Laura E. Miller, #17 Exhibit 15 to Declaration of Laura E. Miller, #18 Proposed Order)(Miller, Laura) (Filed on 8/20/2018)

August 20, 2018

Filing 89 Administrative Motion to File Under Seal filed by Plexxikon Inc.. (Attachments: #1 Declaration, #2 Proposed Order, #3 Redacted Version of Exhibit 5, #4 Unredacted Version of Exhibit 5, #5 Redacted Version of Exhibit 7, #6 Unredacted Version of Exhibit 7, #7 Redacted Version of Exhibit 8, #8 Unredacted Version of Exhibit 8, #9 Redacted Version of Exhibit 9, #10 Unredacted Version of Exhibit 9, #11 Redacted Version of Exhibit 10, #12 Unredacted Version of Exhibit 10, #13 Redacted Version of Exhibit 11, #14 Unredacted Version of Exhibit 11, #15 Redacted Version of Exhibit 12, #16 Unredacted Version of Exhibit 12, #17 Redacted Version of Exhibit 13, #18 Unredacted Version of Exhibit 13)(Miller, Laura) (Filed on 8/20/2018)

July 23, 2018

Filing 88 ORDER on Third Discovery Letter by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 7/23/2018)

July 21, 2018

Filing 87 Transcript of Proceedings held on June 19, 2018, before Judge Haywood S. Gilliam. Court Reporter/Transcriber Joan Marie Columbini, CSR, RPR, telephone number (510) 367-3043, joan.columbini.csr@gmail.com. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re #85 Transcript Order ) Redaction Request due 8/13/2018. Redacted Transcript Deadline set for 8/21/2018. Release of Transcript Restriction set for 10/19/2018. (Related documents(s) #85 ) (Columbini, Joan) (Filed on 7/21/2018)

July 19, 2018

Filing 86 Third Joint Statement for Determination of Discovery Disputes filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Woodworth, Eddie) (Filed on 7/19/2018) Modified on 7/20/2018 (jjbS, COURT STAFF).

July 10, 2018

Filing 85 TRANSCRIPT ORDER for proceedings held on 06/19/2018 before Judge Haywood S Gilliam, Jr by Plexxikon Inc., for Court Reporter FTR - Oakland. (Miller, Laura) (Filed on 7/10/2018)

July 10, 2018

Filing 84 ORDER by Judge Haywood S. Gilliam, Jr. Granting #83 Motion for Pro Hac Vice As To Ryan T. McCleary. (ndrS, COURT STAFF) (Filed on 7/10/2018) Modified on 7/11/2018 (jjbS, COURT STAFF).

July 9, 2018

Filing 83 Corrected MOTION for leave to appear in Pro Hac Vice - Ryan T. McCleary ( Filing fee $310, receipt number 0971-12420367.) Filing fee previously paid on 6/8/2018 filed by Plexxikon Inc.. (Attachments: #1 Certificate/Proof of Service Certificate of Good Standing)(McCleary, Ryan) (Filed on 7/9/2018) Modified on 7/10/2018 (jjbS, COURT STAFF).

July 3, 2018

Filing 82 ORDER by Judge Haywood S. Gilliam, Jr. Denying #78 Motion for Pro Hac Vice as to Ryan T. McCleary. (ndrS, COURT STAFF) (Filed on 7/3/2018)

June 20, 2018

Filing 80 REVISED SCHEDULING ORDER: Amended Pleadings due by 8/20/2018; Close of Fact Discovery due by 1/17/2019; Opening Reports due by 2/4/2019; Rebuttal Reports due by 3/14/2019; Close of Expert Discovery due by 5/2/2019; Motion Hearing set for 6/20/2019 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr.; Final Pretrial Conference set for 9/17/2019 03:00 PM in Oakland, Courtroom 2, 4th Floor; Jury Selection /Jury Trial (10-day) set for 10/7/2019 08:30 AM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S. Gilliam Jr. (This order terminates docket no. #76 ). Signed by Judge Haywood S. Gilliam, Jr. on 6/20/2018. (ndrS, COURT STAFF) (Filed on 6/20/2018)

June 19, 2018

Filing 81 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 6/19/2018. FTR Time: 2:10-2:25 (Assigned Transcriber: Joan Columbini). Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. The Court vacates the previously scheduled tutorial and claim construction hearing. Written scheduling order to issue. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 6/19/2018) Modified on 7/10/2018 (napS, COURT STAFF).

June 15, 2018

Filing 79 NOTICE by Plexxikon Inc. for Withdrawal of Attorney (Roberts, Clement) (Filed on 6/15/2018)

June 8, 2018

Filing 78 MOTION for leave to appear in Pro Hac Vice - Ryan T. McCleary ( Filing fee $ 310, receipt number 0971-12420367.) filed by Plexxikon Inc.. (Attachments: #1 Certificate of Good Standing)(McCleary, Ryan) (Filed on 6/8/2018)

June 6, 2018

Filing 77 ORDER by Hon. Haywood S. Gilliam, Jr., SETTING a further case management conference on June 19, 2018 at 2:00 p.m. The parties shall be prepared to discuss the #76 Joint Motion to Amend Scheduling Order and Set Trial Date. The parties do not need to file an additional case management statement. (This is a text-only entry generated by the court. There is no document associated with this entry.)(hsglc1S, COURT STAFF) (Filed on 6/6/2018)

June 6, 2018

Set Hearing Pursuant to Docket No. 77 : Further Case Management Conference set for 6/19/2018 02:00 PM in Oakland, Courtroom 2, 4th Floor. (ndrS, COURT STAFF) (Filed on 6/6/2018)

June 5, 2018

Filing 76 Joint MOTION to Amend/Correct Scheduling Order and Set Trial Date filed by Plexxikon Inc.. and Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/6/2018 02:00 PM in Oakland, Courtroom 2, 4th Floor before Judge Haywood S Gilliam Jr.. Responses due by 6/19/2018. Replies due by 6/26/2018. (Woodworth, Eddie) (Filed on 6/5/2018) Modified on 6/6/2018 (jjbS, COURT STAFF).

June 4, 2018

Filing 75 AUDIO RECORDINGS ORDER (re: 56 Case Management Conference - Further,,,, Set Deadlines/Hearings,,, ), by Plexxikon Inc.. Court will send to Hind Samona at samona@youngbasile.com a link to the files requested in this order. ( Filing fee $ 31, receipt number 0971-12403621). (Woodworth, Eddie) (Filed on 6/4/2018)

June 1, 2018

Filing 74 AUDIO RECORDINGS ORDER (re: 56 Case Management Conference - Further,,,, Set Deadlines/Hearings,,, ), by Novartis Pharmaceuticals Corporation. Court will send to Lisa Marth at lmarth@mwe.com a link to the files requested in this order. ( Filing fee $ 31, receipt number 0971-12399960). (Steindler, Thomas) (Filed on 6/1/2018)

May 9, 2018

Filing 73 NOTICE of Appearance by Laura Elizabeth Miller (Miller, Laura) (Filed on 5/9/2018)

April 26, 2018

Filing 72 ORDER on First Joint Statement for Determination of Discovery Disputes by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 4/26/2018)

April 23, 2018

Filing 71 CLERK'S NOTICE. Notice is hereby given that the claim construction hearing, previously set for July 13, 2018, is continued to July 20, 2018 before Judge Haywood S. Gilliam, Jr., at 10:00 a.m., in Courtroom 2, 4th Floor, 1301 Clay Street, Oakland, CA. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 4/23/2018)

April 23, 2018

Filing 70 CLERK'S NOTICE. Notice is hereby given that the tutorial, previously set for July 6, 2018, is continued to July 13, 2018 before Judge Haywood S. Gilliam, Jr., at 10:00 a.m., in Courtroom 2, 4th Floor, 1301 Clay Street, Oakland, CA. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 4/23/2018)

April 23, 2018

Filing 69 ORDER Granting Plaintiff Leave to Amend Infringement Contentions by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 4/23/2018)

April 20, 2018

Filing 68 NOTICE of Filing by Plexxikon Inc. re #64 First Joint Discovery Letter Brief for Determination of Discovery Disputes Notice of Filing Exhibits (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Woodworth, Eddie) (Filed on 4/20/2018) Modified on 4/23/2018 (jjbS, COURT STAFF).

April 20, 2018

Filing 67 ORDER Directing Plaintiff to File Copies of Discovery Requests and Responses by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 4/20/2018)

April 17, 2018

Filing 66 Joint CLAIM CONSTRUCTION STATEMENT and Prehearing Statement Under Patent L.R. 4-3 filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation (Woodworth, Eddie) (Filed on 4/17/2018) Modified on 4/18/2018 (jjbS, COURT STAFF).

April 17, 2018

Filing 65 Second Joint Statement for Determination of Discovery Dispute filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Declaration of Clement S. Roberts, #2 Exhibit B)(Woodworth, Eddie) (Filed on 4/17/2018) Modified on 4/18/2018 (jjbS, COURT STAFF). Modified on 4/18/2018 (jjbS, COURT STAFF).

April 13, 2018

Filing 64 First Joint Discovery Letter Brief for Determination of Discovery Disputes filed by Plexxikon Inc. and Novartis Pharmaceuticals Corporation. (Woodworth, Eddie) (Filed on 4/13/2018) Modified on 4/16/2018 (jjbS, COURT STAFF). Modified on 4/16/2018 (jjbS, COURT STAFF).

January 31, 2018

Filing 63 STIPULATED PROTECTIVE ORDER signed by Magistrate Judge Elizabeth D. Laporte: granting #62 Stipulation. (shyS, COURT STAFF) (Filed on 1/31/2018)

January 26, 2018

Filing 62 STIPULATION WITH PROPOSED ORDER for Entry of Protective Order filed by Plexxikon Inc.. (Attachments: #1 Proposed Order)(Woodworth, Eddie) (Filed on 1/26/2018) Modified on 1/29/2018 (vlkS, COURT STAFF).

January 25, 2018

Filing 61 AMENDED ANSWER to Second #55 Amended Complaint, byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/25/2018)

January 9, 2018

Filing 60 JOINT STATUS REPORT by Plexxikon Inc.. (Wilson, Jeffrey) (Filed on 1/9/2018) Modified on 1/10/2018 (vlkS, COURT STAFF).

January 9, 2018

Filing 59 ORDER by Hon. Haywood S. Gilliam, Jr. DIRECTING the parties to file a joint status report of no more than two pages indicating when they anticipate the mediation in this case will occur. The parties shall file their joint status report by January 16, 2017. If a mediation date is scheduled before the status report is due, the parties may simply report the date once set. (This is a text-only entry generated by the court. There is no document associated with this entry.)(hsglc1S, COURT STAFF) (Filed on 1/9/2018)

January 4, 2018

Filing 58 ANSWER to #55 Second Amended Complaint by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 1/4/2018) Modified on 1/5/2018 (cjlS, COURT STAFF).

December 22, 2017

Filing 57 SCHEDULING ORDER: Motions due by 6/1/2018; Responses due by 6/15/2018; Replies due by 6/22/2018; Tutorial Hearing set for 7/6/2018 10:00 AM; Claims Construction Hearing set for 7/13/2018 02:00 PM. Signed by Judge Haywood S. Gilliam, Jr. on 12/22/2017. (ndrS, COURT STAFF) (Filed on 12/22/2017)

December 20, 2017

Filing 55 Second AMENDED COMPLAINT against All Defendants. Filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G)(Wilson, Jeffrey) (Filed on 12/20/2017) Modified on 12/21/2017 (vlkS, COURT STAFF).

December 19, 2017

Filing 56 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Further Case Management Conference held on 12/19/2017. FTR Time: 2:05-2:12.Total Time in Court: 7 Minutes. Plaintiff Attorney: Clement Roberts. Defendant Attorney: Thomas Steindler. The Court adopts the dates proposed by the parties in their joint case management conference statement through claim construction. Parties orally stipulate to the filing of an amended complaint by 5:00 p.m. on December 20, 2017. Parties are directed to e-file a joint status report once a mediator has been selected. Written scheduling order to issue. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 12/19/2017)

December 12, 2017

Filing 54 REVISED JOINT CASE MANAGEMENT STATEMENT filed by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Krishnapriyan, Raghav) (Filed on 12/12/2017) Modified on 12/12/2017 (vlkS, COURT STAFF).

December 7, 2017

Filing 53 ORDER by Judge Haywood S. Gilliam, Jr. DENYING DEFENDANTS VENUE-RELATED ( #33 , #37 ) MOTIONS. Case Management Statement due by 12/12/2017; Case Management Conference set for 12/19/2017 02:00 PM. (ndrS, COURT STAFF) (Filed on 12/7/2017)

December 5, 2017

Filing 52 ORDER by Judge Haywood S. Gilliam, Jr. Granting #47 Motion for Pro Hac Vice as to Eddie D. Woodworth. (ndrS, COURT STAFF) (Filed on 12/5/2017)

November 28, 2017

Filing 51 Minute Entry for proceedings held before Judge Haywood S. Gilliam, Jr.: Initial Case Management Conference held on 11/28/2017. FTR Time: 2:31-2:37. Total Time in Court: 6 Minutes. Plaintiff Attorney: Daralyn Durie. Defendant Attorney: Thomas Steindler. Hearings on Defendant's motion to dismiss or transfer and motion to transfer (docket nos. #33 and #37 ) are advanced to December 12, 2017 at 10:00 a.m. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Date Filed: 11/28/2017)

November 24, 2017

Filing 50 REPLY (re #37 MOTION to Transfer Case ) filed byNovartis Pharmaceuticals Corporation. (Attachments: #1 Declaration Mlaver Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Steindler, Thomas) (Filed on 11/24/2017)

November 21, 2017

Filing 49 JOINT CASE MANAGEMENT STATEMENT filed by Plexxikon Inc., Novartis Pharmaceuticals Corporation. (Wilson, Jeffrey) (Filed on 11/21/2017) Modified on 11/22/2017 (cpS, COURT STAFF).

November 16, 2017

Filing 48 OPPOSITION/RESPONSE (re #37 MOTION to Transfer Case ) filed by Plexxikon Inc.. (Attachments: #1 Declaration of Robert Bernstein, #2 Declaration of Raghav Krishnapriyan, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9)(Krishnapriyan, Raghav) (Filed on 11/16/2017) Modified on 11/17/2017 (vlkS, COURT STAFF).

November 16, 2017

Filing 47 MOTION for leave to appear in Pro Hac Vice - Eddie D. Woodworth ( Filing fee $ 310, receipt number 0971-11881872.) filed by Plexxikon Inc.. (Attachments: #1 Certificate of Good Standing)(Woodworth, Eddie) (Filed on 11/16/2017)

November 15, 2017

Filing 46 ORDER by Judge Haywood S. Gilliam, Jr. Granting #45 Stipulation selecting Private ADR. (ndrS, COURT STAFF) (Filed on 11/15/2017)

November 14, 2017

Filing 45 STIPULATION and Proposed Order selecting Private ADR by Plexxikon Inc. filed by Plexxikon Inc.. (Krishnapriyan, Raghav) (Filed on 11/14/2017)

November 13, 2017

Filing 44 ADR Clerk's Notice re: Non-Compliance with Court Order (ewh, COURT STAFF) (Filed on 11/13/2017)

November 7, 2017

Filing 43 ADR Certification (ADR L.R. 3-5 b) of discussion of ADR options (Krishnapriyan, Raghav) (Filed on 11/7/2017)

November 7, 2017

Filing 42 ADR Certification (ADR L.R. 3-5 b) of discussion of ADR options (Steindler, Thomas) (Filed on 11/7/2017)

November 3, 2017

Filing 41 ORDER by Judge Haywood S. Gilliam, Jr. Granting #38 Administrative Motion to Consolidate Hearings on Venue-Related Motions. (ndrS, COURT STAFF) (Filed on 11/3/2017)

November 3, 2017

Reset Hearings as to #33 MOTION to Dismiss MOTION to Transfer Case Pursuant to docket no. #41 : Motion Hearing set for 1/25/2018 02:00 PM before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 11/3/2017)

November 2, 2017

Filing 40 AMENDED COMPLAINT against Novartis Pharmaceuticals Corporation. Filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Wilson, Jeffrey) (Filed on 11/2/2017)

November 2, 2017

Filing 39 STIPULATION re #38 Consent ADMINISTRATIVE MOTION to Consolidate Hearings on Venue-Related Motions filed by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 11/2/2017)

November 2, 2017

Filing 38 Consent ADMINISTRATIVE MOTION to Consolidate Hearings on Venue-Related Motions filed by Novartis Pharmaceuticals Corporation. Responses due by 11/6/2017. (Attachments: #1 Proposed Order)(Steindler, Thomas) (Filed on 11/2/2017)

November 2, 2017

Filing 37 MOTION to Transfer Case filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 1/25/2018 02:00 PM in Courtroom 2, 4th Floor, Oakland before Judge Haywood S Gilliam Jr.. Responses due by 11/16/2017. Replies due by 11/24/2017. (Attachments: #1 Affidavit Ferraro Declaration, #2 Proposed Order)(Steindler, Thomas) (Filed on 11/2/2017)

November 2, 2017

Filing 36 REPLY (re #33 MOTION to Dismiss MOTION to Transfer Case ) filed byNovartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 11/2/2017)

October 26, 2017

Filing 35 OPPOSITION/RESPONSE (re #33 MOTION to Dismiss MOTION to Transfer Case ) filed by Plexxikon Inc.. (Attachments: #1 Declaration of Raghav Krishnapriyan, #2 Exhibit A)(Krishnapriyan, Raghav) (Filed on 10/26/2017) Modified on 10/27/2017 (vlkS, COURT STAFF).

October 19, 2017

Filing 34 Certificate of Interested Entities by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 10/19/2017)

October 12, 2017

Filing 33 MOTION to Dismiss , MOTION to Transfer Case filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 11/30/2017 02:00 PM in Courtroom 2, 4th Floor, Oakland before Judge Haywood S Gilliam Jr.. Responses due by 10/26/2017. Replies due by 11/2/2017. (Attachments: #1 Declaration, #2 Proposed Order)(Steindler, Thomas) (Filed on 10/12/2017)

September 18, 2017

Filing 32 ORDER by Judge Haywood S. Gilliam, Jr. Granting #31 Motion for Pro Hac Vice as to Mlaver, David. (ndrS, COURT STAFF) (Filed on 9/18/2017)

September 18, 2017

Filing 31 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 310, receipt number 0971-11724612.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Certificate of Good Standing, #2 Proposed Order)(Mlaver, David) (Filed on 9/18/2017)

September 18, 2017

Filing 30 ORDER by Judge Haywood S. Gilliam, Jr. Granting #29 Motion to Continue Case Management Conference. Case Management Statement due by 11/21/2017; Case Management Conference set for 11/28/2017 02:00 PM. (ndrS, COURT STAFF) (Filed on 9/18/2017)

September 18, 2017

Filing 29 Joint MOTION to Continue Case Mangement Conference filed by Novartis Pharmaceuticals Corporation. (Steindler, Thomas) (Filed on 9/18/2017)

September 14, 2017

Filing 28 ORDER by Judge Haywood S. Gilliam, Jr. Granting #19 Motion for Pro Hac Vice as to Clouse, Katherine. (ndrS, COURT STAFF) (Filed on 9/14/2017)

September 14, 2017

Filing 27 ORDER by Judge Haywood S. Gilliam, Jr. Granting #18 Motion for Pro Hac Vice as to Steindler, Thomas. (ndrS, COURT STAFF) (Filed on 9/14/2017)

September 13, 2017

Filing 26 ORDER Re Discovery Procedures by Magistrate Judge Elizabeth D. Laporte. (shyS, COURT STAFF) (Filed on 9/13/2017)

September 13, 2017

CASE REFERRED to Magistrate Judge Elizabeth D. Laporte for Discovery (ahm, COURT STAFF) (Filed on 9/13/2017)

September 12, 2017

Filing 25 ORDER REFERRING CASE to Magistrate Judge for Discovery purposes. Signed by Judge Haywood S. Gilliam, Jr. on 9/12/2017. (ndrS, COURT STAFF) (Filed on 9/12/2017)

September 11, 2017

Filing 24 STIPULATION re #16 Summons Returned Executed [For Extension to Respond to Complaint] filed by Novartis Pharmaceuticals Corporation. (Gaede, William) (Filed on 9/11/2017)

September 11, 2017

Filing 23 CLERK'S NOTICE SETTING CASE MANAGEMENT CONFERENCE FOR REASSIGNED CIVIL CASE. Notice is hereby given that a Case Management Conference has been set for November 7, 2017, before Judge Haywood S. Gilliam, Jr., at 2:00 p.m., in Courtroom 2, 4th Floor, 1301 Clay Street, Oakland, CA. Case Management Statement due by October 31, 2017. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ndrS, COURT STAFF) (Filed on 9/11/2017)

September 11, 2017

Filing 22 ORDER REASSIGNING CASE. Case reassigned to Hon. Haywood S Gilliam, Jr for all further proceedings. Magistrate Judge Howard R. Lloyd no longer assigned to the case. Reassignment Order signed by Executive committee on 9/11/2017. (Attachments: ATTACHED IN ERROR. DISREGARD.#1 Notice of Eligibioity for Video Recording)(bwS, COURT STAFF) (Filed on 9/11/2017) Modified on 9/12/2017 (vlkS, COURT STAFF).

September 8, 2017

Filing 21 CLERK'S NOTICE OF IMPENDING REASSIGNMENT TO A U.S. DISTRICT COURT JUDGE: The Clerk of this Court will now randomly reassign this case to a District Judge because either (1) a party has not consented to the jurisdiction of a Magistrate Judge, or (2) time is of the essence in deciding a pending judicial action for which the necessary consents to Magistrate Judge jurisdiction have not been secured. You will be informed by separate notice of the district judge to whom this case is reassigned. ALL HEARING DATES PRESENTLY SCHEDULED BEFORE THE CURRENT MAGISTRATE JUDGE ARE VACATED AND SHOULD BE RE-NOTICED FOR HEARING BEFORE THE JUDGE TO WHOM THIS CASE IS REASSIGNED. This is a text only docket entry; there is no document associated with this notice. (pmc, COURT STAFF) (Filed on 9/8/2017)

September 8, 2017

Filing 20 CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by Plexxikon Inc... (Krishnapriyan, Raghav) (Filed on 9/8/2017)

September 6, 2017

Filing 19 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 310, receipt number 0971-11693802.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Certificate of Good Standing, #2 Proposed Order)(Clouse, Katherine) (Filed on 9/6/2017)

September 6, 2017

Filing 18 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 310, receipt number 0971-11693746.) filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A - Certificate of Good Standing, #2 Proposed Order)(Steindler, Thomas) (Filed on 9/6/2017)

September 6, 2017

Filing 17 NOTICE of Appearance by William G. Gaede, III (Gaede, William) (Filed on 9/6/2017)

August 28, 2017

Filing 16 SUMMONS Returned Executed by Plexxikon Inc.. Novartis Pharmaceuticals Corporation served on 8/22/2017, answer due 9/12/2017. (Durie, Daralyn) (Filed on 8/28/2017)

August 28, 2017

Electronic filing error. Incorrect event used. [err101]Please re-file in its entirety using correct event Summons Returned Executed. Re: #14 Certificate of Service filed by Plexxikon Inc. (dhmS, COURT STAFF) (Filed on 8/28/2017)

August 25, 2017

Filing 15 CLERK'S NOTICE Re: Consent or Declination: Plaintiffs/Defendants shall file a consent or declination to proceed before a magistrate judge. Consent/Declination due by 9/8/2017. Note that any party is free to withhold consent to proceed before a magistrate judge without adverse substantive consequences. The forms are available at: http://cand.uscourts.gov/civilforms. (pmc, COURT STAFF) (Filed on 8/25/2017)

August 25, 2017

Filing 14 ***INCORRECT EVENT SELECTED WHEN POSTING DOCUMENT*** CERTIFICATE OF SERVICE by Plexxikon Inc. re #1 Complaint, #10 Summons Issued (Durie, Daralyn) (Filed on 8/25/2017) Modified text on 8/28/2017 (dhmS, COURT STAFF).

August 21, 2017

Filing 13 Order by Magistrate Judge Howard R. Lloyd granting #12 Motion for Pro Hac Vice. (hrllc3S, COURT STAFF) (Filed on 8/21/2017)

August 18, 2017

Filing 12 MOTION for leave to appear in Pro Hac Vice - Jeffrey D. Wilson ( Filing fee $ 310, receipt number 0971-11642620.) filed by Plexxikon Inc.. (Attachments: #1 Certificate of Good Standing)(Wilson, Jeffrey) (Filed on 8/18/2017)

August 4, 2017

Filing 11 REPORT on the filing or determination of an action regarding patent infringement (cc: form mailed to register). (dhmS, COURT STAFF) (Filed on 8/4/2017)

August 4, 2017

Filing 10 Summons Issued as to Novartis Pharmaceuticals Corporation. (dhmS, COURT STAFF) (Filed on 8/4/2017)

August 4, 2017

Filing 8 NOTICE of Appearance by Andrew R Basile (Basile, Andrew) (Filed on 8/4/2017)

August 3, 2017

Filing 9 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 10/31/2017. Initial Case Management Conference set for 11/7/2017 01:30 PM in Courtroom 2, 5th Floor, San Jose. (dhmS, COURT STAFF) (Filed on 8/3/2017)

August 3, 2017

Filing 7 NOTICE of Appearance by Raghav R. Krishnapriyan (Krishnapriyan, Raghav) (Filed on 8/3/2017)

August 3, 2017

Filing 6 NOTICE of Appearance by Clement S. Roberts (Roberts, Clement) (Filed on 8/3/2017)

August 3, 2017

Filing 5 NOTICE of Appearance by Daralyn J. Durie (Durie, Daralyn) (Filed on 8/3/2017)

August 3, 2017

Filing 4 Certificate of Interested Entities by Plexxikon Inc. identifying Corporate Parent Daiichi Sankyo Co., Ltd., Corporate Parent Daiichi Sankyo US Holdings Inc for Plexxikon Inc.. (Durie, Daralyn) (Filed on 8/3/2017)

August 3, 2017

Filing 3 Proposed Summons. (Durie, Daralyn) (Filed on 8/3/2017)

August 3, 2017

Filing 2 Case assigned to Magistrate Judge Howard R. Lloyd. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 8/17/2017. (as, COURT STAFF) (Filed on 8/3/2017)

August 3, 2017

Filing 1 COMPLAINT for Patent Infringement against Novartis Pharmaceuticals Corporation ( Filing fee $ 400, receipt number 0971-11600499.). Filed byPlexxikon Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(Durie, Daralyn) (Filed on 8/3/2017)

Search for this case: Plexxikon Inc. v. Novartis Pharmaceuticals Corporation
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Web	[ Unicourt \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Novartis Pharmaceuticals Corporation
Represented By:	Thomas P. Steindler
Represented By:	William G. Gaede, III
Represented By:	David Mlaver
Represented By:	Ian Barnett Brooks
Represented By:	Jennifer Butler Routh
Represented By:	Katherine Nicole Clouse
Represented By:	Michael S. Nadel
Represented By:	Nicole Marie Jantzi
Represented By:	Paul M. Schoenhard
Represented By:	Sarah Chapin Columbia
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: Plexxikon Inc.
Represented By:	Andrew R Basile
Represented By:	Andrew Treloar Jones
Represented By:	Clement S. Roberts
Represented By:	David Floyd McGowan
Represented By:	E. Joshua Rosenkranz
Represented By:	Eddie Dean Woodworth
Represented By:	Elizabeth R Moulton
Represented By:	Eugene Novikov
Represented By:	Hannah Jiam
Represented By:	Jeffrey D. Wilson
Represented By:	Katherine E. McNutt
Represented By:	Daralyn J. Durie
Represented By:	Kira A. Davis
Represented By:	Laura Elizabeth Miller
Represented By:	Matthew Walter Samuels
Represented By:	Raghav R. Krishnapriyan
Represented By:	Ryan T McCleary
Represented By:	Stephen J Elkind
Represented By:	Victoria Leigh Weatherford
Represented By:	Whitney Rose O'Byrne
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
3rd party defendant: GlaxoSmithKline PLC
Represented By:	William Rolland Zimmerman
Represented By:	Nathanael R Luman
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
3rd party defendant: GlaxoSmithKline LLC
Represented By:	William Rolland Zimmerman
Represented By:	Nathanael R Luman
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]